Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
cytoplasmic translation (GO:0002181),78/93,1.44E-100,3.88E-97,0,0,167.0402662,38401.96581,RPL4;EIF4A1;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPL7A;RPS14;RPS17;RPS16;RPL18A;RPS18;RPL36;RPL35;RPL38;RPL37;RPS11;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;ETF1;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;GSPT1;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS26;RPS25;EIF3M;RPS28;RPS29;EIF3I;RPL27A;RPL22L1;RPS20;RPS21;RPS24;RPS23
cotranslational protein targeting to membrane (GO:0006613),78/94,8.19E-100,1.11E-96,0,0,156.5921381,35727.37834,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPL7A;RPS14;SEC61A1;RPS17;RPS16;RPL18A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;SEC62;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;SSR2;RPL22;RPS6;RPL13A;RPS3A;RPSA;SRP9;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RPL14;RPS3;RPL13;SSR1;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS29;RPL27A;RPS20;RPS21;RPS24;RPS23
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),76/90,1.87E-98,1.69E-95,0,0,173.8133144,39112.50367,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPL7A;RPS14;SEC61A1;RPS17;RPS16;RPL18A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;SEC61B;RPS11;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;RPS3A;RPSA;SRP9;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS29;RPL27A;RPS20;RPS21;RPS24;RPS23
protein targeting to ER (GO:0045047),78/103,7.68E-94,5.19E-91,0,0,100.1722463,21477.3158,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;SEC61A1;RPS17;RPS16;RPL18A;RPS18;SEC61G;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;SEC62;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;RPSA;RPS3A;SRP9;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS28;SPCS1;RPS29;RPL27A;RPS20;RPS21;RPS24;RPS23
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",80/113,3.50E-92,1.89E-89,0,0,78.06141549,16438.50707,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS17;RPS16;RPL18A;PPP2R1A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;ETF1;RPL26;PABPC1;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;GSPT1;PPP2CA;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS29;RPL27A;RPS20;EIF3E;RPS21;RPS24;EIF4G1;RPS23
nuclear-transcribed mRNA catabolic process (GO:0000956),82/171,2.60E-74,1.17E-71,0,0,29.68068808,5028.944497,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS17;RPS16;RPL18A;PPP2R1A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;RPSA;RPS3A;CSDE1;RPL37A;RPL24;RPL27;ETF1;RPL26;PABPC1;RPL29;RPL28;UBA52;DDX5;RPL10;RPL12;RPL11;RPL36A;GSPT1;PPP2CA;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS29;RPL27A;RPS20;EIF3E;RPS21;RPS24;EIF4G1;RPS23
peptide biosynthetic process (GO:0043043),80/162,8.08E-74,2.84E-71,0,0,31.33515208,5273.767316,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;MRPL42;RPL7A;RPS17;RPS16;RPL18A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;MRPS21;RPL13A;RPSA;RPS3A;EEF1A1;MRPL52;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;RPL10;RPL12;RPL11;RPL36A;RRBP1;GSPT1;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;MRPL23;RPS26;RPS25;RPS28;RPS29;RPL27A;RPS20;RPS21;RPS24;EIF4G1;RPS23
translation (GO:0006412),89/214,8.42E-74,2.84E-71,0,0,23.16534237,3897.826015,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;EEF1B2;RPS4X;RPS14;MRPL42;RPL7A;RPS17;RPS16;RPL18A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;MRPS21;RPL13A;RPSA;RPS3A;MRPL52;EEF1A1;EEF1G;PPA1;EEF1D;RPL37A;RPL24;RPL27;ETF1;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RRBP1;GSPT1;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;NDUFA7;RPL35A;RPL23A;MRPL23;EEF2;RPS26;RPS25;RPS28;RPS29;RPL27A;RPS20;RPL22L1;RPS21;RPS24;RPS23;EIF4G1
aerobic electron transport chain (GO:0019646),55/70,7.98E-68,2.40E-65,0,0,113.4433761,17526.85299,COX7B;NDUFA13;NDUFA11;NDUFA12;COX4I1;NDUFA10;COX6A1;COX7C;UQCRFS1;COX8A;NDUFC2;NDUFC1;SDHC;SDHD;SDHA;COX6B1;NDUFS7;NDUFS6;NDUFS5;NDUFS4;UQCRC1;NDUFS2;UQCRC2;NDUFB9;NDUFB8;NDUFB10;NDUFB6;UQCRB;NDUFB11;NDUFB5;NDUFB4;NDUFB3;NDUFB2;UQCR11;UQCR10;COX5B;COX5A;UQCRH;CYC1;NDUFV3;NDUFV2;NDUFV1;NDUFA9;NDUFA8;NDUFA7;NDUFA6;NDUFA5;NDUFA4;NDUFA3;NDUFA2;NDUFA1;COX6C;UQCRQ;NDUFAB1;CYCS
mitochondrial ATP synthesis coupled electron transport (GO:0042775),55/71,3.43E-67,9.27E-65,0,0,106.3476563,16275.40417,COX7B;NDUFA13;NDUFA11;NDUFA12;COX4I1;NDUFA10;COX6A1;COX7C;UQCRFS1;COX8A;NDUFC2;NDUFC1;SDHC;SDHD;SDHA;COX6B1;NDUFS7;NDUFS6;NDUFS5;NDUFS4;UQCRC1;NDUFS2;UQCRC2;NDUFB9;NDUFB8;NDUFB10;NDUFB6;UQCRB;NDUFB11;NDUFB5;NDUFB4;NDUFB3;NDUFB2;UQCR11;UQCR10;COX5B;COX5A;UQCRH;CYC1;NDUFV3;NDUFV2;NDUFV1;NDUFA9;NDUFA8;NDUFA7;NDUFA6;NDUFA5;NDUFA4;NDUFA3;NDUFA2;NDUFA1;COX6C;UQCRQ;NDUFAB1;CYCS
cellular macromolecule biosynthetic process (GO:0034645),93/314,1.93E-61,4.73E-59,0,0,13.71596683,1917.522507,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;PTMS;RPS15;EEF1B2;RPS4X;RPS14;MRPL42;RPL7A;RPS17;RPS16;RPL18A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;MRPS21;RPL13A;RPSA;RPS3A;MRPL52;EEF1A1;EEF1G;EEF1D;RPL37A;RPL24;RPL27;RPL26;TOP1;RPL29;RPL28;PTMA;SET;RPL10;RPL12;RPL11;RPL36A;RRBP1;GSPT1;TBRG1;RPL14;RPS3;RPL13;POLR2F;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;POLR2L;RPL41;RPL35A;RPL23A;MRPL23;EEF2;RPS26;RPS25;RPS28;GOLPH3;RPS29;RPL27A;RPS20;RPS21;RPS24;EIF4G2;RPS23;EIF4G1
gene expression (GO:0010467),94/356,4.04E-57,9.09E-55,0,0,11.68882364,1517.815595,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;HNRNPU;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;MRPL42;RPL7A;RPS17;RPS16;RPL18A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS10;RPS13;RPS12;SEC13;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;MRPS21;RPL13A;RPSA;RPS3A;THOC7;MRPL52;EEF1A1;RPL37A;RPL24;SRSF3;RPL27;RPL26;SRSF5;RPL29;RPL28;PTMA;RPL10;RPL12;RPL11;RPL36A;RRBP1;GSPT1;HSPD1;RPL14;RPS3;RPL13;POLR2F;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;POLR2L;RPL41;ALYREF;RPL35A;RPL23A;MRPL23;RPS26;RPS25;RPS28;GOLPH3;HNRNPK;RPS29;RPL27A;HNRNPA2B1;RPS20;STUB1;RPS21;RPS24;RPS23;EIF4G1
cellular protein metabolic process (GO:0044267),96/417,1.73E-52,3.59E-50,0,0,9.746557445,1161.665916,RPL4;RPL5;APP;RPL3;RPL32;RPL31;RPLP1;RPLP0;UBE2D3;RPL8;RPL10A;RPL9;RPL6;RPL7;UBE2L3;RPS15;RPS4X;MRPL42;UBL5;RPL7A;RPS14;RPS17;RPS16;RPL18A;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS10;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;MRPS21;RPSA;RPS3A;PDIA6;MRPL52;EEF1A1;FDX1;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPN2;RPL10;RPL12;RPN1;RPL11;RPL36A;NEDD8;RRBP1;GSPT1;HSP90B1;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;MRPL23;RPS26;RPS25;RPS28;SPCS1;RPS29;UBE2S;RPL27A;NUCB1;RPS20;P4HB;RPS21;RPS24;EIF4G1;RPS23;UBE2M
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",33/39,4.12E-43,7.94E-41,0,0,164.4465944,16049.40381,NDUFB9;NDUFA13;NDUFB8;NDUFA11;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;NDUFB4;NDUFA10;NDUFB3;NDUFB2;NDUFV3;NDUFV2;NDUFV1;NDUFA9;NDUFA8;NDUFA7;NDUFA6;NDUFA5;NDUFA4;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;NDUFS7;NDUFS6;NDUFS5;NDUFAB1;NDUFS4;NDUFS2
rRNA metabolic process (GO:0016072),56/162,3.06E-41,5.52E-39,0,0,16.29425482,1520.025688,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS14;RPL7A;RPS17;RPS16;RPL18A;RPL36;RPL35;RPLP2;RPL38;RPL37;RPL39;RPS9;RPL21;RPS7;RPL23;RPL22;RPS6;RPL13A;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RPL14;RPL13;RPL15;RPS2;RPL18;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS28;RPL27A;RPS24
rRNA processing (GO:0006364),57/173,1.25E-40,2.11E-38,0,0,15.17192871,1393.979852,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS14;RPL7A;RPS17;RPS16;RPL18A;RPL36;RPL35;RPLP2;RPL38;RPL37;RPL39;RPS9;RPL21;RPS7;RPL23;RPL22;RPS6;RPL13A;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RPL14;RPL13;RPL15;RPS2;RPL18;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS28;EIF6;RPL27A;RPS24
ribosome biogenesis (GO:0042254),59/192,4.63E-40,7.35E-38,0,0,13.72898375,1243.456072,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS14;RPL7A;RPS17;RPS16;RPL18A;RPL36;RPL35;RPLP2;RPL38;RPL37;RPL39;RPS9;RPL21;RPS7;RPL23;RPL22;RPS6;RPL13A;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RPL14;RPL13;RPL15;RPS2;RPL18;RPL17;RPL19;RPL41;NPM1;RPL35A;RPL23A;RPS25;RPS28;EIF6;RPL27A;RPS24;RAN
ncRNA processing (GO:0034470),58/201,1.10E-37,1.65E-35,0,0,12.525748,1065.950457,RPL4;RPL5;RPL3;RPL32;RPL31;RPLP1;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS14;RPL7A;RPS17;RPS16;RPL18A;RPL36;RPL35;RPLP2;RPL38;RPL37;RPL39;RPS9;RPL21;RPS7;RPL23;RPL22;RPS6;RPL13A;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RPL14;RPL13;RPL15;RPS2;RPL18;RPL17;RPL19;RPL41;SSB;RPL35A;RPL23A;RPS25;RPS28;RPL27A;HNRNPA2B1;RPS24
mitochondrial respiratory chain complex I assembly (GO:0032981),32/58,4.56E-32,6.16E-30,0,0,36.70431578,2648.768674,NDUFB9;NDUFA13;NDUFB8;NDUFA11;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;NDUFB4;NDUFA10;NDUFB3;NDUFB2;NDUFV3;NDUFV2;NDUFV1;NDUFA9;NDUFA8;NDUFA7;NDUFA6;NDUFA5;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;NDUFS7;NDUFS6;NDUFS5;NDUFS4;NDUFAB1;NDUFS2
NADH dehydrogenase complex assembly (GO:0010257),32/58,4.56E-32,6.16E-30,0,0,36.70431578,2648.768674,NDUFB9;NDUFA13;NDUFB8;NDUFA11;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;NDUFB4;NDUFA10;NDUFB3;NDUFB2;NDUFV3;NDUFV2;NDUFV1;NDUFA9;NDUFA8;NDUFA7;NDUFA6;NDUFA5;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;NDUFS7;NDUFS6;NDUFS5;NDUFS4;NDUFAB1;NDUFS2
mitochondrial respiratory chain complex assembly (GO:0033108),33/90,1.05E-25,1.35E-23,0,0,17.26446146,993.0067672,NDUFB9;NDUFA13;NDUFB8;NDUFA11;NDUFB10;NDUFB6;NDUFA12;NDUFB11;NDUFB5;NDUFB4;NDUFA10;NDUFB3;NDUFB2;UQCRFS1;NDUFV3;NDUFV2;NDUFV1;NDUFA9;NDUFA8;NDUFA7;NDUFA6;NDUFA5;NDUFA3;NDUFA2;NDUFA1;NDUFC2;NDUFC1;NDUFS7;NDUFS6;NDUFS5;NDUFS4;NDUFAB1;NDUFS2
pre-replicative complex assembly (GO:0036388),26/64,7.07E-22,8.68E-20,0,0,20.20464254,983.9954821,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBA52
regulation of mRNA stability (GO:0043488),36/146,3.08E-21,3.62E-19,0,0,9.777972572,461.8003355,PSMD11;SET;YWHAB;HNRNPU;YBX1;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;UBB;PSMB2;PSMB3;PSMD2;UBC;PSMB1;PSMD1;RPS27A;HSPA8;NPM1;YWHAZ;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;SERBP1;PABPC1;UBA52;EIF4G1
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),27/75,5.12E-21,5.76E-19,0,0,16.62739647,776.8516403,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBA52
regulation of mRNA catabolic process (GO:0061013),33/122,6.16E-21,6.65E-19,0,0,11.03864751,513.7014924,PSMD11;SET;YWHAB;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;UBB;PSMB2;PSMB3;PSMD2;UBC;PSMB1;PSMD1;RPS27A;HSPA8;YWHAZ;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;SERBP1;PABPC1;UBA52;EIF4G1
regulation of cellular amine metabolic process (GO:0033238),23/51,9.04E-21,9.39E-19,0,0,24.15826437,1114.978872,PSMD11;OAZ1;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
anaphase-promoting complex-dependent catabolic process (GO:0031145),28/84,1.08E-20,1.08E-18,0,0,14.79646697,680.2894499,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBE2S;ANAPC5;UBA52
interleukin-1-mediated signaling pathway (GO:0070498),29/94,2.57E-20,2.48E-18,0,0,13.21713609,596.1900241,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBE2N;SQSTM1;UBA52
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),28/87,3.19E-20,2.97E-18,0,0,14.04191726,630.3490981,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBA52;ATF4
regulation of cellular amino acid metabolic process (GO:0006521),23/54,4.53E-20,4.08E-18,0,0,21.81697482,971.74749,PSMD11;OAZ1;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
cellular response to hypoxia (GO:0071456),33/131,6.94E-20,6.05E-18,0,0,10.02020282,442.0371995,PSMD11;HP1BP3;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;UBB;PSMB2;FAM162A;PSMB3;PSMD2;UBC;LMNA;PSMB1;PGK1;PSMD1;RPS27A;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;STUB1;P4HB;UBA52
negative regulation of cell cycle G2/M phase transition (GO:1902750),23/57,2.01E-19,1.70E-17,0,0,19.88885402,856.2069837,PSMD11;PSMA7;RBX1;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",27/85,2.23E-19,1.83E-17,0,0,13.75346414,590.6714872,PSMD11;PSMA7;PSMD8;CDC42;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;AP2S1;PSMD1;RAC1;AP2M1;RHOA;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2
ribonucleoprotein complex assembly (GO:0022618),33/136,2.43E-19,1.93E-17,0,0,9.531305419,408.51699,RPL5;RPL3;HSP90AB1;RPL10;DDX1;RPLP0;RPL11;RPS27L;RPL6;RPS15;RPS14;MRPL20;SNRPD2;PUF60;EIF4H;RPL38;TXNL4A;EIF4B;HSP90AA1;RPS5;PTGES3;RPSA;RPL23A;EIF2S2;RPS28;EIF5;EIF6;RPL24;STRAP;SNRPF;SRSF5;EIF3A;SNRPB
regulation of establishment of planar polarity (GO:0090175),27/88,6.18E-19,4.77E-17,0,0,13.07502766,548.2124291,PSMD11;PSMA7;PSMD8;CDC42;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;AP2S1;PSMD1;RAC1;AP2M1;RHOA;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2
regulation of cellular ketone metabolic process (GO:0010565),23/64,4.45E-18,3.34E-16,0,0,16.48720999,658.7338193,PSMD11;OAZ1;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",24/73,9.12E-18,6.66E-16,0,0,14.4112167,565.4324967,PDIA3;PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1;CALR
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),23/66,9.91E-18,7.04E-16,0,0,15.71873227,615.4347284,PSMD11;PSMA7;RBX1;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
non-canonical Wnt signaling pathway (GO:0035567),30/124,1.16E-17,8.03E-16,0,0,9.454971642,368.7007344,PSMD11;PSMA7;PSMD8;CDC42;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;AP2S1;PSMD1;RAC1;AP2M1;RHOA;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;GNB1;CTNNB1;CALM1
regulation of mitotic cell cycle phase transition (GO:1901990),36/188,2.24E-17,1.51E-15,0,0,7.060694115,270.6866254,YWHAE;PSMD11;DCTN2;DCTN3;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;UBB;PSMB2;PPP2R1A;PSMB3;PSMD2;UBC;PSMB1;PSMD1;RPS27A;HSP90AA1;DYNLL1;TUBB4B;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;UBE2S;PSMA2;ANAPC5;UBA52
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),24/78,5.19E-17,3.42E-15,0,0,13.07345208,490.2145156,PDIA3;PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1;CALR
protein-DNA complex assembly (GO:0065004),31/143,9.65E-17,6.20E-15,0,0,8.204902447,302.5734291,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;UBB;PSMB2;PSMB3;PSMD2;UBC;PSMB1;PSMD1;RPS27A;NPM1;SMARCA5;RBX1;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;ANP32B;UBA52
neutrophil degranulation (GO:0043312),57/481,1.72E-16,1.08E-14,0,0,4.084242098,148.2528568,HSP90AB1;DDX3X;HMGB1;PSMD7;LAMP1;PSMD2;FTH1;LAMP2;PSMD1;RAC1;CTSB;CCT2;HSP90AA1;PGAM1;ATP6AP2;NME2;NDUFC2;MIF;DYNLL1;DDOST;RHOA;PSMA5;EEF1A1;PSMA2;TMBIM1;CSNK2B;ALDOA;ATP6V0C;PPIA;CD63;CSTB;VCP;PSMD11;BRI3;GSTP1;COPB1;PSMB7;PGRMC1;CYB5R3;PSMB1;CCT8;RAB6A;S100A11;HSPA8;SURF4;PDAP1;PA2G4;TUBB4B;EEF2;PRDX6;RAB10;ERP44;PSMC3;RAB14;VAPA;RAB18;LAMTOR2
neutrophil activation involved in immune response (GO:0002283),57/485,2.50E-16,1.54E-14,0,0,4.045215164,145.3183292,HSP90AB1;DDX3X;HMGB1;PSMD7;LAMP1;PSMD2;FTH1;LAMP2;PSMD1;RAC1;CTSB;CCT2;HSP90AA1;PGAM1;ATP6AP2;NME2;NDUFC2;MIF;DYNLL1;DDOST;RHOA;PSMA5;EEF1A1;PSMA2;TMBIM1;CSNK2B;ALDOA;ATP6V0C;PPIA;CD63;CSTB;VCP;PSMD11;BRI3;GSTP1;COPB1;PSMB7;PGRMC1;CYB5R3;PSMB1;CCT8;RAB6A;S100A11;HSPA8;SURF4;PDAP1;PA2G4;TUBB4B;EEF2;PRDX6;RAB10;ERP44;PSMC3;RAB14;VAPA;RAB18;LAMTOR2
neutrophil mediated immunity (GO:0002446),57/488,3.31E-16,1.95E-14,0,0,4.016420349,143.165216,HSP90AB1;DDX3X;HMGB1;PSMD7;LAMP1;PSMD2;FTH1;LAMP2;PSMD1;RAC1;CTSB;CCT2;HSP90AA1;PGAM1;ATP6AP2;NME2;NDUFC2;MIF;DYNLL1;DDOST;RHOA;PSMA5;EEF1A1;PSMA2;TMBIM1;CSNK2B;ALDOA;ATP6V0C;PPIA;CD63;CSTB;VCP;PSMD11;BRI3;GSTP1;COPB1;PSMB7;PGRMC1;CYB5R3;PSMB1;CCT8;RAB6A;S100A11;HSPA8;SURF4;PDAP1;PA2G4;TUBB4B;EEF2;PRDX6;RAB10;ERP44;PSMC3;RAB14;VAPA;RAB18;LAMTOR2
regulation of G2/M transition of mitotic cell cycle (GO:0010389),31/149,3.32E-16,1.95E-14,0,0,7.7852715,277.4846825,YWHAE;PSMD11;DCTN2;DCTN3;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PPP2R1A;PSMB3;PSMD2;PSMB1;PSMD1;HSP90AA1;DYNLL1;TUBB4B;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;CDK4;PSMA2
regulation of cell cycle phase transition (GO:1901987),25/95,7.17E-16,4.12E-14,0,0,10.51277851,366.5911449,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBE2S;ANAPC5
regulation of hematopoietic stem cell differentiation (GO:1902036),22/71,8.89E-16,5.00E-14,0,0,13.17006803,456.4304049,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
NIK/NF-kappaB signaling (GO:0038061),22/74,2.37E-15,1.31E-13,0,0,12.40832455,417.8666506,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
regulation of hematopoietic progenitor cell differentiation (GO:1901532),22/75,3.25E-15,1.75E-13,0,0,12.17357342,406.1230733,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
negative regulation of mitotic cell cycle phase transition (GO:1901991),24/92,3.39E-15,1.80E-13,0,0,10.37431522,345.6415265,PSMD11;PSMA7;RBX1;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;CDK4;PSMD2;PSMB1;PSMD1
regulation of translation (GO:0006417),32/178,8.98E-15,4.66E-13,0,0,6.495733734,210.0970841,APP;RPL5;DDX3X;RPL10;DDX1;RPS27L;YBX1;TOB1;GSPT1;RPS4X;EIF4H;RPS3;EIF4B;NPM1;RPL13A;EEF2;EIF1;EIF5;EIF6;NCL;CAPRIN1;CSDE1;EIF3H;ETF1;EIF3E;RPL26;CALR;EIF3C;GAPDH;EIF4G2;EIF4G1;EIF3B
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),23/89,1.60E-14,8.15E-13,0,0,10.22877402,324.9291964,PSMD11;PSMA7;RBX1;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
ribosome assembly (GO:0042255),18/50,1.88E-14,9.40E-13,0,0,16.414618,518.792532,RPL5;NPM1;DDX3X;RPL3;RPL10;RPS5;RPLP0;RPL11;RPS27L;RPSA;RPL23A;RPL6;RPS15;RPS14;MRPL20;RPS28;EIF6;RPL24
DNA-dependent DNA replication (GO:0006261),27/129,2.36E-14,1.16E-12,0,0,7.80273367,244.8403872,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;UBB;PSMB2;PSMB3;PSMD2;UBC;PSMB1;PSMD1;RPS27A;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;CDK2AP1;UBA52
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),13/22,2.67E-14,1.28E-12,0,0,41.88455122,1309.100175,PSMA7;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMA4;PSMB5;PSMB2;PSMA2;PSMB3;PSMB1
regulation of stem cell differentiation (GO:2000736),23/91,2.70E-14,1.28E-12,0,0,9.926896521,310.151971,PSMD11;HNRNPU;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
cellular response to interleukin-1 (GO:0071347),29/155,5.60E-14,2.61E-12,0,0,6.796764347,207.3976515,PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;UBB;PSMB2;PSMB3;PSMD2;UBC;PSMB1;PSMD1;RPS27A;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBE2N;SQSTM1;UBA52
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),42/321,6.39E-14,2.92E-12,0,0,4.500059081,136.7202838,VCP;UBXN1;PSMD11;UBE2D3;PSMA7;HSP90B1;PSMD8;PCNP;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;SEC61B;UBXN4;RPS27A;HSPA5;RBX1;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBE2S;NEDD4;CTNNB1;ANAPC5;STUB1;UBA52;UBE2K
tumor necrosis factor-mediated signaling pathway (GO:0033209),25/116,1.07E-13,4.80E-12,0,0,8.077931243,241.279074,PSMD11;PSMA7;TXNDC17;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;EIF5A;ACTN4;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",12-Oct,1.18E-13,5.24E-12,0,0,144.387145,4297.763456,UQCRB;UQCRQ;UQCRC1;CYCS;UQCRFS1;UQCR11;CYC1;UQCR10;UQCRC2;UQCRH
cellular respiration (GO:0045333),16/42,1.91E-13,8.34E-12,0,0,17.90927022,524.4574218,UQCRB;NDUFA5;MDH2;ETFA;SDHC;ETFB;UQCR10;SDHA;SDHB;UQCRH;NDUFS7;NDUFS4;UQCRC1;UQCRFS1;CYCS;UQCRC2
Fc-epsilon receptor signaling pathway (GO:0038095),24/111,3.08E-13,1.32E-11,0,0,8.100658068,233.360124,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1;RAC1;CALM1
Fc receptor signaling pathway (GO:0038093),24/112,3.80E-13,1.60E-11,0,0,8.008188758,229.0208942,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1;RAC1;CALM1
proteasomal protein catabolic process (GO:0010498),32/205,5.25E-13,2.18E-11,0,0,5.474229659,154.784202,VCP;UBXN1;PSMD11;UBE2D3;PSMA7;PSMD8;PCNP;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;RBX1;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;NEDD4;CTNNB1;STUB1;UBE2K
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",21/85,5.85E-13,2.39E-11,0,0,9.602892287,270.4849208,NAPA;ARF4;COPB2;TMED9;COPA;TMED10;KDELR1;COPB1;SURF4;COPZ1;ARCN1;GOLPH3;RER1;TMED3;TMED2;KDELR2;ERGIC3;RAB6A;ARF5;ERGIC1;COPE
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",17-Nov,6.55E-13,2.64E-11,0,0,53.01022954,1487.130822,COX8A;COX7B;NDUFA4;COX4I1;CYCS;COX5B;COX6A1;COX6C;COX5A;COX7C;COX6B1
positive regulation of canonical Wnt signaling pathway (GO:0090263),25/130,1.62E-12,6.45E-11,0,0,6.995776904,189.9041057,VCP;PSMD11;DDX3X;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;ATP6AP2;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2
protein stabilization (GO:0050821),29/179,2.51E-12,9.84E-11,0,0,5.70214359,152.3027446,RPL5;HSP90AB1;RPL11;PARK7;PHB;PHB2;RTN4;HSPD1;TBRG1;LAMP1;SUMO1;LAMP2;BAG1;CCT8;CCT7;CCT5;CCT4;CCT3;CCT2;HSP90AA1;RPS7;RPL23;PTGES3;CCT6A;CDC37;TCP1;CALR;PPIB;GAPDH
ribosomal large subunit biogenesis (GO:0042273),17/57,3.41E-12,1.32E-10,0,0,12.3782855,326.8379658,RPL5;NPM1;RPL3;RPL10;RPLP0;RPL11;RPL35A;RPL23A;RPL10A;RPL6;RPL7;RPL7A;MRPL20;EIF6;RPL14;RPL24;RPL26
positive regulation of Wnt signaling pathway (GO:0030177),26/153,1.13E-11,4.25E-10,0,0,6.01758088,151.6966846,VCP;PSMD11;DDX3X;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;ATP6AP2;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;ATP6V0C
regulation of primary metabolic process (GO:0080090),24/130,1.13E-11,4.25E-10,0,0,6.642085554,167.4012462,PSMD11;EDF1;OAZ1;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
protein modification by small protein removal (GO:0070646),35/276,2.00E-11,7.41E-10,0,0,4.302724157,105.9907684,VCP;PSMD11;COPS7A;NEDD8;TOMM20;ACTB;PSMA7;PSMD8;SNX3;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;RHOA;PSMA5;PSMA6;PSMA3;PSMC5;COPS6;PSMA4;PSMC6;PSMC3;PSMA2;EIF3F;UBA52
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),28/185,3.21E-11,1.17E-09,0,0,5.250051366,126.8459123,NAPA;COPB2;ARF4;COPA;TMED10;SAR1A;DCTN2;KDELR1;PDCD6;COPB1;DCTN3;IER3IP1;TFG;TMED3;TMED2;SEC31A;RAB2A;BCAP31;SEC13;TMED9;DYNLL1;COPZ1;ARCN1;VAPA;KDELR2;ERGIC3;COPE;ERGIC1
protein deubiquitination (GO:0016579),34/267,3.47E-11,1.25E-09,0,0,4.318408357,104.0042406,ENY2;VCP;PSMD11;NEDD8;TOMM20;ACTB;PSMA7;PSMD8;SNX3;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;RHOA;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;EIF3F;UBA52
cellular response to lectin (GO:1990858),22/115,3.95E-11,1.38E-09,0,0,6.923225479,165.847131,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
stimulatory C-type lectin receptor signaling pathway (GO:0002223),22/115,3.95E-11,1.38E-09,0,0,6.923225479,165.847131,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
protein polyubiquitination (GO:0000209),37/314,4.69E-11,1.62E-09,0,0,3.962279429,94.23600458,ANAPC13;PSMD11;UBE2D3;PSMA7;UBE2L3;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBE2S;NEDD4;UBE2N;CTNNB1;ANAPC5;STUB1;UBA52;UBE2K
negative regulation of canonical Wnt signaling pathway (GO:0090090),26/165,6.50E-11,2.22E-09,0,0,5.494640123,128.8822183,GSK3B;PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;CSNK1A1;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;PFDN5
regulation of mitotic cell cycle (GO:0007346),27/178,6.87E-11,2.32E-09,0,0,5.257282737,123.0269417,APP;PSMD11;HNRNPU;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;UBE2S;PSMA2;ANAPC5
positive regulation of establishment of protein localization to telomere (GO:1904851),10-Aug,7.18E-11,2.39E-09,0,0,115.1654247,2689.928708,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
innate immune response activating cell surface receptor signaling pathway (GO:0002220),22/119,7.96E-11,2.62E-09,0,0,6.636350798,154.3177115,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;PSMD1
ribonucleoprotein complex biogenesis (GO:0022613),16/60,9.73E-11,3.17E-09,0,0,10.5728781,243.7347889,RPL5;NPM1;RPS7;RPS6;RPL11;RPL35A;RPL7;RPS15;RPS25;RPS17;RPS28;RPS16;RPL14;RPL38;RPL26;RPS24
ubiquitin-dependent protein catabolic process (GO:0006511),39/354,1.07E-10,3.46E-09,0,0,3.676755952,84.39568737,VCP;UBXN1;PSMD11;UBE2D3;NEDD8;PSMA7;UBE2L3;PSMD8;PCNP;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;NDFIP1;RBX1;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBE2S;NEDD4;CTNNB1;ANAPC5;UBA1;STUB1;SQSTM1;UBE2K
post-translational protein modification (GO:0043687),38/345,1.88E-10,5.99E-09,0,0,3.671644977,82.21665728,APP;PSMD11;COPS7A;NEDD8;PSMA7;HSP90B1;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;RBBP7;RAB2A;COMMD1;PDIA6;RAB11B;RBX1;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;COPS6;PSMA4;PSMC6;PSMC3;PSMA2;STT3A;NUCB1;P4HB;UBE2M
positive regulation of telomerase RNA localization to Cajal body (GO:1904874),15-Sep,2.37E-10,7.44E-09,0,0,43.24253731,958.3810661,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;NOP10;CCT4
regulation of establishment of protein localization to telomere (GO:0070203),11-Aug,2.55E-10,7.75E-09,0,0,76.77297566,1695.764786,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
regulation of protein localization to Cajal body (GO:1904869),11-Aug,2.55E-10,7.75E-09,0,0,76.77297566,1695.764786,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
positive regulation of protein localization to Cajal body (GO:1904871),11-Aug,2.55E-10,7.75E-09,0,0,76.77297566,1695.764786,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
negative regulation of programmed cell death (GO:0043069),40/381,2.66E-10,7.99E-09,0,0,3.484183039,76.81316994,ARF4;GSK3B;DDX3X;RPL10;GSTP1;GLO1;PARK7;PHB2;HSP90B1;HSPD1;PRDX2;PRDX5;UBB;CFL1;BAG1;UBC;RPS27A;HSPA9;PRELID1;NPM1;HSPA5;GPX4;ANXA4;NME2;RPS3A;MIF;PA2G4;YWHAZ;PSMC5;GOLPH3;UFM1;HNRNPK;TAX1BP1;CTNNB1;VDAC1;TMBIM6;UBA52;PTMA;SQSTM1;TPT1
ribosomal small subunit biogenesis (GO:0042274),13/40,3.67E-10,1.09E-08,0,0,13.94850406,303.0380442,NPM1;RPS7;RPS5;RPS6;RPS27L;RPSA;RPS15;RPS14;RPS25;RPS17;RPS28;RPS16;RPS24
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",12-Aug,7.43E-10,2.18E-08,0,0,57.57675112,1210.244065,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
regulation of apoptotic process (GO:0042981),59/742,1.20E-09,3.50E-08,0,0,2.596802532,53.33305179,ITGB1;ARF4;MTCH1;GSK3B;MTCH2;DDX3X;PARK7;HMGB1;IER3IP1;PHB2;FAM162A;CFL1;CTSB;HSP90AA1;ANXA4;RPS6;NME2;RPS3A;MIF;ACTN4;YWHAZ;NME1;TAX1BP1;TMBIM6;VDAC1;UBA52;SQSTM1;PTMA;PPIA;ATF4;VCP;RPL10;MAGED1;GSTP1;GLO1;PHB;RTN4;HSP90B1;HSPD1;PRDX2;PRDX5;UBB;BAG1;UBC;RPS3;RPS27A;HSPA9;PRELID1;NPM1;HSPA5;PA2G4;SOD1;GOLPH3;UFM1;HNRNPK;CTNNB1;CALR;ANP32B;TPT1
negative regulation of Wnt signaling pathway (GO:0030178),26/191,1.71E-09,4.92E-08,0,0,4.62254397,93.30749992,GSK3B;PSMD11;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;CSNK1A1;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;PFDN5
regulation of telomerase RNA localization to Cajal body (GO:1904872),18-Sep,2.10E-09,5.93E-08,0,0,28.8238806,575.9296141,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;NOP10;CCT4
cytokine-mediated signaling pathway (GO:0019221),52/621,2.11E-09,5.93E-08,0,0,2.73319823,54.60180702,ITGB1;ARF1;RPLP0;TXNDC17;PSMD8;PSMD7;PSMD4;PSMD2;CFL1;PSMD1;EIF5A;HSP90AA1;GSTO1;ACTN4;MIF;YWHAZ;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA2;TCP1;CSNK2B;CANX;UBA52;SQSTM1;PPIA;PSMD11;PSMA7;HSP90B1;PSMB6;CDC42;PSMB7;PSMB4;PSMB5;PSMB2;UBB;PSMB3;PSMB1;UBC;RPS27A;HSPA9;HSPA8;SOD2;SOD1;PSMC5;PSMC6;PSMC3;HNRNPA2B1;UBE2N;P4HB
cellular response to tumor necrosis factor (GO:0071356),26/194,2.40E-09,6.69E-08,0,0,4.539287537,90.09151963,PSMD11;PSMA7;TXNDC17;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;RPS3;PSMD1;EIF5A;ACTN4;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2
interleukin-12-mediated signaling pathway (GO:0035722),13/46,2.57E-09,7.09E-08,0,0,11.40886341,225.6480111,HSPA9;ARF1;GSTO1;RPLP0;MIF;SOD2;SOD1;CDC42;CFL1;HNRNPA2B1;TCP1;P4HB;PPIA
regulation of canonical Wnt signaling pathway (GO:0060828),30/253,2.80E-09,7.63E-08,0,0,3.958763741,77.9656784,GSK3B;VCP;PSMD11;DDX3X;PSMA7;PSMD8;PSMB6;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;PSMB3;PSMD2;PSMB1;PSMD1;CSNK1A1;ATP6AP2;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;CTNNB1;PFDN5
negative regulation of apoptotic process (GO:0043066),44/485,3.47E-09,9.38E-08,0,0,2.966486332,57.78176865,ITGB1;YWHAE;ARF4;GSK3B;SET;DDX3X;RPL10;GSTP1;GLO1;PARK7;PHB2;HSP90B1;HSPD1;PRDX2;PRDX5;DNAJB6;UBB;CFL1;BAG1;UBC;RPS27A;HSPA9;PRELID1;NPM1;HSPA5;ANXA4;NME2;RPS3A;PA2G4;MIF;SOD2;YWHAZ;SOD1;GOLPH3;UFM1;HNRNPK;TAX1BP1;CTNNB1;TMBIM6;VDAC1;UBA52;SQSTM1;PTMA;TPT1
cytoplasmic translational initiation (GO:0002183),19-Sep,3.87E-09,1.04E-07,0,0,25.94014925,502.452228,EIF4A1;EIF3M;EIF5;EIF3I;EIF4H;EIF2S2;EIF3A;EIF4B;EIF4G1
MAPK cascade (GO:0000165),33/303,3.99E-09,1.05E-07,0,0,3.604420365,69.71054832,YWHAE;PSMD11;YWHAB;PEBP1;PSMA7;PSMD8;PSMB6;PPP1CB;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;RBX1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;LAMTOR2;CALM1;UBA52
T cell receptor signaling pathway (GO:0050852),23/158,4.02E-09,1.05E-07,0,0,4.982813911,96.33000204,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;UBE2N;PSMD1
cellular response to interleukin-12 (GO:0071349),13/48,4.58E-09,1.19E-07,0,0,10.75581296,206.5249852,HSPA9;ARF1;GSTO1;RPLP0;MIF;SOD2;SOD1;CDC42;CFL1;HNRNPA2B1;TCP1;P4HB;PPIA
aerobic respiration (GO:0009060),21-Sep,1.16E-08,2.98E-07,0,0,21.61455224,394.968698,UQCRB;NDUFS7;MDH2;UQCRC1;SDHC;UQCR10;UQCRC2;SDHB;UQCRH
substantia nigra development (GO:0021762),12/43,1.24E-08,3.17E-07,0,0,11.19504764,203.7840985,YWHAE;CDC42;GLUD1;YWHAQ;HSPA5;CALM3;DYNLL1;CALM1;CALM2;ACTB;RHOA;COX6B1
cellular protein-containing complex assembly (GO:0034622),23/168,1.33E-08,3.36E-07,0,0,4.636753574,84.08589379,CCT2;HSP90AA1;PSMD11;HSP90AB1;GPX4;HSPA4;PTGES3;POMP;CLTB;COX7A2;TBCA;RTN4;HSPD1;FKBP1A;PSMD4;CSNK2B;TCP1;CHMP2A;AP2S1;EIF4H;RPL38;AP2M1;EIF4B
regulation of translational initiation (GO:0006446),14/68,5.35E-08,1.34E-06,0,0,7.511500975,125.7742813,NPM1;DDX3X;DDX1;EIF1;EIF5;CSDE1;EIF4H;EIF3H;EIF3E;EIF4B;EIF4G2;ATF4;EIF3B;EIF4G1
ribosomal large subunit assembly (GO:0000027),25-Sep,7.13E-08,1.77E-06,0,0,16.20755597,266.7191597,RPL5;MRPL20;RPL3;RPL10;RPL11;RPLP0;RPL24;RPL23A;RPL6
gluconeogenesis (GO:0006094),11/41,7.95E-08,1.95E-06,0,0,10.58887226,173.1017103,SLC25A1;TPI1;MDH1;MDH2;PGAM1;GOT2;PGK1;ENO1;ALDOA;GAPDH;ATF4
antigen receptor-mediated signaling pathway (GO:0050851),23/185,8.27E-08,2.01E-06,0,0,4.14650143,67.620709,PSMD11;PSMA7;PSMD8;PSMA5;PSMB6;PSMA6;PSMB7;PSMA3;PSMB4;PSMC5;PSMD7;PSMA4;PSMB5;PSMC6;PSMD4;PSMB2;PSMC3;PSMA2;PSMB3;PSMD2;PSMB1;UBE2N;PSMD1
positive regulation of establishment of protein localization (GO:1904951),19-Aug,9.19E-08,2.22E-06,0,0,20.92941336,339.1122142,CCT3;CCT6A;CCT2;TCP1;CCT8;CCT7;CCT5;CCT4
hexose biosynthetic process (GO:0019319),11/44,1.76E-07,4.20E-06,0,0,9.624750499,149.698074,SLC25A1;TPI1;MDH1;MDH2;PGAM1;GOT2;PGK1;ENO1;ALDOA;GAPDH;ATF4
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),10/36,2.18E-07,5.16E-06,0,0,11.0929056,170.171271,CCT3;CCT6A;CCT2;HNRNPA2B1;TCP1;CTNNB1;CCT8;CCT7;CCT5;CCT4
protein targeting to mitochondrion (GO:0006626),12/55,2.45E-07,5.75E-06,0,0,8.065827551,122.7841585,BCAP31;TIMM8B;NDUFA13;HSP90AA1;HSPA4;TIMM17A;TIMM13;TOMM7;TIMM23;ROMO1;TOMM20;HSPD1
electron transport chain (GO:0022900),15-Jul,2.56E-07,5.95E-06,0,0,25.14713542,381.7104728,POR;NDUFA5;UQCRFS1;ETFA;ETFB;SDHA;SDHB
ATP synthesis coupled electron transport (GO:0042773),06-May,2.59E-07,5.99E-06,0,0,143.3234421,2173.562416,NDUFB6;NDUFA12;NDUFS2;NDUFV3;NDUFV1
protein ubiquitination (GO:0016567),42/525,2.71E-07,6.21E-06,0,0,2.571565081,38.88341558,RNF10;VCP;PSMD11;UBE2D3;NEDD8;PSMA7;UBE2L3;PSMD8;PSMB6;PCNP;PSMB7;PSMB4;PSMD7;PSMB5;PSMD4;PSMB2;UBB;PSMB3;PSMD2;PSMB1;UBC;PSMD1;RPS27A;COMMD1;RBX1;DDB1;PSMA5;PSMA6;PSMA3;PSMC5;PSMA4;PSMC6;PSMC3;PSMA2;UBE2S;NEDD4;UBE2N;CTNNB1;STUB1;UBA1;UBA52;UBE2K
modulation by symbiont of host process (GO:0044003),10-Jun,2.80E-07,6.35E-06,0,0,43.05423477,649.6282516,UBB;UBC;PGK1;ENO1;RPS27A;UBA52
positive regulation of signal transduction by p53 class mediator (GO:1901798),22-Aug,3.55E-07,7.99E-06,0,0,16.44198425,244.1755556,EIF5A;RPS15;DDX5;RPS7;UBB;RPL23;RPS20;RPL37
intracellular protein transport (GO:0006886),31/336,5.12E-07,1.14E-05,0,0,2.982675572,43.20585591,NAPA;VPS29;ARF4;COPB2;ARF1;COPA;TMED10;SAR1A;PDCD6;RPL11;ARL1;PHB2;GABARAP;LAMP2;TMED3;TMED2;RAB6A;SEC31A;SEC13;TMED9;NPM1;SURF4;COPZ1;ARCN1;CTTN;RAB14;CDC37;RAB18;CALR;ARF5;RAN
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",23-Aug,5.28E-07,1.17E-05,0,0,15.34505713,221.7885905,DDB1;COPS6;UBB;UBC;COPS7A;RPS27A;UBA52;RBX1
selective autophagy (GO:0061912),12/59,5.52E-07,1.21E-05,0,0,7.377842993,106.3165279,MAP1LC3B;UFM1;UBB;UBC;UFC1;UBE2N;PARK7;DYNLL1;RPS27A;PHB2;SQSTM1;UBA52
positive regulation of DNA biosynthetic process (GO:2000573),12/61,8.07E-07,1.76E-05,0,0,7.075972218,99.27679457,CCT3;CCT6A;CCT2;HSP90AA1;HSP90AB1;PTGES3;TCP1;CTNNB1;CCT8;CCT7;CCT5;CCT4
"posttranslational protein targeting to membrane, translocation (GO:0031204)",07-May,8.82E-07,1.91E-05,0,0,71.65801187,998.9933511,SEC61A1;HSPA5;SEC61G;SEC61B;SEC62
glucose metabolic process (GO:0006006),12/62,9.70E-07,2.08E-05,0,0,6.934092954,96.00978058,SLC25A1;TPI1;MDH1;MDH2;PGAM1;GOT2;AKR1A1;PGK1;ENO1;ALDOA;GAPDH;ATF4
positive regulation of telomere maintenance via telomerase (GO:0032212),9/33,1.05E-06,2.24E-05,0,0,10.8005597,148.6382366,CCT3;CCT6A;CCT2;TCP1;CTNNB1;CCT8;CCT7;CCT5;CCT4
regulation of telomere maintenance via telomerase (GO:0032210),11/52,1.08E-06,2.28E-05,0,0,7.743537316,106.3708275,CCT3;CCT6A;CCT2;TCP1;HNRNPU;CTNNB1;CCT8;HNRNPC;CCT7;CCT5;CCT4
protein transport (GO:0015031),32/369,1.31E-06,2.75E-05,0,0,2.786143763,37.73304167,NAPA;VPS29;ARF4;COPB2;ARF1;COPA;TMED10;SAR1A;PDCD6;ARL1;HSP90B1;LAMP2;TMED3;TMED2;RAB6A;SEC31A;ATP6V1F;SEC13;TMED9;NPM1;COPZ1;ARCN1;RAB11B;RAB10;GOLPH3;CTTN;RAB14;CANX;CHMP2A;RAB18;ATP6V0C;ARF5
intracellular protein transmembrane transport (GO:0065002),10/44,1.66E-06,3.45E-05,0,0,8.479293063,112.8383126,SEC61A1;HSPA5;SEC61G;TIMM17A;TIMM23;ROMO1;SEC61B;SEC62;TOMM20;HSPD1
cellular response to heat (GO:0034605),9/36,2.35E-06,4.85E-05,0,0,9.599004975,124.4114583,YWHAE;VCP;HSP90AA1;HSP90AB1;SUMO1;HSBP1;PDCD6;STUB1;RBBP7
respiratory electron transport chain (GO:0022904),14-Jun,3.56E-06,7.29E-05,0,0,21.52265973,270.0024685,NDUFA5;UQCRFS1;ETFA;ETFB;SDHA;SDHB
aggrephagy (GO:0035973),29-Aug,3.86E-06,7.84E-05,0,0,10.95734866,136.5776543,UBB;UBC;UBE2N;PARK7;RPS27A;DYNLL1;SQSTM1;UBA52
response to unfolded protein (GO:0006986),10/49,4.72E-06,9.52E-05,0,0,7.390287839,90.62784391,HSPA9;HSPA8;ERP44;HSP90AA1;HSP90AB1;HSPA5;HSPA4;TMBIM6;HSPE1;HSPD1
cellular response to oxidative stress (GO:0034599),16/125,5.23E-06,1.05E-04,0,0,4.253559716,51.73096057,GSTP1;TXNRD1;TPM1;PARK7;SOD2;PRDX6;SOD1;PRDX2;CHCHD2;PRDX5;PRDX1;RPS3;CYCS;ROMO1;PPIA;ATF4
endoplasmic reticulum organization (GO:0007029),12/73,5.87E-06,1.17E-04,0,0,5.680438469,68.42434727,RAB10;APP;SEC61A1;RTN3;REEP5;VAPA;SEC61G;RAB18;TOR1AIP2;SEC61B;RTN4;SEC31A
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),05-Apr,6.41E-06,1.26E-04,0,0,114.4888889,1369.060996,EIF5A;RPS7;UBB;RPL26
'de novo' posttranslational protein folding (GO:0051084),31-Aug,6.68E-06,1.30E-04,0,0,10.003499,119.2009523,HSPA9;CCT2;HSPA8;HSPA5;ST13;PTGES3;BAG1;HSPE1
protein localization to organelle (GO:0033365),17/142,6.70E-06,1.30E-04,0,0,3.943589124,46.98211535,YWHAE;APP;MTCH2;DDX3X;SSB;DDX1;RPL11;ARL1;YBX1;LAMP1;VAPA;SEC61G;LAMP2;LMNA;CALR;SEC61B;RAB6A
"mRNA splicing, via spliceosome (GO:0000398)",25/274,7.80E-06,1.50E-04,0,0,2.92791963,34.43626814,SF3B2;DDX5;DDX1;HNRNPU;YBX1;UBL5;SNRPD2;PUF60;PCBP1;TRA2B;POLR2F;TXNL4A;POLR2L;HSPA8;HNRNPA3;ALYREF;HNRNPK;HNRNPA2B1;STRAP;SRSF3;HNRNPC;PABPC1;SNRPF;SRSF5;SNRPB
cellular response to chemical stress (GO:0062197),14/101,7.93E-06,1.52E-04,0,0,4.654325469,54.66613572,DDX3X;GSTP1;TXNRD1;PARK7;SOD2;PRDX6;SOD1;PRDX2;CHCHD2;PRDX5;PRDX1;CYCS;PPIA;ATF4
cellular protein localization (GO:0034613),28/329,8.53E-06,1.62E-04,0,0,2.717822313,31.72146399,NAPA;VPS29;ARF4;CD63;COPB2;ARF1;COPA;TMED10;SAR1A;PDCD6;ARL1;TM9SF3;TMED3;TMED2;RAB6A;SEC31A;SEC13;TMED9;NPM1;COPZ1;ARCN1;TM9SF2;CTTN;RAB14;RAB18;CTNNB1;LAMTOR2;ARF5
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),14/102,8.91E-06,1.68E-04,0,0,4.601196172,53.50639448,GSK3B;VCP;HSP90AB1;UBXN1;CSNK1A1;RPL11;PARK7;COMMD1;GABARAP;RBX1;SUMO1;SUMO2;EIF3H;STUB1
modification-dependent macromolecule catabolic process (GO:0043632),10-May,9.72E-06,1.82E-04,0,0,28.65875371,330.7639391,UBB;UBC;NEDD8;RPS27A;UBA52
regulation of cellular response to stress (GO:0080135),15/118,1.11E-05,2.08E-04,0,0,4.214966663,48.06892969,YWHAE;HSPA8;GSK3B;HSP90AA1;SEC13;NPM1;HSP90AB1;HSBP1;PTGES3;CHCHD2;DNAJB6;BAG1;FKBP4;ATF4;EIF4G1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),15/119,1.24E-05,2.29E-04,0,0,4.174220922,47.17246641,BCAP31;MTCH1;NDUFA13;VCP;DDX3X;PDCD6;RPS27L;HMGB1;HSPE1;HSPD1;DAP;FAM162A;RPS3;CYCS;ANP32B
ribosomal small subunit assembly (GO:0000028),17-Jun,1.35E-05,2.47E-04,0,0,15.650412,175.5385458,RPS15;RPS14;RPS28;RPS5;RPS27L;RPSA
pyruvate metabolic process (GO:0006090),10/55,1.40E-05,2.55E-04,0,0,6.402923102,71.56580241,TPI1;PDHA1;PGAM1;GLO1;BSG;PGK1;VDAC1;ENO1;ALDOA;GAPDH
mitochondrial transport (GO:0006839),10/56,1.65E-05,2.99E-04,0,0,6.263404172,68.96566431,BCAP31;TIMM8B;HSP90AA1;TIMM17A;TIMM13;TOMM7;TIMM23;SLC25A5;TOMM20;TMEM14C
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",23/251,1.67E-05,3.00E-04,0,0,2.936049155,32.30415139,HSPA8;SF3B2;DDX5;HNRNPA3;ALYREF;HNRNPU;YBX1;UBL5;HNRNPK;SNRPD2;PUF60;PCBP1;TRA2B;HNRNPA2B1;SRSF3;POLR2F;HNRNPC;PABPC1;SNRPF;SRSF5;TXNL4A;SNRPB;POLR2L
chaperone cofactor-dependent protein refolding (GO:0051085),26-Jul,1.89E-05,3.37E-04,0,0,10.58223684,115.116561,HSPA9;HSPA8;HSPA5;ST13;PTGES3;BAG1;HSPE1
protein targeting (GO:0006605),15/125,2.24E-05,3.99E-04,0,0,3.945303943,42.23315697,BCAP31;TIMM8B;RPL11;TIMM13;TIMM23;TOMM20;GABARAP;SEC61A1;SPCS1;NACA;CDC37;SEC61G;LAMP2;TIMM17A;TOMM7
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),12-May,2.89E-05,5.03E-04,0,0,20.46841882,213.95744,FKBP1A;GSTO1;CALM3;CALM1;CALM2
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),12-May,2.89E-05,5.03E-04,0,0,20.46841882,213.95744,FKBP1A;GSTO1;CALM3;CALM1;CALM2
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),12-May,2.89E-05,5.03E-04,0,0,20.46841882,213.95744,SEC61A1;HSPA5;SEC61G;SEC61B;SEC62
establishment of protein localization to mitochondrion (GO:0072655),9/48,2.91E-05,5.04E-04,0,0,6.641331803,69.36737056,BCAP31;TIMM8B;TIMM13;TIMM17A;TOMM7;TIMM23;ROMO1;TOMM20;HSPD1
transcription-coupled nucleotide-excision repair (GO:0006283),11/73,3.34E-05,5.67E-04,0,0,5.115148735,52.72278784,DDB1;COPS6;UBB;UBC;POLR2F;TCEA1;COPS7A;RPS27A;UBA52;RBX1;POLR2L
positive regulation of translation (GO:0045727),13/100,3.34E-05,5.67E-04,0,0,4.31538435,44.47731762,EIF5A;RPL5;RPS9;NPM1;DDX3X;CNBP;RPS27L;EEF2;RPS4X;EIF6;EIF3E;RPL26;EIF3C
regulation of phosphoprotein phosphatase activity (GO:0043666),8/38,3.36E-05,5.67E-04,0,0,7.666567312,78.97689573,FKBP1A;GSK3B;HSP90AB1;CSNK2B;CALM3;CALM1;CALM2;HSP90B1
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),8/38,3.36E-05,5.67E-04,0,0,7.666567312,78.97689573,RPL5;HSP90AB1;UBXN1;RPS7;RPL23;RPL11;EIF3H;PARK7
proteolysis involved in cellular protein catabolic process (GO:0051603),11/74,3.80E-05,6.38E-04,0,0,5.033694516,51.22770892,DDB1;PSMA6;VCP;PDCD6IP;UBB;UBC;NEDD8;STUB1;RPS27A;UBA52;CTSB
positive regulation of cellular protein metabolic process (GO:0032270),13/102,4.13E-05,6.89E-04,0,0,4.21797078,42.57869604,RPL5;HSP90AA1;NPM1;DDX3X;RPS27L;EEF2;RPS4X;EIF6;EIF3E;STUB1;RPL26;EIF3C;EIF4G1
response to host defenses (GO:0052200),07-Apr,4.25E-05,6.95E-04,0,0,38.15901235,384.1374677,UBB;UBC;RPS27A;UBA52
modulation by symbiont of host defense response (GO:0052031),07-Apr,4.25E-05,6.95E-04,0,0,38.15901235,384.1374677,UBB;UBC;RPS27A;UBA52
protein localization to cytoplasmic stress granule (GO:1903608),07-Apr,4.25E-05,6.95E-04,0,0,38.15901235,384.1374677,DDX3X;SSB;DDX1;YBX1
positive regulation of protein-containing complex assembly (GO:0031334),14/118,4.75E-05,7.72E-04,0,0,3.890080972,38.72761013,GSK3B;VCP;HSP90AA1;DDX3X;PARK7;RBX1;DDB1;PSMC5;PSMC6;SUMO1;PSMC3;RPS3;STUB1;EIF4G1
protein N-linked glycosylation via asparagine (GO:0018279),30-Jul,5.19E-05,8.39E-04,0,0,8.740036232,86.23605738,OST4;RPN2;DAD1;OSTC;RPN1;STT3A;DDOST
peptidyl-asparagine modification (GO:0018196),31-Jul,6.50E-05,0.001045811,0,0,8.375434028,80.74233212,OST4;RPN2;DAD1;OSTC;RPN1;STT3A;DDOST
chaperone-mediated protein complex assembly (GO:0051131),22-Jun,7.01E-05,0.001114225,0,0,10.75687221,102.888191,CCT2;HSP90AA1;HSP90AB1;HSPA4;PTGES3;HSPD1
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",22-Jun,7.01E-05,0.001114225,0,0,10.75687221,102.888191,DDB1;UBB;UBC;RPS27A;UBA52;RBX1
regulation of cellular response to heat (GO:1900034),11/79,7.05E-05,0.001114225,0,0,4.662359105,44.56893779,YWHAE;GSK3B;HSPA8;HSP90AA1;SEC13;HSP90AB1;DNAJB6;HSBP1;PTGES3;BAG1;FKBP4
intra-Golgi vesicle-mediated transport (GO:0006891),7/32,8.08E-05,0.001269487,0,0,8.04,75.76112205,NAPA;COPB2;COPA;COPB1;RAB6A;COPZ1;COPE
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),08-Apr,8.27E-05,0.00129025,0,0,28.61777778,269.0324718,GSTO1;CALM3;CALM1;CALM2
regulation of protein ubiquitination (GO:0031396),13/109,8.31E-05,0.00129025,0,0,3.908987112,36.72587603,HSP90AA1;NDFIP1;HSP90AB1;UBXN1;PARK7;COMMD1;UBE2L3;FKBP1A;UBB;UBE2N;RPS3;STUB1;SQSTM1
response to endoplasmic reticulum stress (GO:0034976),13/110,9.14E-05,0.001410457,0,0,3.868487044,35.97860328,PDIA3;BCAP31;GSK3B;VCP;HSPA5;ATP2A2;HSP90B1;ERP44;UFM1;GORASP2;UFC1;P4HB;ATF4
positive regulation of protein localization to nucleus (GO:1900182),10/68,9.36E-05,0.001435867,0,0,4.964434823,46.05446569,CCT3;CCT6A;CCT2;TCP1;PARK7;CCT8;CCT7;CCT5;RAN;CCT4
cellular protein modification process (GO:0006464),58/1025,9.75E-05,0.001488354,0,0,1.77272205,16.37164185,ARF4;APP;GSK3B;UBE2D3;PARK7;UBE2L3;PSMD8;PPP1CB;UBL5;PSMD7;PSMD4;PPP2R1A;PSMD2;PSMD1;RAB2A;COMMD1;PDIA6;YWHAZ;DDOST;RBX1;PSMA5;DDB1;PSMA6;PSMA3;PSMA4;PSMA2;DAD1;UBA52;PSMD11;RPN2;CTBP1;RPN1;COPS7A;NEDD8;PSMA7;HSP90B1;PSMB6;PPP2CA;PSMB7;PSMB4;PSMB5;PSMB2;PSMB3;PSMB1;RBBP7;CSNK1A1;RAB11B;PSMC5;COPS6;PSMC6;PSMC3;CDK4;UBE2S;STT3A;NUCB1;P4HB;METAP2;UBE2M
mRNA processing (GO:0006397),24/300,9.82E-05,0.001489696,0,0,2.528377033,23.33382733,HSPA8;SF3B2;DDX5;HNRNPA3;ALYREF;HNRNPU;YBX1;THOC7;UBL5;HNRNPK;SNRPD2;PUF60;PCBP1;TRA2B;HNRNPA2B1;SRSF3;POLR2F;HNRNPC;PABPC1;SNRPF;SRSF5;TXNL4A;SNRPB;POLR2L
negative regulation of ubiquitin-protein transferase activity (GO:0051444),15-May,1.01E-04,0.001516781,0,0,14.32566766,131.8700137,RPL5;RPS7;RPL23;RPL11;PARK7
protein-containing complex disassembly (GO:0032984),9/56,1.03E-04,0.001548799,0,0,5.508605907,50.56181781,GSK3B;HSPA8;MAP1LC3B;VCP;CSNK1A1;RPL23;LAMP2;CTNNB1;GABARAP
canonical glycolysis (GO:0061621),24-Jun,1.19E-04,0.001743517,0,0,9.560673601,86.36034689,TPI1;PGAM1;PGK1;ENO1;ALDOA;GAPDH
glucose catabolic process to pyruvate (GO:0061718),24-Jun,1.19E-04,0.001743517,0,0,9.560673601,86.36034689,TPI1;PGAM1;PGK1;ENO1;ALDOA;GAPDH
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",24-Jun,1.19E-04,0.001743517,0,0,9.560673601,86.36034689,UBB;UBC;UBE2N;RPS27A;AAMP;UBA52
protein exit from endoplasmic reticulum (GO:0032527),24-Jun,1.19E-04,0.001743517,0,0,9.560673601,86.36034689,SEC13;TMED9;VCP;SURF4;SEC61B;HSP90B1
protein insertion into mitochondrial membrane (GO:0051204),24-Jun,1.19E-04,0.001743517,0,0,9.560673601,86.36034689,TIMM8B;HSP90AA1;NDUFA13;HSPA4;TIMM13;ROMO1
positive regulation of telomerase activity (GO:0051973),7/34,1.22E-04,0.001768837,0,0,7.44367284,67.09029705,CCT2;HSP90AA1;HSP90AB1;PTGES3;TCP1;CTNNB1;CCT4
nucleic acid metabolic process (GO:0090304),10/71,1.36E-04,0.001958923,0,0,4.719547159,42.03053759,HNRNPA3;HNRNPK;DDX1;PCBP1;HNRNPA2B1;HNRNPU;POLR2F;HNRNPC;RAN;POLR2L
negative regulation of ubiquitin protein ligase activity (GO:1904667),09-Apr,1.45E-04,0.00207995,0,0,22.89303704,202.3823821,RPL5;RPS7;RPL23;RPL11
glycolytic process through glucose-6-phosphate (GO:0061620),25-Jun,1.53E-04,0.002179295,0,0,9.057011027,79.58744751,TPI1;PGAM1;PGK1;ENO1;ALDOA;GAPDH
negative regulation of cellular amide metabolic process (GO:0034249),11/86,1.54E-04,0.002179295,0,0,4.225668663,37.09231879,RTN3;DDX3X;NCL;CAPRIN1;RPS3;RPL13A;YBX1;CALR;GAPDH;TOB1;RTN4
positive regulation of proteasomal protein catabolic process (GO:1901800),11/86,1.54E-04,0.002179295,0,0,4.225668663,37.09231879,GSK3B;VCP;PSMC5;PSMC6;SUMO1;PSMC3;CSNK1A1;SUMO2;STUB1;GABARAP;RBX1
global genome nucleotide-excision repair (GO:0070911),26-Jun,1.93E-04,0.002711997,0,0,8.60371471,73.59576327,DDB1;UBB;UBC;RPS27A;UBA52;RBX1
translational elongation (GO:0006414),12/104,2.12E-04,0.002967375,0,0,3.760315494,31.80762419,EEF1B2;EEF1A1;MRPL30;EEF1G;MRPL52;MRPL20;MRPL42;EEF1D;MRPS21;EEF2;MRPL23;MRPL33
nucleotide-excision repair (GO:0006289),12/105,2.32E-04,0.003219389,0,0,3.719688543,31.12691893,DDB1;COPS6;UBB;UBC;POLR2F;TCEA1;COPS7A;COMMD1;RPS27A;UBA52;RBX1;POLR2L
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),10-Apr,2.35E-04,0.003219389,0,0,19.07654321,159.4176583,PSMC5;PSMC6;PSMC3;HMGB1
formation of translation preinitiation complex (GO:0001731),10-Apr,2.35E-04,0.003219389,0,0,19.07654321,159.4176583,EIF5;EIF4H;EIF2S2;EIF4B
removal of superoxide radicals (GO:0019430),10-Apr,2.35E-04,0.003219389,0,0,19.07654321,159.4176583,PRDX2;PRDX1;SOD2;SOD1
membrane organization (GO:0061024),20/242,2.38E-04,0.003246048,0,0,2.610972125,21.78445584,NAPA;MTCH1;HSPA8;PDCD6IP;SAR1A;ARPC1A;CLTB;TOR1AIP2;ACTB;ACTG1;SNX3;CTTN;UBB;VAPA;UBC;AP2S1;CHMP2A;RPS27A;UBA52;AP2M1
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),27-Jun,2.41E-04,0.003268327,0,0,8.193589471,68.26529565,UBB;UBC;UBE2N;RPS27A;AAMP;UBA52
organelle organization (GO:0006996),29/420,2.58E-04,0.003480982,0,0,2.160023608,17.84935666,TMED10;SAR1A;ARL1;TOR1AIP2;PARK7;PHB;PHB2;CDC42;SEC61A1;CHCHD2;CFL1;TMED3;TMED2;SEC31A;RAB2A;TMED9;PDCD6IP;CSNK1A1;TPM1;SURF4;GOLPH3;REEP5;RAB14;VAPA;GORASP2;RAB18;CHMP2A;CYCS;PPIA
Wnt signaling pathway (GO:0016055),11/92,2.82E-04,0.003787301,0,0,3.911436386,31.97276153,SNX3;GSK3B;VPS29;DDX3X;UBB;CSNK1A1;UBC;CTNNB1;RPS27A;UBA52;RBX1
mitotic nuclear membrane organization (GO:0101024),8/51,2.97E-04,0.003922945,0,0,5.345163415,43.41998046,PPP2CA;SEC13;SUMO1;PPP2R1A;LMNA;CHMP2A;BANF1;RAN
mitotic nuclear membrane reassembly (GO:0007084),8/51,2.97E-04,0.003922945,0,0,5.345163415,43.41998046,PPP2CA;SEC13;SUMO1;PPP2R1A;LMNA;CHMP2A;BANF1;RAN
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),28-Jun,2.98E-04,0.003922945,0,0,7.820748345,63.49884547,YWHAE;FKBP1A;GSTO1;CALM3;CALM1;CALM2
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),28-Jun,2.98E-04,0.003922945,0,0,7.820748345,63.49884547,UBB;UBC;UBE2N;RPS27A;AAMP;UBA52
regulation of exit from mitosis (GO:0007096),7/39,3.01E-04,0.003941422,0,0,6.278971354,50.92066733,UBB;UBE2S;UBC;ANAPC5;RPS27A;PHB2;UBA52
fatty acid beta-oxidation (GO:0006635),8/52,3.40E-04,0.00443914,0,0,5.223411462,41.71391968,HADHB;HADHA;ACADL;SCP2;ETFA;ETFB;HADH;ACAT1
cellular response to superoxide (GO:0071451),11-Apr,3.59E-04,0.004640682,0,0,16.35047619,129.6909474,PRDX2;PRDX1;SOD2;SOD1
positive regulation by host of viral process (GO:0044794),11-Apr,3.59E-04,0.004640682,0,0,16.35047619,129.6909474,VAPA;CFL1;NUCKS1;PPIB
glycolytic process (GO:0006096),29-Jun,3.65E-04,0.004668897,0,0,7.480328187,59.21690862,TPI1;PGAM1;PGK1;ENO1;ALDOA;GAPDH
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",29-Jun,3.65E-04,0.004668897,0,0,7.480328187,59.21690862,DDB1;UBB;UBC;RPS27A;UBA52;RBX1
RNA localization to Cajal body (GO:0090670),05-Mar,3.70E-04,0.004671689,0,0,42.86760355,338.7241936,CCT2;TCP1;CCT4
scaRNA localization to Cajal body (GO:0090666),05-Mar,3.70E-04,0.004671689,0,0,42.86760355,338.7241936,CCT2;TCP1;CCT4
positive regulation by host of viral genome replication (GO:0044829),05-Mar,3.70E-04,0.004671689,0,0,42.86760355,338.7241936,VAPA;NUCKS1;PPIB
positive regulation of cellular amide metabolic process (GO:0034250),10/81,4.07E-04,0.00511617,0,0,4.052716899,31.63586651,RPS4X;RPL5;NPM1;DDX3X;EIF6;RPS27L;EIF3E;RPL26;EEF2;EIF3C
nuclear membrane reassembly (GO:0031468),8/54,4.43E-04,0.005541993,0,0,4.995788246,38.57497914,PPP2CA;SEC13;SUMO1;PPP2R1A;LMNA;CHMP2A;BANF1;RAN
positive regulation of protein ubiquitination (GO:0031398),10/82,4.50E-04,0.005600693,0,0,3.996221558,30.79626189,FKBP1A;NDFIP1;UBB;PDCD6;UBE2N;STUB1;COMMD1;RPS2;UBE2L3;RBX1
endomembrane system organization (GO:0010256),17/199,4.66E-04,0.005778685,0,0,2.700466452,20.71382364,RAB2A;TMED9;TMED10;CSNK1A1;SURF4;ARL1;TOR1AIP2;CDC42;SEC61A1;GOLPH3;REEP5;VAPA;GORASP2;TMED3;TMED2;SQSTM1;SEC31A
modification-dependent protein catabolic process (GO:0019941),17/201,5.23E-04,0.006377844,0,0,2.670834428,20.18016599,NDFIP1;PSMD11;NEDD8;UBE2L3;RBX1;DDB1;UBB;UBE2S;NEDD4;UBC;ANAPC5;UBA1;STUB1;RPS27A;UBA52;SQSTM1;UBE2K
maintenance of protein localization in endoplasmic reticulum (GO:0035437),12-Apr,5.24E-04,0.006377844,0,0,14.30592593,108.0616028,HSPA5;RER1;KDELR1;KDELR2
tricarboxylic acid metabolic process (GO:0072350),12-Apr,5.24E-04,0.006377844,0,0,14.30592593,108.0616028,GLUD1;IDH3B;ACO2;IDH3A
protein insertion into mitochondrial inner membrane (GO:0045039),12-Apr,5.24E-04,0.006377844,0,0,14.30592593,108.0616028,TIMM8B;NDUFA13;TIMM13;ROMO1
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),8/56,5.70E-04,0.006904101,0,0,4.787133631,35.7581111,YWHAE;UBL5;YWHAQ;YWHAB;UBE2D3;TOMM7;YWHAZ;UBE2L3
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),21-May,5.75E-04,0.006904101,0,0,8.950760386,66.78087774,GSTO1;ATP2A2;CALM3;CALM1;CALM2
regulation of ubiquitin protein ligase activity (GO:1904666),21-May,5.75E-04,0.006904101,0,0,8.950760386,66.78087774,RPL5;RPS7;UBE2S;RPL23;RPL11
COPII-coated vesicle budding (GO:0090114),9/70,5.81E-04,0.006944592,0,0,4.241252753,31.59844093,NAPA;SEC13;TMED10;TFG;SAR1A;VAPA;PDCD6;TMED2;SEC31A
regulation of protein-containing complex assembly (GO:0043254),12/116,5.84E-04,0.006944592,0,0,3.324357052,24.7538919,NAPA;CDC42;HSPA8;GSK3B;VCP;HSP90AA1;DDX3X;SAR1A;HSPA5;SUMO1;RPS3;PARK7
COPI coating of Golgi vesicle (GO:0048205),06-Mar,7.22E-04,0.00842494,0,0,28.57692308,206.7276449,TMED9;TMED10;TMED2
COPI-coated vesicle budding (GO:0035964),06-Mar,7.22E-04,0.00842494,0,0,28.57692308,206.7276449,TMED9;TMED10;TMED2
Golgi transport vesicle coating (GO:0048200),06-Mar,7.22E-04,0.00842494,0,0,28.57692308,206.7276449,TMED9;TMED10;TMED2
macromolecule biosynthetic process (GO:0009059),06-Mar,7.22E-04,0.00842494,0,0,28.57692308,206.7276449,EIF4G2;EIF4G1;RPS23
error-free translesion synthesis (GO:0070987),22-May,7.24E-04,0.00842494,0,0,8.423808693,60.91423646,VCP;UBB;UBC;RPS27A;UBA52
ribosomal subunit export from nucleus (GO:0000054),13-Apr,7.37E-04,0.00854266,0,0,12.71572016,91.71876674,RPS15;NPM1;EIF6;RAN
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),6/33,7.58E-04,0.008747142,0,0,6.370810632,45.77481245,BCAP31;PDIA3;SEC13;CANX;CALR;SEC31A
macroautophagy (GO:0016236),12/120,7.91E-04,0.009096261,0,0,3.200566383,22.85743256,VCP;MAP1LC3B;LAMP2;CSNK2B;CHMP2A;TOMM7;VDAC1;DYNLL1;TOMM20;SQSTM1;GABARAP;TOMM6
regulation of telomerase activity (GO:0051972),7/46,8.52E-04,0.009749719,0,0,5.150106838,36.40127652,CCT2;HSP90AA1;HSP90AB1;PTGES3;TCP1;CTNNB1;CCT4
autophagosome maturation (GO:0097352),6/34,8.94E-04,0.010189615,0,0,6.142963277,43.1217801,VCP;MAP1LC3B;LAMP2;ATP2A2;CALM1;GABARAP
negative regulation of translation (GO:0017148),10/90,9.45E-04,0.010718974,0,0,3.595104634,25.039352,DDX3X;NCL;CAPRIN1;RPS3;RPL13A;EIF3E;YBX1;CALR;GAPDH;TOB1
regulation of programmed cell death (GO:0043067),16/194,9.88E-04,0.011167462,0,0,2.595353094,17.95897324,PRELID1;VCP;HSP90AA1;MAGED1;NME2;ACTN4;PHB;RTN4;NME1;PRDX2;PSMC5;RPS3;ANP32B;CALR;TPT1;CTSB
positive regulation of intracellular signal transduction (GO:1902533),33/546,0.001059741,0.011926499,0,0,1.872865859,12.82862729,ITGB1;APP;HSP90AB1;DDX3X;DDX1;PARK7;PHB;HMGB1;PHB2;RTN4;RPS15;TFG;RPS3;RPL37;RAC1;BCAP31;HSP90AA1;SEC13;NDFIP1;RPL23;ACTN4;MIF;RHOA;FKBP1A;GOLPH3;VAPA;RHEB;EEF1D;NEDD4;UBE2N;LAMTOR2;RPS20;GAPDH
ribosomal small subunit export from nucleus (GO:0000056),07-Mar,0.001230906,0.013625724,0,0,21.43158284,143.5917111,RPS15;NPM1;RAN
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),07-Mar,0.001230906,0.013625724,0,0,21.43158284,143.5917111,NPM1;EIF6;RAN
positive regulation of mRNA binding (GO:1902416),07-Mar,0.001230906,0.013625724,0,0,21.43158284,143.5917111,EIF3E;EIF3C;EIF4G1
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),07-Mar,0.001230906,0.013625724,0,0,21.43158284,143.5917111,PSMC5;PSMC6;PSMC3
protein modification process (GO:0036211),9/78,0.00128244,0.014138249,0,0,3.747955873,24.95760299,UBL5;RPN2;UBE2S;UBE2D3;RPN1;NEDD8;UBA52;UBE2L3;UBE2M
negative regulation of cellular protein metabolic process (GO:0032269),10/94,0.001322887,0.014500301,0,0,3.423197381,22.68874226,CSTB;DDX3X;NCL;CAPRIN1;RPS3;RPL13A;YBX1;CALR;GAPDH;TOB1
endoplasmic reticulum tubular network organization (GO:0071786),15-Apr,0.001332711,0.014500301,0,0,10.4026936,68.87145368,RAB10;RTN3;RAB18;RTN4
modulation by host of viral genome replication (GO:0044827),15-Apr,0.001332711,0.014500301,0,0,10.4026936,68.87145368,VAPA;NUCKS1;PHB;PPIB
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),25-May,0.001342123,0.014500301,0,0,7.159124629,47.34688713,FKBP1A;GSTO1;CALM3;CALM1;CALM2
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),25-May,0.001342123,0.014500301,0,0,7.159124629,47.34688713,APP;CALM3;CALM1;CALM2;UBE2K
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),8/64,0.001401225,0.015055455,0,0,4.101554184,26.9488861,NDUFA13;DDX3X;TMBIM6;ENO1;PARK7;SOD2;PPIA;TPT1
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),9/79,0.001404656,0.015055455,0,0,3.694221748,24.26351227,BCAP31;GSK3B;VCP;SUMO1;CSNK1A1;SUMO2;STUB1;GABARAP;RBX1
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",6/37,0.001417865,0.015136972,0,0,5.547620189,36.38463787,DDB1;UBB;UBC;RPS27A;UBA52;RBX1
DNA duplex unwinding (GO:0032508),7/51,0.001592023,0.016876454,0,0,4.563683712,29.40267134,DDB1;UBB;DDX1;UBC;RPS27A;UBA52;RBX1
Golgi organization (GO:0007030),12/130,0.001593297,0.016876454,0,0,2.927807283,18.86078725,RAB2A;CDC42;TMED9;GOLPH3;TMED10;GORASP2;CSNK1A1;SURF4;ARL1;TMED3;TMED2;YWHAZ
maturation of LSU-rRNA (GO:0000470),26-May,0.001615777,0.01698138,0,0,6.817860675,43.8247933,RPL7A;EIF6;RPL35;RPL10A;RPL7
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),26-May,0.001615777,0.01698138,0,0,6.817860675,43.8247933,RPL5;HSP90AB1;RPS7;RPL23;RPL11
positive regulation of intracellular protein transport (GO:0090316),13/148,0.001629552,0.017059765,0,0,2.774085196,17.80810194,YWHAE;GSK3B;SAR1A;YWHAB;UBE2D3;OAZ1;YWHAZ;UBE2L3;UBL5;YWHAQ;TOMM7;ANP32B;RAN
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),9/81,0.001677171,0.017490499,0,0,3.591231343,22.95029085,MTCH1;VCP;DAP;FAM162A;RPS27L;CYCS;ANP32B;HSPE1;HSPD1
negative regulation of protein-containing complex assembly (GO:0031333),7/52,0.001786751,0.018561591,0,0,4.462037037,28.23289925,CDC42;GSK3B;DDX3X;HSPA5;RPL13A;HMGB1;PARK7
regulation of peptidyl-threonine phosphorylation (GO:0010799),6/39,0.001878905,0.019289879,0,0,5.210860462,32.70891495,APP;CALM3;CALM1;CALM2;UBE2K;EIF4G1
"nucleotide-excision repair, DNA incision (GO:0033683)",6/39,0.001878905,0.019289879,0,0,5.210860462,32.70891495,DDB1;UBB;UBC;RPS27A;UBA52;RBX1
protein N-linked glycosylation (GO:0006487),8/67,0.001889462,0.019289879,0,0,3.892394352,24.41100694,OST4;KRTCAP2;RPN2;DAD1;OSTC;RPN1;STT3A;DDOST
protein retention in ER lumen (GO:0006621),08-Mar,0.001919863,0.019289879,0,0,17.1443787,107.2466876,RER1;KDELR1;KDELR2
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),08-Mar,0.001919863,0.019289879,0,0,17.1443787,107.2466876,CALM3;CALM1;CALM2
regulation of endodeoxyribonuclease activity (GO:0032071),08-Mar,0.001919863,0.019289879,0,0,17.1443787,107.2466876,NPM1;RPS3;HMGB1
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),08-Mar,0.001919863,0.019289879,0,0,17.1443787,107.2466876,EIF5A;RPS7;UBB
mitophagy (GO:0000423),08-Mar,0.001919863,0.019289879,0,0,17.1443787,107.2466876,MAP1LC3B;PHB2;SQSTM1
cellular response to unfolded protein (GO:0034620),27-May,0.001928274,0.019289879,0,0,6.507620718,40.67998378,HSPA9;HSPA8;HSPA5;TMBIM6;HSPD1
negative regulation of cation channel activity (GO:2001258),27-May,0.001928274,0.019289879,0,0,6.507620718,40.67998378,FKBP1A;GSTO1;CALM3;CALM1;CALM2
positive regulation of NIK/NF-kappaB signaling (GO:1901224),7/53,0.001999462,0.019928217,0,0,4.364809783,27.12675646,APP;DDX3X;RPS3;ACTN4;PHB;PHB2;RHOA
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),6/40,0.002148039,0.021330346,0,0,5.057337645,31.06823567,BCAP31;EIF5A;UBB;RPS7;RPS3;SOD1
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),17-Apr,0.002201515,0.021544541,0,0,8.801367521,53.85212923,GSTO1;CALM3;CALM1;CALM2
copper ion homeostasis (GO:0055070),17-Apr,0.002201515,0.021544541,0,0,8.801367521,53.85212923,APP;ARF1;COMMD1;ATOX1
establishment of protein localization to endoplasmic reticulum (GO:0072599),17-Apr,0.002201515,0.021544541,0,0,8.801367521,53.85212923,RAB10;SEC61A1;SPCS1;SEC61G
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),17-Apr,0.002201515,0.021544541,0,0,8.801367521,53.85212923,CALM3;CALM1;CALM2;EIF4G1
carbohydrate catabolic process (GO:0016052),6/41,0.00244525,0.02375763,0,0,4.912587561,29.5423747,TPI1;PGAM1;PGK1;ENO1;ALDOA;GAPDH
regulation of protein dephosphorylation (GO:0035304),6/41,0.00244525,0.02375763,0,0,4.912587561,29.5423747,YWHAB;CALM3;CALM1;CALM2;PPIA;HSP90B1
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),7/55,0.00248322,0.024040066,0,0,4.182508681,25.08751944,RPL5;UBXN1;RPL11;RPS3;CTNNB1;PARK7;SQSTM1
mitochondrion organization (GO:0007005),14/175,0.002648344,0.025547065,0,0,2.50539392,14.86655807,BCAP31;TIMM8B;TIMM13;TIMM23;COX7A2;PARK7;PHB;PHB2;TOMM20;HSPD1;CHCHD2;TIMM17A;TOMM7;CYCS
hydrogen peroxide metabolic process (GO:0042743),29-May,0.002682325,0.025600562,0,0,5.964700791,35.31741941,PRDX2;PRDX5;PRDX1;PARK7;SOD1
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),29-May,0.002682325,0.025600562,0,0,5.964700791,35.31741941,UBB;UBC;RPS27A;UBA52;HSPD1
protein K11-linked ubiquitination (GO:0070979),29-May,0.002682325,0.025600562,0,0,5.964700791,35.31741941,ANAPC13;UBE2S;UBE2D3;ANAPC5;UBE2L3
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),18-Apr,0.002755235,0.02611189,0,0,8.172275132,48.16945458,P4HB;SOD2;PPIA;SOD1
positive regulation of phosphoprotein phosphatase activity (GO:0032516),18-Apr,0.002755235,0.02611189,0,0,8.172275132,48.16945458,HSP90AB1;CALM3;CALM1;CALM2
ATF6-mediated unfolded protein response (GO:0036500),09-Mar,0.002807412,0.026329239,0,0,14.2862426,83.93870513,HSPA5;CALR;HSP90B1
CD40 signaling pathway (GO:0023035),09-Mar,0.002807412,0.026329239,0,0,14.2862426,83.93870513,ITGB1;PHB;PHB2
positive regulation of autophagy of mitochondrion (GO:1903599),09-Mar,0.002807412,0.026329239,0,0,14.2862426,83.93870513,VDAC1;PARK7;SLC25A5
RNA-dependent DNA biosynthetic process (GO:0006278),30-May,0.003130202,0.029154054,0,0,5.725816024,33.01882134,HSP90AA1;HSP90AB1;PTGES3;PPIA;NOP10
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),30-May,0.003130202,0.029154054,0,0,5.725816024,33.01882134,UBB;UBE2D3;UBC;RPS27A;UBA52
post-Golgi vesicle-mediated transport (GO:0006892),9/89,0.003218381,0.029872331,0,0,3.230764925,18.54096158,NAPA;RAB10;APP;HSPA8;ARF1;RAB14;FTH1;CHMP2A;COMMD1
chromosome organization (GO:0051276),10/106,0.003247148,0.029933603,0,0,2.993429248,17.15228475,DDB1;COPS6;UBB;UBC;GATAD1;NUCKS1;COPS7A;RPS27A;UBA52;RBX1
protein localization to nucleus (GO:0034504),10/106,0.003247148,0.029933603,0,0,2.993429248,17.15228475,YWHAE;TBRG1;SEC13;RPL11;LMNA;HNRNPU;TOR1AIP2;CALR;PHB2;RAN
endoplasmic reticulum mannose trimming (GO:1904380),19-Apr,0.003397252,0.031105013,0,0,7.627061728,43.35823121,UBB;UBC;RPS27A;UBA52
protein import into mitochondrial matrix (GO:0030150),19-Apr,0.003397252,0.031105013,0,0,7.627061728,43.35823121,TIMM17A;TIMM23;ROMO1;TOMM20
positive regulation of cellular biosynthetic process (GO:0031328),14/180,0.003420573,0.031212724,0,0,2.429296132,13.79341549,RPL5;HSP90AA1;NPM1;DDX3X;HSP90AB1;RPS27L;PARK7;EEF2;RPS4X;DDB1;EIF6;EIF3E;RPL26;EIF3C
"regulation of mRNA splicing, via spliceosome (GO:0048024)",9/90,0.003471035,0.031566548,0,0,3.190713101,18.06997366,DDX5;MBNL2;HNRNPK;PUF60;NCL;TRA2B;HNRNPU;SRSF3;PRDX6
MyD88-independent toll-like receptor signaling pathway (GO:0002756),31-May,0.003629542,0.032787268,0,0,5.505307008,30.93238659,UBB;UBE2D3;UBC;RPS27A;UBA52
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),31-May,0.003629542,0.032787268,0,0,5.505307008,30.93238659,HSP90AB1;UBXN1;RPL11;EIF3H;PARK7
response to reactive oxygen species (GO:0000302),7/59,0.003716029,0.033456646,0,0,3.859975962,21.59695036,PRDX5;GSTP1;TPM1;RPS3;ROMO1;SOD2;SOD1
toll-like receptor signaling pathway (GO:0002224),9/91,0.003739005,0.033551674,0,0,3.151638151,17.61430272,UBB;UBE2D3;UBC;HMGB1;RPS27A;UBA52;CTSB;HSP90B1;HSPD1
endothelial tube morphogenesis (GO:0061154),10-Mar,0.003909962,0.034854146,0,0,12.24471682,67.88749849,CSNK2B;CTNNB1;RHOA
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),10-Mar,0.003909962,0.034854146,0,0,12.24471682,67.88749849,ACADL;ETFA;ETFB
regulation of programmed necrotic cell death (GO:0062098),20-Apr,0.004133894,0.036729103,0,0,7.15,39.24302883,HSP90AA1;PDCD6IP;CDC37;STUB1
protein transmembrane import into intracellular organelle (GO:0044743),5/32,0.004183508,0.036926978,0,0,5.301131993,29.03220674,TIMM17A;TIMM23;ROMO1;TOMM20;HSPD1
cellular response to topologically incorrect protein (GO:0035967),5/32,0.004183508,0.036926978,0,0,5.301131993,29.03220674,HSPA9;HSPA8;HSPA5;STUB1;TMBIM6
positive regulation of gene expression (GO:0010628),28/482,0.004262243,0.03749941,0,0,1.787409407,9.755608467,RPL5;APP;GSK3B;DDX5;DDX3X;RPL11;RPS27L;PARK7;PHB;ACTB;ACTG1;RPS4X;RPS3;POLR2F;POLR2L;NPM1;RPS7;RPL23;SMARCA5;MIF;EEF2;SOD1;EIF6;EIF3E;RPL26;EIF3C;GAPDH;ATF4
regulation of cellular protein localization (GO:1903827),6/46,0.004415863,0.038474989,0,0,4.297399703,23.30287313,VCP;HSP90AA1;HSP90AB1;SUMO3;CTNNB1;RAB11B
regulation of fibroblast proliferation (GO:0048145),6/46,0.004415863,0.038474989,0,0,4.297399703,23.30287313,CDK4;GSTP1;FTH1;NDUFS4;CTNNB1;MIF
postreplication repair (GO:0006301),6/46,0.004415863,0.038474989,0,0,4.297399703,23.30287313,VCP;UBB;UBC;UBE2N;RPS27A;UBA52
pattern recognition receptor signaling pathway (GO:0002221),7/61,0.004484014,0.038943161,0,0,3.716628086,20.09668721,UBB;UBC;HMGB1;RPS27A;UBA52;CTSB;HSP90B1
positive regulation of transferase activity (GO:0051347),12/148,0.004659522,0.040337724,0,0,2.537922215,13.62570422,CCT2;HSP90AA1;HSP90AB1;PTGES3;TCP1;HNRNPA2B1;UBE2N;CTNNB1;DBI;RPS2;UBE2L3;CCT4
negative regulation of apoptotic signaling pathway (GO:2001234),8/78,0.004911033,0.042319956,0,0,3.278858846,17.43130196,NDUFA13;PRELID1;DDX3X;GSTP1;TMBIM6;GHITM;PARK7;SLC25A5
regulation of DNA binding (GO:0051101),6/47,0.004919832,0.042319956,0,0,4.192367629,22.28025768,SUMO1;SUMO3;CSNK2B;EDF1;HMGB1;NME1
error-prone translesion synthesis (GO:0042276),21-Apr,0.004971253,0.042491629,0,0,6.729063181,35.69151179,UBB;UBC;RPS27A;UBA52
positive regulation of phosphatase activity (GO:0010922),21-Apr,0.004971253,0.042491629,0,0,6.729063181,35.69151179,HSP90AB1;CALM3;CALM1;CALM2
actin filament depolymerization (GO:0030042),11-Mar,0.005241544,0.04410408,0,0,10.71357249,56.25846056,CFL1;DSTN;TWF1
negative regulation of calcium ion transmembrane transport (GO:1903170),11-Mar,0.005241544,0.04410408,0,0,10.71357249,56.25846056,FKBP1A;YWHAE;VDAC1
positive regulation of cellular respiration (GO:1901857),11-Mar,0.005241544,0.04410408,0,0,10.71357249,56.25846056,PRELID1;VCP;PARK7
positive regulation of viral release from host cell (GO:1902188),11-Mar,0.005241544,0.04410408,0,0,10.71357249,56.25846056,DDB1;VAPA;CHMP2A
proteasome assembly (GO:0043248),11-Mar,0.005241544,0.04410408,0,0,10.71357249,56.25846056,PSMD11;PSMD4;POMP
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),8/79,0.005306119,0.044323406,0,0,3.232509813,16.93477823,GSK3B;VCP;SUMO1;CSNK1A1;SUMO2;STUB1;GABARAP;RBX1
translational termination (GO:0006415),9/96,0.005330766,0.044323406,0,0,2.969737519,15.54437908,MRPL52;MRPL30;MRPL42;MRPL20;MRPS21;ETF1;MRPL23;GSPT1;MRPL33
amyloid fibril formation (GO:1990000),7/63,0.00536607,0.044323406,0,0,3.583519345,18.73341919,FKBP1A;APP;UBB;UBC;RPS27A;UBA52;ITM2B
COPII vesicle coating (GO:0048208),7/63,0.00536607,0.044323406,0,0,3.583519345,18.73341919,NAPA;SEC13;TMED10;TFG;PDCD6;TMED2;SEC31A
vesicle coating (GO:0006901),7/63,0.00536607,0.044323406,0,0,3.583519345,18.73341919,NAPA;SEC13;TMED10;TFG;PDCD6;TMED2;SEC31A
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",7/63,0.00536607,0.044323406,0,0,3.583519345,18.73341919,NAPA;SEC13;TMED10;TFG;PDCD6;TMED2;SEC31A
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),5/34,0.005467857,0.044889609,0,0,4.935025069,25.70589677,YWHAE;GSK3B;YWHAQ;YWHAB;YWHAZ
positive regulation of protein dephosphorylation (GO:0035307),5/34,0.005467857,0.044889609,0,0,4.935025069,25.70589677,HSP90AB1;CALM3;CALM1;CALM2;PPIA
glutathione derivative biosynthetic process (GO:1901687),22-Apr,0.005915167,0.04797858,0,0,6.354897119,32.60211866,GSTO1;GSTP1;ESD;AKR1A1
glutathione derivative metabolic process (GO:1901685),22-Apr,0.005915167,0.04797858,0,0,6.354897119,32.60211866,GSTO1;GSTP1;ESD;AKR1A1
negative regulation of protein dephosphorylation (GO:0035308),22-Apr,0.005915167,0.04797858,0,0,6.354897119,32.60211866,YWHAE;FKBP1A;GSK3B;YWHAB
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),22-Apr,0.005915167,0.04797858,0,0,6.354897119,32.60211866,GSTO1;CALM3;CALM1;CALM2
inner mitochondrial membrane organization (GO:0007007),6/49,0.006052565,0.048946044,0,0,3.996959121,20.41356174,HSPA9;TIMM8B;NDUFA13;TIMM13;ROMO1;GHITM
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),9/98,0.006097182,0.04901336,0,0,2.902699983,14.80356257,ARF1;SEC13;DCTN2;CANX;DCTN3;AP2S1;DYNLL1;AP2M1;SEC31A
RNA splicing (GO:0008380),9/98,0.006097182,0.04901336,0,0,2.902699983,14.80356257,PPP2CA;SF3B2;SNRPD2;PPP2R1A;TRA2B;SNRPF;HNRNPC;TXNL4A;SNRPB
ephrin receptor signaling pathway (GO:0048013),8/82,0.00663782,0.053201046,0,0,3.100978773,15.55132059,CDC42;ARPC1A;AP2S1;RAC1;ACTB;AP2M1;RHOA;ACTG1
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),12-Mar,0.006813995,0.053972438,0,0,9.522682446,47.50653576,CALM3;CALM1;CALM2
early endosome to Golgi transport (GO:0034498),12-Mar,0.006813995,0.053972438,0,0,9.522682446,47.50653576,TMED9;SURF4;RAB6A
Golgi localization (GO:0051645),12-Mar,0.006813995,0.053972438,0,0,9.522682446,47.50653576,CDC42;YWHAZ;ARCN1
morphogenesis of a polarized epithelium (GO:0001738),12-Mar,0.006813995,0.053972438,0,0,9.522682446,47.50653576,RAB10;ACTB;ACTG1
protein modification by small protein conjugation (GO:0032446),24/409,0.006905479,0.054106879,0,0,1.80217706,8.96662416,VCP;UBE2D3;NEDD8;COMMD1;RBX1;UBE2L3;DDB1;PCNP;UFM1;SUMO1;UBB;UBE2S;SUMO3;NEDD4;SUMO2;UBC;UFC1;UBE2N;STUB1;UBA1;RPS27A;UBA52;UBE2K;UBE2M
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),9/100,0.00694574,0.054106879,0,0,2.838609152,14.1068281,ARF1;SEC13;DCTN2;CANX;DCTN3;AP2S1;DYNLL1;AP2M1;SEC31A
regulation of necroptotic process (GO:0060544),23-Apr,0.006971194,0.054106879,0,0,6.020116959,29.89571309,HSP90AA1;PDCD6IP;CDC37;STUB1
regulation of protein export from nucleus (GO:0046825),23-Apr,0.006971194,0.054106879,0,0,6.020116959,29.89571309,YWHAE;GSK3B;PARK7;ANP32B
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),23-Apr,0.006971194,0.054106879,0,0,6.020116959,29.89571309,GSTO1;CALM3;CALM1;CALM2
nucleotide metabolic process (GO:0009117),23-Apr,0.006971194,0.054106879,0,0,6.020116959,29.89571309,NME2;CMPK1;PARK7;REXO2
positive regulation of protein autophosphorylation (GO:0031954),23-Apr,0.006971194,0.054106879,0,0,6.020116959,29.89571309,DDX3X;CALM3;CALM1;CALM2
cellular response to starvation (GO:0009267),12/158,0.007766622,0.060107868,0,0,2.362859666,11.47858313,HSPA8;DAP;MAP1LC3B;SEC13;HSPA5;RHEB;LAMP2;LAMTOR2;ATP6V0C;GABARAP;ATF4;ATP6V1F
tRNA transport (GO:0051031),5/37,0.007881404,0.060652502,0,0,4.471670994,21.65741725,SEC13;SSB;YBX1;TOMM20;RAN
regulation of protein catabolic process (GO:0042176),9/102,0.007881906,0.060652502,0,0,2.777274916,13.45085768,EEF1A1;SNX3;DDB1;GSK3B;NDUFA13;VCP;NEDD4;PHB;OAZ1
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),7/68,0.008135796,0.062142763,0,0,3.288934426,15.82464791,FKBP1A;UBB;UBC;STRAP;STUB1;RPS27A;UBA52
"nucleotide-excision repair, DNA gap filling (GO:0006297)",24-Apr,0.00814459,0.062142763,0,0,5.718814815,27.50979448,UBB;UBC;RPS27A;UBA52
"protein alpha-1,2-demannosylation (GO:0036508)",24-Apr,0.00814459,0.062142763,0,0,5.718814815,27.50979448,UBB;UBC;RPS27A;UBA52
regulation of cell cycle G2/M phase transition (GO:1902749),8/85,0.008208139,0.06245122,0,0,2.979696905,14.31037899,YWHAE;HSP90AA1;NPM1;DCTN2;PPP2R1A;DCTN3;DYNLL1;TUBB4B
antigen processing and presentation of exogenous peptide antigen (GO:0002478),9/103,0.008384567,0.063614373,0,0,2.747586535,13.13720714,ARF1;SEC13;DCTN2;CANX;DCTN3;AP2S1;DYNLL1;AP2M1;SEC31A
protein neddylation (GO:0045116),13-Mar,0.008637122,0.064622899,0,0,8.569970414,40.72180724,NEDD8;RBX1;UBE2M
regulation of actomyosin structure organization (GO:0110020),13-Mar,0.008637122,0.064622899,0,0,8.569970414,40.72180724,CDC42;RAC1;ACTG1
regulation of cell communication by electrical coupling (GO:0010649),13-Mar,0.008637122,0.064622899,0,0,8.569970414,40.72180724,CALM3;CALM1;CALM2
detection of calcium ion (GO:0005513),13-Mar,0.008637122,0.064622899,0,0,8.569970414,40.72180724,CALM3;CALM1;CALM2
regulation of protein acetylation (GO:1901983),13-Mar,0.008637122,0.064622899,0,0,8.569970414,40.72180724,GSK3B;DDX3X;PARK7
negative regulation of proteasomal protein catabolic process (GO:1901799),5/38,0.008827666,0.065866092,0,0,4.335941012,20.50841414,HSP90AB1;UBXN1;RPL11;EIF3H;PARK7
IRE1-mediated unfolded protein response (GO:0036498),6/53,0.008869357,0.065994854,0,0,3.656033638,17.2753184,HSPA5;LMNA;SSR1;HDGF;PDIA6;SEC31A
regulation of proteasomal protein catabolic process (GO:0061136),6/54,0.009699122,0.071970683,0,0,3.579680535,16.59439633,PSMC5;HSP90AB1;PSMC6;UBB;PSMC3;COMMD1
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),7/71,0.010234953,0.073506937,0,0,3.134277344,14.36109145,CDC42;HSP90AA1;HSP90AB1;ARPC1A;RAC1;ACTB;ACTG1
response to metal ion (GO:0010038),7/71,0.010234953,0.073506937,0,0,3.134277344,14.36109145,PPP2CA;PDCD6;NEDD4;CALM3;CALM1;CALM2;SEC31A
interstrand cross-link repair (GO:0036297),6/55,0.010582704,0.073506937,0,0,3.506443885,15.94918044,VCP;UBB;UBC;NUCKS1;RPS27A;UBA52
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),8/89,0.010715544,0.073506937,0,0,2.831962613,12.84595209,YWHAE;BCAP31;NDUFA13;DDX3X;DNAJB6;PDCD6;CYCS;HMGB1
cellular copper ion homeostasis (GO:0006878),14-Mar,0.010718855,0.073506937,0,0,7.790478752,35.33567153,APP;ARF1;ATOX1
regulation of lamellipodium organization (GO:1902743),14-Mar,0.010718855,0.073506937,0,0,7.790478752,35.33567153,CDC42;TWF1;RAC1
COPII-coated vesicle cargo loading (GO:0090110),14-Mar,0.010718855,0.073506937,0,0,7.790478752,35.33567153,SEC13;SAR1A;SEC31A
regulation of response to interferon-gamma (GO:0060330),14-Mar,0.010718855,0.073506937,0,0,7.790478752,35.33567153,HSP90AB1;SUMO1;CDC37
polarized epithelial cell differentiation (GO:0030859),14-Mar,0.010718855,0.073506937,0,0,7.790478752,35.33567153,CDC42;RAB10;RHOA
protein polyufmylation (GO:1990564),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,UFM1;UFC1
activation of protein kinase C activity (GO:1990051),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,PHB;PHB2
beta-catenin destruction complex assembly (GO:1904885),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,GSK3B;CSNK1A1
regulation of cytochrome-c oxidase activity (GO:1904959),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,NDUFA4;PHB2
cellular response to indole-3-methanol (GO:0071681),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,CTNNA1;CTNNB1
CRD-mediated mRNA stabilization (GO:0070934),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,HNRNPU;YBX1
regulation of mitophagy (GO:1901524),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,VDAC1;SLC25A5
regulation of mRNA binding (GO:1902415),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,EIF3E;EIF3C
regulation of protein monoubiquitination (GO:1902525),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,UBB;PDCD6
response to indole-3-methanol (GO:0071680),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,CTNNA1;CTNNB1
ribosome localization (GO:0033750),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,EIF6;RAN
isocitrate metabolic process (GO:0006102),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,IDH3B;IDH3A
"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,SEC61A1;SEC61B
stress granule disassembly (GO:0035617),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,VCP;KIF5B
mature ribosome assembly (GO:0042256),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,DDX3X;EIF6
negative regulation of calcium ion transport into cytosol (GO:0010523),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,FKBP1A;TMBIM6
negative regulation of protein acetylation (GO:1901984),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,GSK3B;PARK7
positive regulation of low-density lipoprotein receptor activity (GO:1905599),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,HNRNPK;CNPY2
positive regulation of protein monoubiquitination (GO:1902527),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,UBB;PDCD6
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,HMGB1;RTN4
positive regulation of translation in response to stress (GO:0032056),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,DDX3X;EIF4G1
protein K69-linked ufmylation (GO:1990592),05-Feb,0.010749811,0.073506937,0,0,19.02314131,86.22937121,UFM1;UFC1
clathrin-dependent endocytosis (GO:0072583),26-Apr,0.010862946,0.073720647,0,0,5.198383838,23.50915922,CANX;CLTB;AP2S1;AP2M1
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),26-Apr,0.010862946,0.073720647,0,0,5.198383838,23.50915922,YWHAE;YWHAQ;YWHAB;YWHAZ
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),26-Apr,0.010862946,0.073720647,0,0,5.198383838,23.50915922,YWHAE;YWHAQ;YWHAB;YWHAZ
Fc-gamma receptor signaling pathway (GO:0038094),7/72,0.01101503,0.074565407,0,0,3.085897436,13.91275171,CDC42;HSP90AA1;HSP90AB1;ARPC1A;RAC1;ACTB;ACTG1
positive regulation of binding (GO:0051099),8/90,0.011422326,0.077129258,0,0,2.797281088,12.50995964,FKBP1A;APP;GSK3B;RPL11;EDF1;HMGB1;RAN;NME1
ubiquitin-dependent ERAD pathway (GO:0030433),7/73,0.011837327,0.079732221,0,0,3.038983586,13.48244283,VCP;PSMC6;HSPA5;STUB1;SEC61B;UBXN4;HSP90B1
regulation of mitochondrial membrane potential (GO:0051881),5/41,0.012130947,0.081304436,0,0,3.973994395,17.53324537,VCP;PRELID1;UBB;PARK7;SOD1
JNK cascade (GO:0007254),5/41,0.012130947,0.081304436,0,0,3.973994395,17.53324537,UBB;UBC;UBE2N;RPS27A;UBA52
protein peptidyl-prolyl isomerization (GO:0000413),27-Apr,0.012416806,0.082605401,0,0,4.972109501,21.82111889,FKBP1A;FKBP4;PPIB;PPIA
stress-activated protein kinase signaling cascade (GO:0031098),27-Apr,0.012416806,0.082605401,0,0,4.972109501,21.82111889,UBB;UBC;RPS27A;UBA52
nucleobase-containing small molecule interconversion (GO:0015949),27-Apr,0.012416806,0.082605401,0,0,4.972109501,21.82111889,TXNRD1;NME2;CMPK1;NME1
dicarboxylic acid metabolic process (GO:0043648),6/57,0.012518267,0.083075773,0,0,3.368586662,14.75631731,MDH1;MDH2;GOT2;OGDH;SDHA;GCLM
positive regulation of macromolecule biosynthetic process (GO:0010557),10/129,0.012598725,0.083404792,0,0,2.411978244,10.55037801,RPS4X;RPL5;NPM1;DDX3X;EIF6;RPS27L;EIF3E;RPL26;EEF2;EIF3C
cellular response to amino acid starvation (GO:0034198),7/74,0.012703049,0.083685208,0,0,2.993470149,13.06923096,SEC13;DAP;RHEB;LAMTOR2;ATP6V0C;ATF4;ATP6V1F
Fc receptor mediated stimulatory signaling pathway (GO:0002431),7/74,0.012703049,0.083685208,0,0,2.993470149,13.06923096,CDC42;HSP90AA1;HSP90AB1;ARPC1A;RAC1;ACTB;ACTG1
cellular response to arsenic-containing substance (GO:0071243),15-Mar,0.013065397,0.085447066,0,0,7.140902367,30.97572039,VCP;DDX3X;GSTO1
endoplasmic reticulum to cytosol transport (GO:1903513),15-Mar,0.013065397,0.085447066,0,0,7.140902367,30.97572039,VCP;SEC61B;HSP90B1
positive regulation of protein export from nucleus (GO:0046827),15-Mar,0.013065397,0.085447066,0,0,7.140902367,30.97572039,YWHAE;GSK3B;ANP32B
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),5/42,0.013395628,0.087184556,0,0,3.866388644,16.67506497,RPL5;RPS7;RPL23;RPL11;COMMD1
translesion synthesis (GO:0019985),5/42,0.013395628,0.087184556,0,0,3.866388644,16.67506497,VCP;UBB;UBC;RPS27A;UBA52
positive regulation of protein binding (GO:0032092),6/58,0.013573638,0.08796592,0,0,3.303634701,14.20439285,PPP2CA;FKBP1A;APP;GSK3B;RPL11;RAN
response to amino acid starvation (GO:1990928),7/75,0.013613386,0.08796592,0,0,2.949295343,12.6722424,SEC13;DAP;RHEB;LAMTOR2;ATP6V0C;ATF4;ATP6V1F
nucleic acid phosphodiester bond hydrolysis (GO:0090305),7/75,0.013613386,0.08796592,0,0,2.949295343,12.6722424,DDB1;UBB;DDX1;UBC;RPS27A;UBA52;RBX1
negative regulation of oxidative stress-induced cell death (GO:1903202),28-Apr,0.014105821,0.090713863,0,0,4.764691358,20.30314906,PARK7;SOD2;PPIA;ATF4
protein localization to Golgi apparatus (GO:0034067),28-Apr,0.014105821,0.090713863,0,0,4.764691358,20.30314906,GOLPH3;TMED10;ARL1;RAB6A
negative regulation of gene expression (GO:0010629),19/322,0.014340065,0.092001225,0,0,1.806890689,7.669705123,APP;RNH1;NDFIP1;DDX3X;RPL13A;CNPY2;MIF;PARK7;YBX1;TOB1;RPS26;NCL;CAPRIN1;RPS3;TMBIM6;CALR;RBBP7;GAPDH;RPS13
regulation of RNA splicing (GO:0043484),7/76,0.01456951,0.09325177,0,0,2.906400966,12.29065897,RPS26;MBNL2;HNRNPK;TRA2B;SRSF3;TMBIM6;RPS13
fatty acid oxidation (GO:0019395),6/59,0.014689596,0.093798104,0,0,3.241133758,13.67958039,HADHB;HADHA;ACADL;SCP2;HADH;ACAT1
DNA synthesis involved in DNA repair (GO:0000731),5/43,0.014746228,0.093937648,0,0,3.764446353,15.87379668,VCP;UBB;UBC;RPS27A;UBA52
RNA metabolic process (GO:0016070),10/133,0.01534839,0.096929305,0,0,2.333053824,9.7445702,HNRNPA3;HNRNPK;DDX3X;PCBP1;HNRNPA2B1;HNRNPU;POLR2F;HNRNPC;SND1;POLR2L
mRNA metabolic process (GO:0016071),8/95,0.015480716,0.096929305,0,0,2.635832605,10.98657248,DDX5;SF3B2;RNH1;SSB;HNRNPA2B1;SNRPF;SRSF5;SNRPB
positive regulation of type I interferon production (GO:0032481),7/77,0.015572576,0.096929305,0,0,2.864732143,11.9237138,HSP90AA1;DDX3X;POLR2F;CTNNB1;GAPDH;HSPD1;POLR2L
neuron projection organization (GO:0106027),16-Mar,0.015681364,0.096929305,0,0,6.59126081,27.3885492,APP;GSK3B;ARF1
protein localization to endoplasmic reticulum (GO:0070972),16-Mar,0.015681364,0.096929305,0,0,6.59126081,27.3885492,BCAP31;HSPA5;VAPA
protein ufmylation (GO:0071569),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,UFM1;UFC1
axo-dendritic transport (GO:0008088),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,APP;HSPA8
cellular heat acclimation (GO:0070370),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,HSBP1;RBBP7
free ubiquitin chain polymerization (GO:0010994),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,UBE2S;UBE2K
heat acclimation (GO:0010286),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,HSBP1;RBBP7
morphogenesis of an endothelium (GO:0003159),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,CSNK2B;CTNNB1
negative regulation of cellular response to hypoxia (GO:1900038),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,TMBIM6;ENO1
positive regulation of RNA binding (GO:1905216),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,EIF3E;EIF3C
positive regulation of tau-protein kinase activity (GO:1902949),06-Feb,0.015763947,0.096929305,0,0,14.26661743,59.2068868,HSP90AA1;HSP90AB1
regulation of calcium ion transmembrane transporter activity (GO:1901019),29-Apr,0.015933584,0.096929305,0,0,4.573866667,18.93272602,YWHAE;FKBP1A;CALM1;CALM2
regulation of ubiquitin-protein transferase activity (GO:0051438),29-Apr,0.015933584,0.096929305,0,0,4.573866667,18.93272602,UBE2N;PARK7;RPS2;UBE2L3
lamellipodium organization (GO:0097581),29-Apr,0.015933584,0.096929305,0,0,4.573866667,18.93272602,ITGB1;GOLPH3;CTTN;RAC1
telomere maintenance via telomerase (GO:0007004),29-Apr,0.015933584,0.096929305,0,0,4.573866667,18.93272602,HSP90AA1;HSP90AB1;PTGES3;NOP10
positive regulation of dephosphorylation (GO:0035306),29-Apr,0.015933584,0.096929305,0,0,4.573866667,18.93272602,CALM3;CALM1;CALM2;PPIA
positive regulation of viral genome replication (GO:0045070),29-Apr,0.015933584,0.096929305,0,0,4.573866667,18.93272602,DDB1;DDX3X;PABPC1;PPIA
cellular transition metal ion homeostasis (GO:0046916),8/96,0.01640344,0.099563351,0,0,2.605744479,10.71029829,APP;ARF1;NDFIP1;GLRX3;FTH1;NEDD8;ATOX1;SOD1
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",30-Apr,0.017903339,0.108423587,0,0,4.397720798,17.69101059,RPS14;RPS16;RPS8;RPS21
negative regulation of neuron death (GO:1901215),8/98,0.018366786,0.110981409,0,0,2.547574102,10.18319209,GSK3B;SET;PARK7;NENF;SOD2;ATF4;EIF4G1;SOD1
positive regulation of cysteine-type endopeptidase activity (GO:2001056),6/62,0.018416679,0.111034487,0,0,3.067023986,12.25122288,BCAP31;NDUFA13;DDX3X;PDCD6;CYCS;HMGB1
"retrograde protein transport, ER to cytosol (GO:0030970)",17-Mar,0.01856991,0.111708968,0,0,6.120139476,24.39617804,VCP;SEC61B;HSP90B1
regulation of NIK/NF-kappaB signaling (GO:1901222),7/80,0.018874632,0.11303854,0,0,2.746575342,10.90372962,APP;DDX3X;RPS3;ACTN4;PHB;PHB2;RHOA
regulation of protein localization to plasma membrane (GO:1903076),7/80,0.018874632,0.11303854,0,0,2.746575342,10.90372962,ITGB1;TMEM59;KIF5B;TMBIM1;SQSTM1;ACTB;AP2M1
regulation of protein binding (GO:0043393),9/118,0.019190392,0.114675328,0,0,2.367629741,9.360058506,PPP2CA;FKBP1A;APP;GSK3B;RPL11;TMBIM6;PARK7;ACTB;RAN
spliceosomal complex assembly (GO:0000245),5/46,0.019336088,0.115036945,0,0,3.48845625,13.7646882,PUF60;SNRPD2;DDX1;SRSF5;TXNL4A
positive regulation of nucleocytoplasmic transport (GO:0046824),5/46,0.019336088,0.115036945,0,0,3.48845625,13.7646882,YWHAE;GSK3B;NEDD4;ANP32B;RAN
RNA processing (GO:0006396),12/179,0.019390913,0.115109575,0,0,2.063471258,8.136165472,TSEN34;PPP2CA;SF3B2;HNRNPK;SNRPD2;PPP2R1A;HNRNPA2B1;HNRNPU;SNRPF;SRSF5;HNRNPC;SNRPB
positive regulation of viral process (GO:0048524),6/63,0.01979043,0.117223575,0,0,3.013060139,11.81889958,DDB1;DDX3X;POLR2F;PABPC1;PPIA;POLR2L
regulation of developmental growth (GO:0048638),4/31,0.02001798,0.117540358,0,0,4.234622771,16.56213644,APP;GSK3B;CTTN;SOD1
organelle transport along microtubule (GO:0072384),4/31,0.02001798,0.117540358,0,0,4.234622771,16.56213644,CDC42;UBB;KIF5B;RAB6A
positive regulation of protein targeting to mitochondrion (GO:1903955),4/31,0.02001798,0.117540358,0,0,4.234622771,16.56213644,UBL5;UBE2D3;TOMM7;UBE2L3
positive regulation of ubiquitin-protein transferase activity (GO:0051443),4/31,0.02001798,0.117540358,0,0,4.234622771,16.56213644,UBE2S;UBE2N;RPS2;UBE2L3
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),8/100,0.020492837,0.120067574,0,0,2.491932871,9.687837308,FKBP1A;HSP90AB1;UBB;UBC;STRAP;STUB1;RPS27A;UBA52
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,GNB1;GNAS
aldehyde biosynthetic process (GO:0046184),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,TPI1;TKT
autophagosome membrane docking (GO:0016240),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,ATP2A2;CALM1
cardiolipin acyl-chain remodeling (GO:0035965),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,HADHB;HADHA
regulation of phospholipid transport (GO:2001138),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,PRELID1;DBI
regulation of T cell mediated immune response to tumor cell (GO:0002840),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,HMGB1;HSPD1
glyceraldehyde-3-phosphate metabolic process (GO:0019682),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,TPI1;TKT
ribonucleoprotein complex disassembly (GO:0032988),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,VCP;KIF5B
ribosomal large subunit export from nucleus (GO:0000055),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,NPM1;RAN
RIG-I signaling pathway (GO:0039529),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,PHB;PHB2
malate metabolic process (GO:0006108),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,MDH1;MDH2
membrane invagination (GO:0010324),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,SNX3;CHMP2A
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,ATP2A2;CALM1
negative regulation of protein sumoylation (GO:0033234),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,CTNNB1;PARK7
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,GSTP1;PPIA
pexophagy (GO:0000425),07-Feb,0.021577181,0.122180223,0,0,11.4127031,43.78048666,MAP1LC3B;SQSTM1
regulation of multicellular organism growth (GO:0040014),18-Mar,0.021732852,0.122547877,0,0,5.71183432,21.87021521,APP;PPIB;SOD1
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",18-Mar,0.021732852,0.122547877,0,0,5.71183432,21.87021521,NCL;TRA2B;PRDX6
regulation of cellular amide metabolic process (GO:0034248),4/32,0.022280052,0.124851494,0,0,4.083174603,15.53265563,APP;TMED10;RPL10;PGAM1
superoxide metabolic process (GO:0006801),4/32,0.022280052,0.124851494,0,0,4.083174603,15.53265563,PRDX2;PRDX1;SOD2;SOD1
peptidyl-proline modification (GO:0018208),4/32,0.022280052,0.124851494,0,0,4.083174603,15.53265563,FKBP1A;FKBP4;PPIB;PPIA
receptor-mediated endocytosis (GO:0006898),10/143,0.02414919,0.135045468,0,0,2.156512357,8.02978338,ITGB1;HSP90AA1;CTTN;NEDD4;CANX;CLTB;AP2S1;CALR;AP2M1;HSP90B1
regulation of protein localization (GO:0032880),6/66,0.024325295,0.135749221,0,0,2.861961367,10.63573104,FKBP1A;HSP90AA1;HSP90AB1;SUMO1;DNAJB6;RAB14
double-strand break repair (GO:0006302),11/164,0.024453683,0.136184324,0,0,2.063011232,7.655781975,MORF4L1;VCP;UBXN1;SFR1;SUMO1;DDX1;SWI5;SMARCA5;UBE2N;NUCKS1;HMGB1
regulation of protein localization to cell surface (GO:2000008),4/33,0.024691754,0.137227216,0,0,3.942171137,14.59110262,HSP90AB1;CTNNB1;COMMD1;RAB11B
regulation of mitotic spindle assembly (GO:1901673),19-Mar,0.025170784,0.138464943,0,0,5.354567308,19.71589878,PDCD6IP;CHMP2A;HNRNPU
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),19-Mar,0.025170784,0.138464943,0,0,5.354567308,19.71589878,PARK7;SOD2;PPIA
negative regulation of protein localization to nucleus (GO:1900181),19-Mar,0.025170784,0.138464943,0,0,5.354567308,19.71589878,GSK3B;UFM1;CTNNA1
negative regulation of RNA metabolic process (GO:0051253),19-Mar,0.025170784,0.138464943,0,0,5.354567308,19.71589878,RPS26;TMBIM6;RPS13
negative regulation of RNA splicing (GO:0033119),19-Mar,0.025170784,0.138464943,0,0,5.354567308,19.71589878,RPS26;TMBIM6;RPS13
positive regulation of protein catabolic process (GO:0045732),7/85,0.025417733,0.139539223,0,0,2.569845085,9.43726314,DDB1;GSK3B;NDUFA13;HSP90AA1;VCP;NEDD4;OAZ1
vascular endothelial growth factor receptor signaling pathway (GO:0048010),6/67,0.025979035,0.142043264,0,0,2.814897815,10.27568716,CDC42;HSP90AA1;PDCD6;RAC1;AAMP;RHOA
positive regulation of catabolic process (GO:0009896),6/67,0.025979035,0.142043264,0,0,2.814897815,10.27568716,DDB1;GSK3B;NDUFA13;VCP;NEDD4;OAZ1
mitochondrial translation (GO:0032543),8/105,0.026561145,0.14493263,0,0,2.362868161,8.573208393,MRPL30;MRPL52;MRPL20;MRPL42;NDUFA7;MRPS21;MRPL23;MRPL33
regulation of autophagy (GO:0010506),14/231,0.026637206,0.145054625,0,0,1.853407713,6.719430154,VPS29;GSK3B;HMGB1;EEF1A1;TMEM59;DAP;RHEB;NEDD4;VDAC1;LAMTOR2;ATP6V0C;GAPDH;EIF4G2;EIF4G1
regulation of phosphorylation (GO:0042325),9/125,0.026727074,0.145251162,0,0,2.223944931,8.055302468,PPP2CA;APP;SEC13;EIF6;PGAM1;PTGES3;NDUFS4;MIF;DYNLL1
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),5/50,0.026785334,0.145275477,0,0,3.177711836,11.50300153,CDC42;CAPRIN1;RAC1;CALR;P4HB
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),4/34,0.027254944,0.14635309,0,0,3.810567901,13.72764835,GSK3B;DDX3X;TMBIM1;PARK7
organelle disassembly (GO:1903008),4/34,0.027254944,0.14635309,0,0,3.810567901,13.72764835,VCP;UFM1;KIF5B;UFC1
positive regulation of DNA binding (GO:0043388),4/34,0.027254944,0.14635309,0,0,3.810567901,13.72764835,EDF1;HMGB1;PARK7;NME1
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),4/34,0.027254944,0.14635309,0,0,3.810567901,13.72764835,GSTO1;CALM3;CALM1;CALM2
protein insertion into membrane (GO:0051205),4/34,0.027254944,0.14635309,0,0,3.810567901,13.72764835,APP;VAPA;SEC61G;SEC61B
regulation of extent of cell growth (GO:0061387),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,GSK3B;CTTN
establishment of Golgi localization (GO:0051683),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,CDC42;YWHAZ
regulation of translational termination (GO:0006449),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,ETF1;GSPT1
translocation of molecules into host (GO:0044417),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,ALYREF;THOC7
tubulin complex assembly (GO:0007021),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,TCP1;TBCA
viral mRNA export from host cell nucleus (GO:0046784),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,ALYREF;THOC7
negative regulation of sodium ion transport (GO:0010766),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,NEDD4;COMMD1
positive regulation of muscle contraction (GO:0045933),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,CTTN;ENO1
progesterone receptor signaling pathway (GO:0050847),08-Feb,0.028129637,0.148394823,0,0,9.51009355,33.9598932,NEDD4;PHB
ERAD pathway (GO:0036503),7/87,0.028421686,0.149643225,0,0,2.505338542,8.920515493,VCP;PSMC6;HSPA5;STUB1;SEC61B;UBXN4;HSP90B1
protein targeting to lysosome (GO:0006622),20-Mar,0.028883183,0.150965192,0,0,5.039331709,17.86188984,HSPA8;NEDD4;LAMP2
establishment of epithelial cell polarity (GO:0090162),20-Mar,0.028883183,0.150965192,0,0,5.039331709,17.86188984,CDC42;GOLPH3;RHOA
mitotic cytokinetic process (GO:1902410),20-Mar,0.028883183,0.150965192,0,0,5.039331709,17.86188984,PDCD6IP;CHMP2A;RHOA
regulation of substrate adhesion-dependent cell spreading (GO:1900024),5/51,0.028896336,0.150965192,0,0,3.108469875,11.01654303,CDC42;RAC1;ACTN4;CALR;P4HB
cellular response to decreased oxygen levels (GO:0036294),6/69,0.029506683,0.153856277,0,0,2.725252954,9.601443572,FAM162A;HP1BP3;LMNA;PGK1;STUB1;P4HB
cellular response to virus (GO:0098586),4/35,0.029971145,0.155677044,0,0,3.687455197,12.93382355,EIF5A;ARF1;HSP90AA1;DDX3X
maturation of SSU-rRNA (GO:0030490),4/35,0.029971145,0.155677044,0,0,3.687455197,12.93382355,RPS14;RPS28;RPS16;RPS8
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),8/108,0.030747969,0.159405498,0,0,2.291624441,7.979278951,FKBP1A;UBB;UBE2D3;UBC;STRAP;STUB1;RPS27A;UBA52
regulation of release of sequestered calcium ion into cytosol (GO:0051279),5/52,0.031109606,0.160971351,0,0,3.04217438,10.55707109,FKBP1A;GSTO1;CALM3;CALM1;CALM2
fatty acid catabolic process (GO:0009062),6/70,0.031382699,0.162073937,0,0,2.682531575,9.285579115,HADHB;HADHA;ACADL;SCP2;HADH;ACAT1
transforming growth factor beta receptor signaling pathway (GO:0007179),7/89,0.031657184,0.162559039,0,0,2.443978659,8.438545486,ITGB1;FKBP1A;UBB;UBC;RPS27A;UBA52;RHOA
mitochondrial translational elongation (GO:0070125),7/89,0.031657184,0.162559039,0,0,2.443978659,8.438545486,MRPL52;MRPL30;MRPL42;MRPL20;MRPS21;MRPL23;MRPL33
mitochondrial translational termination (GO:0070126),7/89,0.031657184,0.162559039,0,0,2.443978659,8.438545486,MRPL52;MRPL30;MRPL42;MRPL20;MRPS21;MRPL23;MRPL33
regulation of cardiac muscle contraction (GO:0055117),4/36,0.032841549,0.165321881,0,0,3.572037037,12.20229583,ATP2A2;CALM3;CALM1;CALM2
retina homeostasis (GO:0001895),4/36,0.032841549,0.165321881,0,0,3.572037037,12.20229583,PRDX1;ACTB;ACTG1;SOD1
telomere maintenance via telomere lengthening (GO:0010833),4/36,0.032841549,0.165321881,0,0,3.572037037,12.20229583,HSP90AA1;HSP90AB1;PTGES3;NOP10
platelet aggregation (GO:0070527),4/36,0.032841549,0.165321881,0,0,3.572037037,12.20229583,GNAS;PPIA;ACTB;ACTG1
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),4/36,0.032841549,0.165321881,0,0,3.572037037,12.20229583,CDC42;RAC1;CALR;P4HB
beta-catenin destruction complex disassembly (GO:1904886),21-Mar,0.032868512,0.165321881,0,0,4.759122288,16.25354562,GSK3B;CSNK1A1;CTNNB1
hydrogen peroxide catabolic process (GO:0042744),21-Mar,0.032868512,0.165321881,0,0,4.759122288,16.25354562,PRDX2;PRDX5;PRDX1
stress granule assembly (GO:0034063),21-Mar,0.032868512,0.165321881,0,0,4.759122288,16.25354562,DDX3X;CSDE1;RPS23
negative regulation of protein localization to cell periphery (GO:1904376),21-Mar,0.032868512,0.165321881,0,0,4.759122288,16.25354562,TMEM59;TMBIM1;AP2M1
negative regulation of protein localization to plasma membrane (GO:1903077),21-Mar,0.032868512,0.165321881,0,0,4.759122288,16.25354562,TMEM59;TMBIM1;AP2M1
neuron apoptotic process (GO:0051402),21-Mar,0.032868512,0.165321881,0,0,4.759122288,16.25354562,APP;FAM162A;GAPDH
DNA topological change (GO:0006265),09-Feb,0.035364574,0.174952649,0,0,8.151086727,27.24129614,HMGB1;TOP1
L-ascorbic acid metabolic process (GO:0019852),09-Feb,0.035364574,0.174952649,0,0,8.151086727,27.24129614,CYB5R3;GSTO1
nucleoside diphosphate phosphorylation (GO:0006165),09-Feb,0.035364574,0.174952649,0,0,8.151086727,27.24129614,CMPK1;NME2
nucleoside triphosphate biosynthetic process (GO:0009142),09-Feb,0.035364574,0.174952649,0,0,8.151086727,27.24129614,CMPK1;NME2
nucleotide phosphorylation (GO:0046939),09-Feb,0.035364574,0.174952649,0,0,8.151086727,27.24129614,CMPK1;NME2
peptidyl-cysteine modification (GO:0018198),09-Feb,0.035364574,0.174952649,0,0,8.151086727,27.24129614,PARK7;RAB6A
positive regulation of ATP biosynthetic process (GO:2001171),09-Feb,0.035364574,0.174952649,0,0,8.151086727,27.24129614,VCP;ENO1
positive regulation of protein polyubiquitination (GO:1902916),09-Feb,0.035364574,0.174952649,0,0,8.151086727,27.24129614,DDX3X;GABARAP
regulation of protein serine/threonine kinase activity (GO:0071900),8/111,0.035366215,0.174952649,0,0,2.224530841,7.434378287,PPP2CA;DDX3X;CDC37;CALM3;CALM1;CALM2;ACTB;RHOA
positive regulation of programmed cell death (GO:0043068),16/286,0.035599641,0.175785431,0,0,1.702787554,5.679511189,ITGB1;MTCH1;MTCH2;DDX3X;RPS6;HMGB1;HSPD1;SOD1;UBB;FAM162A;UBC;CTNNB1;RPS27A;UBA52;SQSTM1;ATF4
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",5/54,0.035847445,0.175820027,0,0,2.917701205,9.711518803,DDX5;MBNL2;PUF60;TRA2B;HNRNPU
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),4/37,0.035867025,0.175820027,0,0,3.463613917,11.52668866,DDX5;UFM1;PARK7;CALR
regulation of protein autophosphorylation (GO:0031952),4/37,0.035867025,0.175820027,0,0,3.463613917,11.52668866,DDX3X;CALM3;CALM1;CALM2
protein insertion into ER membrane (GO:0045048),4/37,0.035867025,0.175820027,0,0,3.463613917,11.52668866,APP;VAPA;SEC61G;SEC61B
positive regulation of apoptotic process (GO:0043065),17/310,0.036406185,0.178139684,0,0,1.667694338,5.525099035,ITGB1;MTCH1;MTCH2;DDX3X;RPS6;HMGB1;HSPD1;SOD1;UBB;FAM162A;UBC;RPS3;CTNNB1;RPS27A;UBA52;SQSTM1;ATF4
positive regulation of cellular component biogenesis (GO:0044089),7/92,0.036958087,0.180346692,0,0,2.357352941,7.774481121,GSK3B;VCP;PDCD6IP;SUMO1;RPS3;CHMP2A;PARK7
regulation of centrosome cycle (GO:0046605),22-Mar,0.03712431,0.180346692,0,0,4.508408595,14.8483683,NPM1;PDCD6IP;CHMP2A
glutamate metabolic process (GO:0006536),22-Mar,0.03712431,0.180346692,0,0,4.508408595,14.8483683,GLUD1;GOT2;GCLM
positive regulation of peptidase activity (GO:0010952),22-Mar,0.03712431,0.180346692,0,0,4.508408595,14.8483683,NDUFA13;PRELID1;VCP
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),9/133,0.037653084,0.182587037,0,0,2.079597978,6.819709704,ITGB1;FKBP1A;DDX5;UBB;UBC;STUB1;RPS27A;UBA52;RHOA
positive regulation of NF-kappaB transcription factor activity (GO:0051092),10/155,0.038920217,0.1883375,0,0,1.976805319,6.417187357,APP;PSMA6;NPM1;UBB;UBC;UBE2N;RPS3;RPS27A;PPIA;UBA52
spliceosomal snRNP assembly (GO:0000387),4/38,0.03904813,0.1883375,0,0,3.361568627,10.90143354,SNRPD2;STRAP;SNRPF;SNRPB
ncRNA export from nucleus (GO:0097064),4/38,0.03904813,0.1883375,0,0,3.361568627,10.90143354,NPM1;SEC13;SSB;RAN
protein-containing complex assembly (GO:0065003),15/267,0.039698634,0.191133707,0,0,1.709426994,5.515361081,NAPA;GSK3B;SEC13;TMED10;ST13;CSNK1A1;PDCD6;RBX1;TFG;PPP2R1A;CSNK2B;TMED2;CTNNB1;AP2M1;SEC31A
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),23-Mar,0.041647284,0.198744371,0,0,4.282766272,13.6128545,HSP90AB1;SUMO1;CDC37
regulation of peptidase activity (GO:0052547),23-Mar,0.041647284,0.198744371,0,0,4.282766272,13.6128545,CSTB;NDUFA13;PSMA3
positive regulation of mRNA processing (GO:0050685),23-Mar,0.041647284,0.198744371,0,0,4.282766272,13.6128545,NCL;TRA2B;PRDX6
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),23-Mar,0.041647284,0.198744371,0,0,4.282766272,13.6128545,PSMC5;PSMC6;PSMC3
protein alkylation (GO:0008213),23-Mar,0.041647284,0.198744371,0,0,4.282766272,13.6128545,ETF1;GSPT1;SNRPB
positive regulation of protein metabolic process (GO:0051247),8/115,0.042222111,0.199248263,0,0,2.140925108,6.775623834,DDB1;APP;GSK3B;NDUFA13;VCP;NEDD4;OAZ1;EIF4G1
regulation of protein targeting to mitochondrion (GO:1903214),4/39,0.042385116,0.199248263,0,0,3.265354497,10.32164849,UBL5;UBE2D3;TOMM7;UBE2L3
ciliary basal body-plasma membrane docking (GO:0097711),7/95,0.042812355,0.199248263,0,0,2.276633523,7.173509588,YWHAE;HSP90AA1;DCTN2;PPP2R1A;DCTN3;DYNLL1;TUBB4B
acetyl-CoA biosynthetic process (GO:0006085),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,PDHA1;ACAT1
adherens junction assembly (GO:0034333),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,CTNNB1;ACTB
regulation of high voltage-gated calcium channel activity (GO:1901841),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,CALM3;CALM1
regulation of low-density lipoprotein particle clearance (GO:0010988),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,HNRNPK;CNPY2
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,PHB;PHB2
regulation of protein neddylation (GO:2000434),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,RPL5;RPL11
regulation of tau-protein kinase activity (GO:1902947),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,HSP90AA1;HSP90AB1
regulation of type B pancreatic cell development (GO:2000074),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,GSK3B;RHEB
low-density lipoprotein particle receptor catabolic process (GO:0032802),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,AP2S1;AP2M1
low-density lipoprotein receptor particle metabolic process (GO:0032799),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,AP2S1;AP2M1
negative regulation of establishment of protein localization (GO:1904950),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,SNX3;NDFIP1
negative regulation of peptidyl-lysine acetylation (GO:2000757),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,SET;CTBP1
negative regulation of sodium ion transmembrane transport (GO:1902306),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,NEDD4;COMMD1
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,PPP2CA;PPP2R1A
negative regulation of voltage-gated calcium channel activity (GO:1901386),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,CALM3;CALM1
nucleic acid transport (GO:0050657),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,HNRNPA2B1;YBX1
protein deneddylation (GO:0000338),10-Feb,0.043228242,0.199248263,0,0,7.13183161,22.40294624,COPS6;COPS7A
RNA transport (GO:0050658),6/76,0.044265094,0.20367976,0,0,2.451836128,7.643743439,ALYREF;HNRNPA2B1;SRSF3;YBX1;SRSF5;THOC7
autophagy of mitochondrion (GO:0000422),4/40,0.045877937,0.209318088,0,0,3.174485597,9.783037496,MAP1LC3B;PHB2;SQSTM1;GABARAP
bone development (GO:0060348),4/40,0.045877937,0.209318088,0,0,3.174485597,9.783037496,VKORC1;GNAS;RPL13;PPIB
carboxylic acid metabolic process (GO:0019752),4/40,0.045877937,0.209318088,0,0,3.174485597,9.783037496,GLUD1;CYB5R3;GSTO1;MIF
nucleocytoplasmic transport (GO:0006913),4/40,0.045877937,0.209318088,0,0,3.174485597,9.783037496,NPM1;SNRPD2;SNRPF;SNRPB
positive regulation of cation channel activity (GO:2001259),4/40,0.045877937,0.209318088,0,0,3.174485597,9.783037496,GSTO1;CALM3;CALM1;CALM2
regulation of monooxygenase activity (GO:0032768),24-Mar,0.04643339,0.210532877,0,0,4.078613694,12.52026921,HSP90AA1;POR;CALM1
iron-sulfur cluster assembly (GO:0016226),24-Mar,0.04643339,0.210532877,0,0,4.078613694,12.52026921,HSPA9;GLRX3;GLRX5
positive regulation of viral life cycle (GO:1903902),24-Mar,0.04643339,0.210532877,0,0,4.078613694,12.52026921,DDB1;CHMP2A;P4HB
cellular iron ion homeostasis (GO:0006879),5/58,0.046592163,0.210532877,0,0,2.696937462,8.269681149,NDFIP1;GLRX3;FTH1;NEDD8;SOD1
positive regulation of mitotic cell cycle phase transition (GO:1901992),5/58,0.046592163,0.210532877,0,0,2.696937462,8.269681149,DDX3X;CDK4;ANAPC5;PHB2;EIF4G1
import into nucleus (GO:0051170),6/77,0.046689816,0.210532877,0,0,2.417177657,7.406786375,SEC13;SNRPD2;SNRPF;PHB2;RAN;SNRPB
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),6/77,0.046689816,0.210532877,0,0,2.417177657,7.406786375,FKBP1A;NDFIP1;UBB;STUB1;COMMD1;UBE2L3
protein methylation (GO:0006479),4/41,0.049526265,0.222299065,0,0,3.088528529,9.281807013,ETF1;RAB6A;GSPT1;SNRPB
positive regulation of TOR signaling (GO:0032008),4/41,0.049526265,0.222299065,0,0,3.088528529,9.281807013,SEC13;GOLPH3;RHEB;LAMTOR2
protein polymerization (GO:0051258),5/59,0.049546108,0.222299065,0,0,2.646856797,7.953411806,GPX4;UBE2S;CHMP2A;RAC1;UBE2K
receptor catabolic process (GO:0032801),25-Mar,0.051477908,0.226940076,0,0,3.893020441,11.54904428,NEDD4;AP2S1;AP2M1
regulation of cardiac muscle cell action potential (GO:0098901),25-Mar,0.051477908,0.226940076,0,0,3.893020441,11.54904428,ATP2A2;CALM3;CALM1
regulation of spindle assembly (GO:0090169),25-Mar,0.051477908,0.226940076,0,0,3.893020441,11.54904428,PDCD6IP;CHMP2A;HNRNPU
negative regulation of response to endoplasmic reticulum stress (GO:1903573),25-Mar,0.051477908,0.226940076,0,0,3.893020441,11.54904428,UBXN1;TMBIM6;PARK7
cardiac muscle cell membrane repolarization (GO:0099622),11-Feb,0.051669745,0.226940076,0,0,6.33907763,18.78194456,YWHAE;ATP1A1
establishment of epithelial cell apical/basal polarity (GO:0045198),11-Feb,0.051669745,0.226940076,0,0,6.33907763,18.78194456,CDC42;RHOA
regulation of toll-like receptor 9 signaling pathway (GO:0034163),11-Feb,0.051669745,0.226940076,0,0,6.33907763,18.78194456,HMGB1;RTN4
tetrahydrobiopterin metabolic process (GO:0046146),11-Feb,0.051669745,0.226940076,0,0,6.33907763,18.78194456,HSP90AA1;CALM1
negative regulation of oxidative stress-induced neuron death (GO:1903204),11-Feb,0.051669745,0.226940076,0,0,6.33907763,18.78194456,PARK7;ATF4
PERK-mediated unfolded protein response (GO:0036499),11-Feb,0.051669745,0.226940076,0,0,6.33907763,18.78194456,HSPA5;ATF4
positive regulation of phospholipid transport (GO:2001140),11-Feb,0.051669745,0.226940076,0,0,6.33907763,18.78194456,PRELID1;DBI
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),11-Feb,0.051669745,0.226940076,0,0,6.33907763,18.78194456,HSPA5;ATF4
DNA metabolic process (GO:0006259),15/277,0.051672768,0.226940076,0,0,1.643319461,4.868866936,NPM1;VCP;PTGES3;CNBP;PARK7;HMGB1;DDB1;UBB;SUMO1;UBC;UBE2N;TOP1;RPS27A;UBA52;RAN
mRNA 3'-end processing (GO:0031124),6/79,0.05178201,0.227050666,0,0,2.350709357,6.959774528,APP;ALYREF;SRSF3;PABPC1;SRSF5;THOC7
positive regulation of ATPase activity (GO:0032781),4/42,0.053329494,0.233456989,0,0,3.007095517,8.814596099,TPM1;HNRNPU;TOR1AIP2;DYNLL1
mitotic cell cycle phase transition (GO:0044772),12/209,0.053636394,0.23442055,0,0,1.74649731,5.109425826,PPP1CB;YWHAE;HSP90AA1;DCTN2;PPP2R1A;CDK4;UBE2S;DCTN3;CHMP2A;DYNLL1;TUBB4B;GSPT1
negative regulation of cellular component organization (GO:0051129),6/80,0.054450179,0.237592782,0,0,2.318822537,6.748861461,CDC42;GSK3B;HSPA8;DDX3X;DNAJB6;HSPA5
iron ion homeostasis (GO:0055072),5/61,0.055777265,0.242990957,0,0,2.552061255,7.366241347,NDFIP1;GLRX3;FTH1;NEDD8;SOD1
positive regulation of protein localization to membrane (GO:1905477),7/101,0.056238064,0.244603881,0,0,2.130651596,6.132359309,ITGB1;YWHAE;YWHAQ;YWHAB;KIF5B;SQSTM1;YWHAZ
regulation of actin filament bundle assembly (GO:0032231),26-Mar,0.056775518,0.24496913,0,0,3.723565732,10.68160706,CDC42;RAC1;ACTG1
DNA geometric change (GO:0032392),26-Mar,0.056775518,0.24496913,0,0,3.723565732,10.68160706,DDX1;HNRNPA2B1;HMGB1
regulation of potassium ion transmembrane transporter activity (GO:1901016),26-Mar,0.056775518,0.24496913,0,0,3.723565732,10.68160706,ITGB1;YWHAE;NEDD4
lamellipodium assembly (GO:0030032),26-Mar,0.056775518,0.24496913,0,0,3.723565732,10.68160706,ITGB1;GOLPH3;RAC1
negative regulation of protein localization to membrane (GO:1905476),26-Mar,0.056775518,0.24496913,0,0,3.723565732,10.68160706,TMEM59;TMBIM1;AP2M1
negative regulation of protein modification process (GO:0031400),6/81,0.057200071,0.246387781,0,0,2.287786033,6.545813726,GSK3B;YWHAB;FKBP8;DBI;PARK7;PPIA
glutathione metabolic process (GO:0006749),4/43,0.057286756,0.246387781,0,0,2.929838557,8.378417788,GSTP1;PARK7;GCLM;SOD1
mitotic sister chromatid segregation (GO:0000070),7/102,0.058702808,0.252076762,0,0,2.108114035,5.977067678,NUDC;SET;PDCD6IP;DCTN2;CSNK2B;CHMP2A;RAN
stress-activated MAPK cascade (GO:0051403),5/62,0.059054512,0.253184505,0,0,2.507158103,7.093488184,UBB;UBC;UBE2N;RPS27A;UBA52
regulation of amyloid precursor protein catabolic process (GO:1902991),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,FKBP1A;TMED10
autophagy of peroxisome (GO:0030242),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,MAP1LC3B;SQSTM1
cellular response to nitrogen levels (GO:0043562),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,MAP1LC3B;GABARAP
cellular response to nitrogen starvation (GO:0006995),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,MAP1LC3B;GABARAP
regulation of oxidative stress-induced cell death (GO:1903201),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,P4HB;PARK7
exit from mitosis (GO:0010458),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,UBE2S;CHMP2A
modulation by host of viral process (GO:0044788),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,CFL1;PPIB
mRNA transcription (GO:0009299),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,DDX5;ATF4
negative regulation by host of viral process (GO:0044793),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,PSMC3;VAPA
negative regulation of cardiac muscle hypertrophy (GO:0010614),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,GLRX3;LMNA
negative regulation of histone acetylation (GO:0035067),12-Feb,0.060640908,0.255524325,0,0,5.704874446,15.98953975,SET;CTBP1
homotypic cell-cell adhesion (GO:0034109),4/44,0.061396929,0.257105589,0,0,2.856444444,7.970609614,GNAS;PPIA;ACTB;ACTG1
mRNA stabilization (GO:0048255),4/44,0.061396929,0.257105589,0,0,2.856444444,7.970609614,HNRNPU;YBX1;HNRNPC;PABPC1
positive regulation of stress fiber assembly (GO:0051496),4/44,0.061396929,0.257105589,0,0,2.856444444,7.970609614,CDC42;TPM1;RAC1;RHOA
protein K63-linked ubiquitination (GO:0070534),4/44,0.061396929,0.257105589,0,0,2.856444444,7.970609614,UBE2S;NEDD4;UBE2N;STUB1
positive regulation of muscle cell differentiation (GO:0051149),27-Mar,0.062320364,0.260165846,0,0,3.568232249,9.903510998,CDC42;CTNNA1;CTNNB1
positive regulation of toll-like receptor signaling pathway (GO:0034123),27-Mar,0.062320364,0.260165846,0,0,3.568232249,9.903510998,DDX3X;HMGB1;RTN4
cellular response to reactive oxygen species (GO:0034614),5/63,0.06243935,0.260260316,0,0,2.463803336,6.833505375,PRDX5;TPM1;RPS3;ROMO1;PARK7
negative regulation of cell growth (GO:0030308),8/126,0.065410054,0.27180393,0,0,1.940235924,5.291177243,PPP2CA;NDUFA13;DDX3X;PPP2R1A;ENO1;PHB;RBBP7;RTN4
negative regulation of growth (GO:0045926),8/126,0.065410054,0.27180393,0,0,1.940235924,5.291177243,PPP2CA;NDUFA13;DDX3X;PPP2R1A;ENO1;PHB;RBBP7;RTN4
protein catabolic process (GO:0030163),5/64,0.065931481,0.273171389,0,0,2.421918222,6.585532874,DDB1;HSPA8;HSP90AA1;VCP;LAMP2
nuclear export (GO:0051168),6/84,0.065941409,0.273171389,0,0,2.199451366,5.98028335,ALYREF;SRSF3;SRSF5;CALR;THOC7;RAN
regulation of cell growth (GO:0001558),12/217,0.067201562,0.27796542,0,0,1.677639229,4.529724541,PPP2CA;CDC42;NDUFA13;DDX3X;PPP2R1A;LAMTOR2;ENO1;PHB;RBBP7;RTN4;EIF4G2;EIF4G1
carbohydrate derivative biosynthetic process (GO:1901137),28-Mar,0.068106115,0.279566286,0,0,3.425325444,9.202781712,GOLPH3;TPI1;TKT
regulation of protein transport (GO:0051223),28-Mar,0.068106115,0.279566286,0,0,3.425325444,9.202781712,SNX3;HSPA8;NDFIP1
histone mRNA metabolic process (GO:0008334),28-Mar,0.068106115,0.279566286,0,0,3.425325444,9.202781712,SSB;SNRPF;SNRPB
positive regulation of fibroblast proliferation (GO:0048146),28-Mar,0.068106115,0.279566286,0,0,3.425325444,9.202781712,CDK4;NDUFS4;MIF
protein depolymerization (GO:0051261),28-Mar,0.068106115,0.279566286,0,0,3.425325444,9.202781712,CFL1;TWF1;DSTN
RNA export from nucleus (GO:0006405),7/106,0.069219266,0.281740643,0,0,2.022516835,5.40108275,SEC13;ALYREF;HNRNPA2B1;SRSF3;SRSF5;THOC7;RAN
pteridine-containing compound metabolic process (GO:0042558),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,HSP90AA1;CALM1
regulation of cell aging (GO:0090342),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,LMNA;MIF
regulation of histone modification (GO:0031056),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,UBE2N;PARK7
central nervous system neuron axonogenesis (GO:0021955),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,HSP90AA1;HSP90AB1
entry into host (GO:0044409),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,CTNNB1;PPIA
reticulophagy (GO:0061709),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,UFM1;UFC1
transport along microtubule (GO:0010970),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,CDC42;APP
negative regulation of nucleocytoplasmic transport (GO:0046823),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,UFM1;PARK7
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,PDCD6;NEDD4
positive regulation of lipid transport (GO:0032370),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,PRELID1;DBI
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,PABPC1;TOB1
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,BCAP31;SAR1A
positive regulation of purine nucleotide biosynthetic process (GO:1900373),13-Feb,0.070096154,0.281740643,0,0,5.185980932,13.78375311,VCP;ENO1
plasma membrane bounded cell projection organization (GO:0120036),8/128,0.070331281,0.282265661,0,0,1.90769995,5.064063187,APP;GSK3B;CTTN;VAPA;NEDD4;TPM1;HMGB1;RAC1
mRNA export from nucleus (GO:0006406),7/107,0.072013248,0.288587216,0,0,2.0021875,5.267565454,ENY2;SEC13;ALYREF;HNRNPA2B1;SRSF3;SRSF5;THOC7
cell-cell junction assembly (GO:0007043),5/66,0.073235834,0.293051835,0,0,2.342267841,6.122853121,CTNNA1;CTNNB1;ACTB;RHOA;ACTG1
negative regulation of cellular process (GO:0048523),26/566,0.07411954,0.295301478,0,0,1.384793829,3.6033389,APP;NDUFA13;DDX3X;CTBP1;ENO1;PARK7;PHB;TOB1;RTN4;SNX3;PPP2CA;TBRG1;PPP2R1A;FTH1;LMNA;RBBP7;S100A11;NPM1;MIF;SOD2;NME1;CSNK2B;CHMP2A;CTNNB1;TMBIM6;ANP32B
negative regulation of mRNA catabolic process (GO:1902373),29-Mar,0.074126028,0.295301478,0,0,3.29341147,8.569418939,HNRNPU;YBX1;PABPC1
negative regulation of transferase activity (GO:0051348),29-Mar,0.074126028,0.295301478,0,0,3.29341147,8.569418939,GSK3B;HNRNPU;PARK7
regulation of cellular metabolic process (GO:0031323),4/47,0.074630146,0.296000037,0,0,2.656744186,6.894811065,ARF4;ARF1;EIF6;STUB1
regulation of protein localization to nucleus (GO:1900180),4/47,0.074630146,0.296000037,0,0,2.656744186,6.894811065,GSK3B;SUMO3;CTNNA1;PARK7
epithelial to mesenchymal transition (GO:0001837),4/47,0.074630146,0.296000037,0,0,2.656744186,6.894811065,GSK3B;DDX5;CTNNB1;HNRNPAB
G2/M transition of mitotic cell cycle (GO:0000086),8/130,0.075472743,0.298903049,0,0,1.87623073,4.848149635,PPP1CB;YWHAE;HSP90AA1;DCTN2;PPP2R1A;DCTN3;DYNLL1;TUBB4B
regulation of viral genome replication (GO:0045069),5/67,0.077046869,0.304044077,0,0,2.304369676,5.906886077,DDB1;DDX3X;BANF1;PABPC1;PPIA
positive regulation of DNA-binding transcription factor activity (GO:0051091),13/246,0.077393394,0.304044077,0,0,1.599092655,4.091844403,APP;NPM1;PARK7;PHB2;PSMA6;UBB;UBC;RPS3;UBE2N;CTNNB1;RPS27A;UBA52;PPIA
cell cycle G2/M phase transition (GO:0044839),8/131,0.078126166,0.304044077,0,0,1.86087989,4.744183485,PPP1CB;YWHAE;HSP90AA1;DCTN2;PPP2R1A;DCTN3;DYNLL1;TUBB4B
"retrograde transport, endosome to Golgi (GO:0042147)",6/88,0.078742707,0.304044077,0,0,2.091726162,5.316267666,SNX3;VPS29;TMED9;SURF4;ARL1;RAB6A
negative regulation of binding (GO:0051100),6/88,0.078742707,0.304044077,0,0,2.091726162,5.316267666,GSK3B;SUMO1;SUMO3;TMBIM6;PARK7;ACTB
cellular response to alcohol (GO:0097306),4/48,0.079336089,0.304044077,0,0,2.596228956,6.579005561,GOLPH3;GNB1;CTNNA1;CTNNB1
cellular response to ionizing radiation (GO:0071479),4/48,0.079336089,0.304044077,0,0,2.596228956,6.579005561,EEF1D;SWI5;NUCKS1;RPL26
regulation of mitochondrion organization (GO:0010821),4/48,0.079336089,0.304044077,0,0,2.596228956,6.579005561,GSK3B;GOLPH3;VDAC1;SQSTM1
regulation of protein metabolic process (GO:0051246),4/48,0.079336089,0.304044077,0,0,2.596228956,6.579005561,FKBP1A;APP;HSP90AB1;NEDD8
2-oxoglutarate metabolic process (GO:0006103),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,GOT2;OGDH
protein maturation by iron-sulfur cluster transfer (GO:0097428),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,GLRX3;GLRX5
antiviral innate immune response (GO:0140374),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,PHB;PHB2
cardiolipin metabolic process (GO:0032048),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,HADHB;HADHA
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,MIF;RPL26
dicarboxylic acid catabolic process (GO:0043649),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,GLUD1;GOT2
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,RPL35;RPL7
membrane repolarization during action potential (GO:0086011),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,YWHAE;ATP1A1
vasodilation (GO:0042311),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,SOD2;SOD1
nucleoside phosphate biosynthetic process (GO:1901293),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,NME2;CMPK1
nucleoside triphosphate metabolic process (GO:0009141),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,NME2;CMPK1
positive regulation of long-term synaptic potentiation (GO:1900273),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,APP;SQSTM1
positive regulation of lymphocyte migration (GO:2000403),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,APP;RHOA
positive regulation of superoxide anion generation (GO:0032930),14-Feb,0.079992382,0.304044077,0,0,4.75356967,12.00667974,GSTP1;SOD1
cell projection organization (GO:0030030),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,ITGB1;CDC42;RAC1
CENP-A containing chromatin organization (GO:0061641),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,NPM1;SMARCA5;RBBP7
CENP-A containing nucleosome assembly (GO:0034080),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,NPM1;SMARCA5;RBBP7
regulation of long-term synaptic potentiation (GO:1900271),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,APP;GSK3B;SQSTM1
regulation of striated muscle contraction (GO:0006942),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,CALM3;CALM1;CALM2
fatty-acyl-CoA biosynthetic process (GO:0046949),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,SLC25A1;TECR;HSD17B12
regulation of type I interferon-mediated signaling pathway (GO:0060338),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,HSP90AB1;CDC37;UBE2K
maintenance of blood-brain barrier (GO:0035633),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,ITGB1;ACTB;ACTG1
positive regulation of phosphate metabolic process (GO:0045937),30-Mar,0.080372999,0.304044077,0,0,3.171268902,7.995013058,APP;PTGES3;MIF
protein import (GO:0017038),6/89,0.082146481,0.310209086,0,0,2.066417229,5.164495876,HSP90AA1;SEC13;HSPA4;LAMP2;PHB2;RAN
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),25/547,0.082232398,0.310209086,0,0,1.376659402,3.439178674,GSK3B;NDUFA13;SET;DDX3X;CTBP1;DBI;ENO1;PHB;YBX1;PHB2;TOB1;SUMO1;YWHAQ;RPS3;S100A11;HSPA8;RPL13A;PA2G4;DAP;NCL;CAPRIN1;CTNNB1;CALR;GAPDH;PFDN5
regulation of Wnt signaling pathway (GO:0030111),7/111,0.083848294,0.315863659,0,0,1.924779647,4.771040105,SNX3;PPP2CA;APP;PPP2R1A;ATP6AP2;CTNNB1;ATP6V0C
DNA repair (GO:0006281),15/298,0.084471259,0.317767229,0,0,1.519700711,3.755703131,NPM1;VCP;UBXN1;DDX1;SMARCA5;NUCKS1;COMMD1;PARK7;DDB1;UBB;SUMO1;UBC;UBE2N;RPS27A;UBA52
positive regulation of protein transport (GO:0051222),5/69,0.084982844,0.319247094,0,0,2.232126298,5.502874093,GOLPH3;TMED10;IER3IP1;PPIA;OAZ1
regulation of cellular component size (GO:0032535),31-Mar,0.086839614,0.323969333,0,0,3.057850803,7.472446711,HP1BP3;RAC1;AP2M1
negative regulation of response to DNA damage stimulus (GO:2001021),31-Mar,0.086839614,0.323969333,0,0,3.057850803,7.472446711,RPS3;MIF;TPT1
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),31-Mar,0.086839614,0.323969333,0,0,3.057850803,7.472446711,PSMC5;PSMC6;PSMC3
positive regulation of RNA splicing (GO:0033120),31-Mar,0.086839614,0.323969333,0,0,3.057850803,7.472446711,TRA2B;NCL;PRDX6
prostaglandin metabolic process (GO:0006693),31-Mar,0.086839614,0.323969333,0,0,3.057850803,7.472446711,GSTP1;PTGES3;MIF
regulated exocytosis (GO:0045055),10/180,0.087202503,0.32487443,0,0,1.683900466,4.107912637,RAB10;APP;CD63;TMED10;LAMP2;ACTN4;CALM1;ALDOA;RAB11B;SOD1
cellular response to light stimulus (GO:0071482),5/70,0.089105934,0.325160253,0,0,2.197671764,5.313815049,NPM1;NEDD4;GNB1;RPL26;ATF4
positive regulation of cell-substrate adhesion (GO:0010811),5/70,0.089105934,0.325160253,0,0,2.197671764,5.313815049,CDC42;GSK3B;RAC1;CALR;P4HB
actin polymerization or depolymerization (GO:0008154),4/50,0.0891773,0.325160253,0,0,2.483091787,6.001952556,CFL1;TWF1;DSTN;RAC1
iron ion transport (GO:0006826),4/50,0.0891773,0.325160253,0,0,2.483091787,6.001952556,FTH1;ATP6V0C;ATP6V1F;RAB11B
regulation of aerobic respiration (GO:1903715),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,VCP;COX7A2
regulation of amyloid fibril formation (GO:1905906),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,APP;PFDN5
central nervous system neuron development (GO:0021954),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,HSP90AA1;HSP90AB1
clathrin coat assembly (GO:0048268),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,CLTB;AP2S1
contractile actin filament bundle assembly (GO:0030038),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,ITGB1;RHOA
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,PABPC1;TOB1
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,PABPC1;TOB1
establishment of apical/basal cell polarity (GO:0035089),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,CDC42;RHOA
regulation of superoxide anion generation (GO:0032928),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,GSTP1;SOD1
response to ethanol (GO:0045471),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,GOT2;SOD1
integrated stress response signaling (GO:0140467),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,HSPA5;ATF4
stress fiber assembly (GO:0043149),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,ITGB1;RHOA
membrane repolarization during cardiac muscle cell action potential (GO:0086013),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,YWHAE;ATP1A1
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,TSEN34;DDX1
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,TMBIM6;PARK7
peptidyl-arginine modification (GO:0018195),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,KRTCAP2;PARK7
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,DDX5;RPL26
positive regulation of exosomal secretion (GO:1903543),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,PDCD6IP;CHMP2A
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,PABPC1;TOB1
prostanoid biosynthetic process (GO:0046457),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,PTGES3;MIF
protein localization to cell-cell junction (GO:0150105),15-Feb,0.090288852,0.325160253,0,0,4.387683218,10.55124295,ACTB;ACTG1
regulation of TOR signaling (GO:0032006),5/71,0.093331023,0.332796631,0,0,2.164261307,5.13276801,SEC13;GOLPH3;RHEB;PDCD6;LAMTOR2
cellular response to transforming growth factor beta stimulus (GO:0071560),7/114,0.093412654,0.332796631,0,0,1.870521807,4.434499284,ITGB1;FKBP1A;UBB;UBC;RPS27A;UBA52;RHOA
positive regulation of cellular component organization (GO:0051130),7/114,0.093412654,0.332796631,0,0,1.870521807,4.434499284,GSK3B;VCP;TMED9;SUMO1;SURF4;RPS3;PARK7
regulation of centrosome duplication (GO:0010824),3/32,0.093518194,0.332796631,0,0,2.952254642,6.995660443,NPM1;PDCD6IP;CHMP2A
regulation of dendrite morphogenesis (GO:0048814),3/32,0.093518194,0.332796631,0,0,2.952254642,6.995660443,GSK3B;CAPRIN1;NEDD4
chromatin remodeling at centromere (GO:0031055),3/32,0.093518194,0.332796631,0,0,2.952254642,6.995660443,NPM1;SMARCA5;RBBP7
ERBB2 signaling pathway (GO:0038128),3/32,0.093518194,0.332796631,0,0,2.952254642,6.995660443,HSP90AA1;CDC37;STUB1
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),3/32,0.093518194,0.332796631,0,0,2.952254642,6.995660443,CDC42;PDCD6IP;RHOA
mitochondrial membrane organization (GO:0007006),3/32,0.093518194,0.332796631,0,0,2.952254642,6.995660443,HSPA9;GHITM;SLC25A5
mesenchymal cell differentiation (GO:0048762),4/51,0.094307598,0.333846427,0,0,2.430133964,5.738016556,GSK3B;DDX5;CTNNB1;HNRNPAB
mitotic metaphase plate congression (GO:0007080),4/51,0.094307598,0.333846427,0,0,2.430133964,5.738016556,NUDC;PDCD6IP;DCTN2;CHMP2A
negative regulation of protein ubiquitination (GO:0031397),4/51,0.094307598,0.333846427,0,0,2.430133964,5.738016556,UBXN1;RPS3;PARK7;SQSTM1
positive regulation of actin filament bundle assembly (GO:0032233),4/51,0.094307598,0.333846427,0,0,2.430133964,5.738016556,CDC42;TPM1;RAC1;RHOA
regulation of heart contraction (GO:0008016),6/93,0.09656385,0.340939817,0,0,1.970999641,4.607311843,TPM1;ATP2A2;CALM3;ATP1A1;CALM1;CALM2
positive regulation of peptidyl-serine phosphorylation (GO:0033138),6/93,0.09656385,0.340939817,0,0,1.970999641,4.607311843,APP;HSP90AA1;HSP90AB1;PARK7;MIF;EIF4G1
cell junction organization (GO:0034330),5/72,0.097656932,0.343900095,0,0,2.131848178,4.959306987,CDC42;APP;ACTB;RHOA;ACTG1
positive regulation of protein secretion (GO:0050714),5/72,0.097656932,0.343900095,0,0,2.131848178,4.959306987,GLUD1;GOLPH3;TMED10;IER3IP1;PPIA
regulation of intrinsic apoptotic signaling pathway (GO:2001242),4/52,0.099574101,0.34470044,0,0,2.379382716,5.488886579,BCAP31;NDUFA13;DDX3X;P4HB
endocytic recycling (GO:0032456),4/52,0.099574101,0.34470044,0,0,2.379382716,5.488886579,SNX3;VPS29;RAB14;RAB11B
negative regulation of protein metabolic process (GO:0051248),4/52,0.099574101,0.34470044,0,0,2.379382716,5.488886579,SNX3;HSP90AB1;PHB;PFDN5
negative regulation of cell death (GO:0060548),6/94,0.100366039,0.34470044,0,0,1.948500608,4.4794692,GSK3B;PSMC5;CHMP2A;NENF;PARK7;EIF4G1
regulation of histone acetylation (GO:0035065),3/33,0.100400843,0.34470044,0,0,2.853698225,6.559466998,SET;CTBP1;PARK7
RNA stabilization (GO:0043489),3/33,0.100400843,0.34470044,0,0,2.853698225,6.559466998,HNRNPU;YBX1;PABPC1
neuron projection extension (GO:1990138),3/33,0.100400843,0.34470044,0,0,2.853698225,6.559466998,HSP90AA1;HSP90AB1;CTNNB1
positive regulation of ATP metabolic process (GO:1903580),3/33,0.100400843,0.34470044,0,0,2.853698225,6.559466998,APP;VCP;ENO1
positive regulation of organelle organization (GO:0010638),3/33,0.100400843,0.34470044,0,0,2.853698225,6.559466998,GSK3B;TMED9;SURF4
regulation of activin receptor signaling pathway (GO:0032925),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,FKBP1A;CSNK2B
regulation of ATP biosynthetic process (GO:2001169),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,VCP;ENO1
cellular response to corticosteroid stimulus (GO:0071384),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,HNRNPU;UBE2L3
regulation of interleukin-1 production (GO:0032652),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,TMED10;HMGB1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,RPS3;TPT1
regulation of oxidative phosphorylation (GO:0002082),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,VCP;COX7A2
histone H2A acetylation (GO:0043968),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,MORF4L1;MORF4L2
retrograde axonal transport (GO:0008090),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,KIF5B;SOD1
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,TSEN34;DDX1
killing by host of symbiont cells (GO:0051873),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,ROMO1;GAPDH
negative regulation of histone modification (GO:0031057),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,SET;CTBP1
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,PPP2CA;PPP2R1A
negative regulation of release of cytochrome c from mitochondria (GO:0090201),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,PRELID1;GHITM
nuclear transport (GO:0051169),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,NPM1;BANF1
nucleoside diphosphate metabolic process (GO:0009132),16-Feb,0.100947075,0.34470044,0,0,4.074066259,9.342481356,NME2;CMPK1
regulation of DNA replication (GO:0006275),4/53,0.104973925,0.357998195,0,0,2.330702948,5.253505356,PPP2CA;PPP2R1A;NUCKS1;S100A11
regulation of stress fiber assembly (GO:0051492),5/74,0.106606035,0.36264849,0,0,2.069840451,4.633576195,CDC42;TPM1;RAC1;RHOA;ACTG1
negative regulation of protein binding (GO:0032091),5/74,0.106606035,0.36264849,0,0,2.069840451,4.633576195,GSK3B;ATP2A2;TMBIM6;PARK7;ACTB
regulation of amyloid-beta formation (GO:1902003),3/34,0.107479483,0.362877606,0,0,2.761500286,6.159402954,RTN3;TMED10;RTN4
regulation of lamellipodium assembly (GO:0010591),3/34,0.107479483,0.362877606,0,0,2.761500286,6.159402954,CDC42;TWF1;RAC1
tRNA export from nucleus (GO:0006409),3/34,0.107479483,0.362877606,0,0,2.761500286,6.159402954,SEC13;SSB;RAN
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),3/34,0.107479483,0.362877606,0,0,2.761500286,6.159402954,SEC13;SSB;RAN
negative regulation of blood vessel endothelial cell migration (GO:0043537),3/34,0.107479483,0.362877606,0,0,2.761500286,6.159402954,CSNK2B;HMGB1;RHOA
negative regulation of mitochondrion organization (GO:0010823),3/34,0.107479483,0.362877606,0,0,2.761500286,6.159402954,PRELID1;GHITM;SLC25A5
regulation of potassium ion transmembrane transport (GO:1901379),4/54,0.110504046,0.372623506,0,0,2.28397037,5.030908715,YWHAE;CD63;NEDD4;GNB1
acyl-CoA biosynthetic process (GO:0071616),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,SLC25A1;ACAT1
regulation of cellular respiration (GO:0043457),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,PRELID1;VCP
regulation of cholesterol biosynthetic process (GO:0045540),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,RAN;SOD1
ruffle organization (GO:0031529),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,TPM1;RAC1
midbody abscission (GO:0061952),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,PDCD6IP;CHMP2A
negative regulation of amyloid-beta formation (GO:1902430),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,RTN3;RTN4
negative regulation of cell aging (GO:0090344),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,MIF;YBX1
negative regulation of phagocytosis (GO:0050765),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,SNX3;HMGB1
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,TPM1;SOD2
positive regulation of heart rate (GO:0010460),17-Feb,0.111930705,0.372780315,0,0,3.802264894,8.326485977,TPM1;ATP2A2
regulation of mitotic spindle organization (GO:0060236),3/35,0.114745895,0.380747741,0,0,2.675064719,5.7916093,PDCD6IP;CHMP2A;HNRNPU
regulation of muscle cell differentiation (GO:0051147),3/35,0.114745895,0.380747741,0,0,2.675064719,5.7916093,CDC42;CTNNA1;CTNNB1
positive regulation of cell cycle G1/S phase transition (GO:1902808),3/35,0.114745895,0.380747741,0,0,2.675064719,5.7916093,DDX3X;PHB2;EIF4G1
establishment of protein localization to organelle (GO:0072594),5/76,0.115942007,0.383230218,0,0,2.011326117,4.333734299,SEC13;LAMP1;LAMP2;PHB2;RAN
regulation of gene silencing by RNA (GO:0060966),4/55,0.116161313,0.383230218,0,0,2.239070443,4.820215815,SEC13;POLR2F;POLR2L;EIF4G1
regulation of posttranscriptional gene silencing (GO:0060147),4/55,0.116161313,0.383230218,0,0,2.239070443,4.820215815,SEC13;POLR2F;POLR2L;EIF4G1
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),4/55,0.116161313,0.383230218,0,0,2.239070443,4.820215815,YWHAE;DDX3X;DNAJB6;PARK7
regulation of neuron apoptotic process (GO:0043523),6/98,0.116345346,0.383230218,0,0,1.863395568,4.00852237,SET;CTNNB1;PARK7;SOD2;ATF4;SOD1
regulation of peptidyl-serine phosphorylation (GO:0033135),6/98,0.116345346,0.383230218,0,0,1.863395568,4.00852237,APP;HSP90AA1;HSP90AB1;PARK7;MIF;EIF4G1
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),6/99,0.120528628,0.393354501,0,0,1.843263193,3.900101568,SEC13;ALYREF;HNRNPA2B1;SRSF3;SRSF5;THOC7
cellular response to UV (GO:0034644),5/77,0.120751189,0.393354501,0,0,1.983287999,4.192716727,DDB1;NPM1;NEDD4;RPL26;ATF4
regulation of protein phosphorylation (GO:0001932),13/266,0.12121695,0.393354501,0,0,1.471139123,3.104358597,APP;NPM1;HSP90AA1;TWF1;PARK7;SOD1;PPP2CA;NDUFS4;FKBP8;CDK2AP1;RAC1;PPIA;ATF4
regulation of ATP metabolic process (GO:1903578),4/56,0.121942457,0.393354501,0,0,2.195897436,4.620620579,SEC13;EIF6;PGAM1;COX7A2
regulation of androgen receptor signaling pathway (GO:0060765),3/36,0.122191748,0.393354501,0,0,2.593867671,5.452734616,DDX5;PARK7;PHB
establishment of protein localization to plasma membrane (GO:0061951),3/36,0.122191748,0.393354501,0,0,2.593867671,5.452734616,RAB10;GOLPH3;GORASP2
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),3/36,0.122191748,0.393354501,0,0,2.593867671,5.452734616,DDX5;HINT1;RPS27L
transferrin transport (GO:0033572),3/36,0.122191748,0.393354501,0,0,2.593867671,5.452734616,ATP6V0C;ATP6V1F;RAB11B
mitochondrion disassembly (GO:0061726),3/36,0.122191748,0.393354501,0,0,2.593867671,5.452734616,MAP1LC3B;SQSTM1;GABARAP
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",3/36,0.122191748,0.393354501,0,0,2.593867671,5.452734616,GNB1;CTNNB1;CALM1
negative regulation of cellular protein localization (GO:1903828),3/36,0.122191748,0.393354501,0,0,2.593867671,5.452734616,GSK3B;CTNNA1;COMMD1
"alternative mRNA splicing, via spliceosome (GO:0000380)",18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,DDX5;PUF60
cellular response to glucocorticoid stimulus (GO:0071385),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,HNRNPU;UBE2L3
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,GSK3B;SLC25A5
DNA conformation change (GO:0071103),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,HMGB1;TOP1
regulation of presynapse assembly (GO:1905606),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,APP;EIF4G1
regulation of presynapse organization (GO:0099174),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,APP;EIF4G1
regulation of protein sumoylation (GO:0033233),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,CTNNB1;PARK7
regulation of protein-containing complex disassembly (GO:0043244),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,ETF1;GSPT1
regulation of transcription by RNA polymerase I (GO:0006356),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,ATF4;POLR2L
leukocyte tethering or rolling (GO:0050901),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,ITGB1;GOLPH3
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,TECR;HSD17B12
negative regulation of biosynthetic process (GO:0009890),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,GSTP1;PARK7
negative regulation of fibroblast proliferation (GO:0048147),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,GSTP1;FTH1
neuron maturation (GO:0042551),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,APP;MTCH1
positive regulation of cell cycle phase transition (GO:1901989),18-Feb,0.123205445,0.393354501,0,0,3.5644387,7.46358543,NPM1;PHB2
regulation of reactive oxygen species metabolic process (GO:2000377),4/57,0.127844099,0.407201547,0,0,2.154353599,4.431384135,ARF4;EIF6;ROMO1;RAC1
"positive regulation of gene expression, epigenetic (GO:0045815)",4/57,0.127844099,0.407201547,0,0,2.154353599,4.431384135,SMARCA5;POLR2F;ACTB;POLR2L
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),9/171,0.128744183,0.40958544,0,0,1.588640133,3.256597762,FKBP1A;NDFIP1;TFG;VAPA;EEF1D;DDX1;UBE2N;GAPDH;RHOA
epithelial cell differentiation (GO:0030855),6/101,0.129114741,0.410073843,0,0,1.804269962,3.693437684,RAB10;ANXA4;PGK1;VDAC1;EDF1;CTSB
proton transmembrane transport (GO:1902600),3/37,0.12980864,0.410073843,0,0,2.51744692,5.139856058,ATP1A1;ATP6V0C;ATP6V1F
centromere complex assembly (GO:0034508),3/37,0.12980864,0.410073843,0,0,2.51744692,5.139856058,NPM1;SMARCA5;RBBP7
regulation of transport (GO:0051049),3/37,0.12980864,0.410073843,0,0,2.51744692,5.139856058,REEP5;ACTB;ACTG1
glutamine family amino acid metabolic process (GO:0009064),3/37,0.12980864,0.410073843,0,0,2.51744692,5.139856058,GLUD1;GOT2;GCLM
phagosome maturation (GO:0090382),3/37,0.12980864,0.410073843,0,0,2.51744692,5.139856058,RAB14;ATP6V0C;ATP6V1F
recombinational repair (GO:0000725),5/79,0.130643513,0.412229123,0,0,1.929485123,3.927048151,MORF4L1;SFR1;SWI5;UBE2N;NUCKS1
platelet degranulation (GO:0002576),7/125,0.133370539,0.419757651,0,0,1.695180085,3.415150507,APP;CD63;LAMP2;ACTN4;CALM1;ALDOA;SOD1
receptor metabolic process (GO:0043112),4/58,0.133862763,0.419757651,0,0,2.114348422,4.251828149,ITGB1;NEDD4;AP2M1;RAB11B
aspartate family amino acid catabolic process (GO:0009068),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,GOT2;OGDH
regulation of autophagy of mitochondrion (GO:1903146),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,VDAC1;PARK7
regulation of exosomal secretion (GO:1903541),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,PDCD6IP;CHMP2A
diol metabolic process (GO:0034311),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,HSP90AA1;CALM1
leukocyte adhesion to vascular endothelial cell (GO:0061756),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,ITGB1;GOLPH3
maintenance of protein localization in organelle (GO:0072595),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,HSPA5;HNRNPU
negative regulation of amyloid precursor protein catabolic process (GO:1902992),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,RTN3;RTN4
positive regulation of oxidoreductase activity (GO:0051353),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,POR;PARK7
prostaglandin biosynthetic process (GO:0001516),19-Feb,0.134738942,0.419757651,0,0,3.354592058,6.723998444,PTGES3;MIF
positive regulation of hydrolase activity (GO:0051345),8/149,0.135159642,0.42058317,0,0,1.621798734,3.245703648,ITGB1;GSK3B;NDUFA13;RPS3;CALM3;CALM1;CALM2;RHOA
regulation of organelle organization (GO:0033043),5/80,0.135723071,0.421365533,0,0,1.903659743,3.801872571,TMED9;GOLPH3;SAR1A;SURF4;SQSTM1
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),5/80,0.135723071,0.421365533,0,0,1.903659743,3.801872571,GSK3B;DDX3X;GSTP1;TMBIM1;PARK7
regulation of apoptotic signaling pathway (GO:2001233),3/38,0.137588116,0.425687858,0,0,2.445393068,4.850414474,RPS3;TMBIM6;PPIA
regulation of axon extension (GO:0030516),3/38,0.137588116,0.425687858,0,0,2.445393068,4.850414474,GSK3B;CTTN;RTN4
histone exchange (GO:0043486),3/38,0.137588116,0.425687858,0,0,2.445393068,4.850414474,NPM1;SMARCA5;RBBP7
cellular response to organonitrogen compound (GO:0071417),6/103,0.137986562,0.425944805,0,0,1.766884698,3.49949002,GOLPH3;CTNNA1;CTNNB1;LAMTOR2;ACTB;HSP90B1
chromatin remodeling (GO:0006338),6/103,0.137986562,0.425944805,0,0,1.766884698,3.49949002,NPM1;GATAD1;SMARCA5;HNRNPC;TOP1;ACTB
cellular response to organic cyclic compound (GO:0071407),8/150,0.138825126,0.428044139,0,0,1.610293655,3.17958959,GOLPH3;GNB1;CTNNA1;CTNNB1;ATP1A1;ACTB;UBE2L3;HSP90B1
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),11/224,0.142001847,0.435407515,0,0,1.477242698,2.883452496,FKBP1A;NDFIP1;TFG;VAPA;EEF1D;GSTP1;DDX1;UBE2N;SQSTM1;GAPDH;RHOA
mRNA transport (GO:0051028),6/104,0.142526806,0.435407515,0,0,1.74876429,3.406986636,SEC13;ALYREF;HNRNPA2B1;SRSF3;SRSF5;THOC7
supramolecular fiber organization (GO:0097435),16/351,0.143849351,0.435407515,0,0,1.367713469,2.651980965,APP;HSP90AB1;TPM1;RHOA;FKBP1A;CDC42;UBB;DNAJB6;UBC;RAC1;P4HB;ALDOA;RPS27A;PPIB;UBA52;ITM2B
regulation of intracellular transport (GO:0032386),3/39,0.145521702,0.435407515,0,0,2.377342209,4.582160805,LAMP1;REEP5;RAB11B
regulation of ion transmembrane transporter activity (GO:0032412),3/39,0.145521702,0.435407515,0,0,2.377342209,4.582160805,YWHAE;NEDD4;PHB2
DNA replication-independent nucleosome assembly (GO:0006336),3/39,0.145521702,0.435407515,0,0,2.377342209,4.582160805,NPM1;SMARCA5;RBBP7
regulation of receptor-mediated endocytosis (GO:0048259),3/39,0.145521702,0.435407515,0,0,2.377342209,4.582160805,ARF1;HNRNPK;RAC1
"regulation of gene expression, epigenetic (GO:0040029)",5/82,0.146139529,0.435407515,0,0,1.85402135,3.565641692,SMARCA5;POLR2F;RBBP7;ACTB;POLR2L
cellular protein catabolic process (GO:0044257),4/60,0.146236825,0.435407515,0,0,2.038624339,3.919312139,PSMA6;AP2S1;AP2M1;CTSB
negative regulation of protein phosphorylation (GO:0001933),8/152,0.14630391,0.435407515,0,0,1.587762875,3.051790193,GSTP1;FKBP8;CALM3;PARK7;CALM1;PPIA;CALM2;EIF4G1
protein-DNA complex disassembly (GO:0032986),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,SET;RPL23
cellular response to interferon-beta (GO:0035458),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,NDUFA13;UBE2K
cellular response to misfolded protein (GO:0071218),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,VCP;STUB1
endoplasmic reticulum calcium ion homeostasis (GO:0032469),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,BCAP31;ATP2A2
regulation of protein modification by small protein conjugation or removal (GO:1903320),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,HSP90AA1;HSP90AB1
regulation of T cell migration (GO:2000404),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,APP;RHOA
insulin secretion (GO:0030073),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,PARK7;RAB11B
maintenance of protein location in nucleus (GO:0051457),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,HNRNPU;PARK7
miRNA metabolic process (GO:0010586),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,SND1;RAN
natural killer cell mediated immunity (GO:0002228),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,KIF5B;TUBB4B
negative regulation of telomere maintenance via telomerase (GO:0032211),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,HNRNPU;HNRNPC
negative regulation of viral life cycle (GO:1903901),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,SNX3;PPIA
positive regulation of activated T cell proliferation (GO:0042104),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,RPS3;HMGB1
positive regulation of interferon-alpha production (GO:0032727),20-Feb,0.1465007,0.435407515,0,0,3.16806171,6.084975561,DDX3X;HSPD1
positive regulation of cellular metabolic process (GO:0031325),6/105,0.14713502,0.435407515,0,0,1.731009951,3.317315447,CD63;CHCHD2;PRELID1;ROMO1;GHITM;EIF4G1
regulation of cell cycle process (GO:0010564),6/106,0.151809967,0.435407515,0,0,1.713610698,3.230371668,CDC42;CTNNB1;CALM3;CALM1;CALM2;SND1
small GTPase mediated signal transduction (GO:0007264),6/106,0.151809967,0.435407515,0,0,1.713610698,3.230371668,RHEB;GNB1;RAB18;NUCB1;PARK7;RAC1
positive regulation of protein serine/threonine kinase activity (GO:0071902),6/106,0.151809967,0.435407515,0,0,1.713610698,3.230371668,PPP2CA;DDX3X;CALM3;CALM1;CALM2;RHOA
regulation of nitric oxide biosynthetic process (GO:0045428),3/40,0.15360093,0.435407515,0,0,2.312969775,4.333111575,HSP90AA1;HSP90AB1;RAC1
positive regulation of protein kinase activity (GO:0045860),8/154,0.153975935,0.435407515,0,0,1.565849376,2.929639909,PPP2CA;HSP90AA1;DDX3X;HSP90AB1;CALM3;CALM1;CALM2;RHOA
response to calcium ion (GO:0051592),6/107,0.156550367,0.435407515,0,0,1.696555985,3.146055224,PDCD6;NEDD4;CALM3;CALM1;CALM2;SEC31A
regulation of cytokinesis (GO:0032465),5/84,0.156885833,0.435407515,0,0,1.806896293,3.346800021,CDC42;CALM3;CALM1;CALM2;RHOA
purinergic nucleotide receptor signaling pathway (GO:0035590),21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,APP;HSP90AB1
regulation of cell-substrate junction assembly (GO:0090109),21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,RHOA;ACTG1
regulation of cholesterol metabolic process (GO:0090181),21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,ACADL;RAN
regulation of fibroblast migration (GO:0010762),21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,ITGB1;RAC1
cellular response to steroid hormone stimulus (GO:0071383),21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,ATP1A1;UBE2L3
mitochondrial calcium ion transmembrane transport (GO:0006851),21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,PHB;PHB2
negative regulation of ion transmembrane transporter activity (GO:0032413),21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,YWHAE;NEDD4
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,DDB1;RBX1
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",21-Feb,0.158461989,0.435407515,0,0,3.001166135,5.528869903,DDB1;RBX1
protein retention in Golgi apparatus (GO:0045053),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,GOLPH3
ADP transport (GO:0015866),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SLC25A5
pyrimidine ribonucleotide metabolic process (GO:0009218),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,CMPK1
anterograde dendritic transport (GO:0098937),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,KIF5B
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,KIF5B
auditory receptor cell morphogenesis (GO:0002093),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SOD1
auditory receptor cell stereocilium organization (GO:0060088),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SOD1
axon choice point recognition (GO:0016198),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,APP
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,CD63
"CD4-positive, alpha-beta T cell activation (GO:0035710)",05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HMGB1
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,RPS3
cell-cell adhesion mediated by integrin (GO:0033631),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,ITGB1
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HNRNPU
cellular response to antibiotic (GO:0071236),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,RPL23
regulation of hormone metabolic process (GO:0032350),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,STUB1
regulation of intracellular cholesterol transport (GO:0032383),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SCP2
regulation of inward rectifier potassium channel activity (GO:1901979),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,ITGB1
constitutive secretory pathway (GO:0045054),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,RAB11B
regulation of morphogenesis of a branching structure (GO:0060688),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,RTN4
embryonic skeletal joint morphogenesis (GO:0060272),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,CTNNB1
regulation of protein import (GO:1904589),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HSPA8
regulation of ribonuclease activity (GO:0060700),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,NPM1
regulation of sodium:proton antiporter activity (GO:0032415),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,ACTN4
fatty acid derivative catabolic process (GO:1901569),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,ACAT1
regulation of synaptic vesicle priming (GO:0010807),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,NAPA
glucuronate catabolic process (GO:0006064),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,AKR1A1
glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,AKR1A1
glutamate catabolic process (GO:0006538),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,GLUD1
response to mitochondrial depolarisation (GO:0098780),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SQSTM1
ribose phosphate metabolic process (GO:0019693),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,TKT
RNA import into mitochondrion (GO:0035927),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,TOMM20
Roundabout signaling pathway (GO:0035385),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,RHOA
rRNA transport (GO:0051029),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,NPM1
intracellular sequestering of iron ion (GO:0006880),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,FTH1
late endosome to Golgi transport (GO:0034499),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SNX3
long-chain fatty acid catabolic process (GO:0042758),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,ACADL
succinyl-CoA metabolic process (GO:0006104),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,OGDH
lysosomal protein catabolic process (GO:1905146),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,LAMP2
tight junction organization (GO:0120193),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,ACTG1
ubiquitin-dependent SMAD protein catabolic process (GO:0030579),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,STUB1
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,PDCD6IP
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,PDCD6
xylulose 5-phosphate biosynthetic process (GO:1901159),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,AKR1A1
"negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HMGB1
negative regulation of cholesterol biosynthetic process (GO:0045541),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SOD1
negative regulation of cholesterol metabolic process (GO:0090206),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SOD1
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,PARK7
negative regulation of histone H4 acetylation (GO:0090241),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,CTBP1
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,PARK7
negative regulation of IRE1-mediated unfolded protein response (GO:1903895),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HSPA5
negative regulation of macrophage chemotaxis (GO:0010760),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,MIF
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,PARK7
negative regulation of protein polyubiquitination (GO:1902915),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,PPIA
negative regulation of response to food (GO:0032096),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,NENF
negative regulation of smooth muscle contraction (GO:0045986),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SOD1
negative regulation of sterol biosynthetic process (GO:0106119),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SOD1
neuroinflammatory response (GO:0150076),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,ITGB1
oxaloacetate metabolic process (GO:0006107),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,MDH1
peptidyl-cysteine S-nitrosylation (GO:0018119),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,GAPDH
PML body organization (GO:0030578),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SERBP1
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HNRNPU
positive regulation of dendritic cell differentiation (GO:2001200),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HMGB1
positive regulation of deoxyribonuclease activity (GO:0032077),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,RPS3
positive regulation of DNA ligation (GO:0051106),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HMGB1
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,HNRNPU
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,SOD2
protein lipoylation (GO:0009249),05-Jan,0.158623101,0.435407515,0,0,7.122787611,13.11464982,NDUFAB1
I-kappaB kinase/NF-kappaB signaling (GO:0007249),4/62,0.159035237,0.435653322,0,0,1.968122605,3.618648252,UBB;UBC;RPS27A;UBA52
negative regulation of kinase activity (GO:0033673),4/62,0.159035237,0.435653322,0,0,1.968122605,3.618648252,GSTP1;HNRNPU;PARK7;PPIA
regulation of release of cytochrome c from mitochondria (GO:0090199),3/41,0.161817354,0.442428945,0,0,2.251985363,4.101511727,PRELID1;FAM162A;GHITM
regulation of signal transduction by p53 class mediator (GO:1901796),8/156,0.161836282,0.442428945,0,0,1.544528135,2.812848396,RPS15;RPL5;RPL23;CSNK2B;RPL11;RPS20;RPL37;RBBP7
B cell activation (GO:0042113),5/85,0.162377501,0.443459687,0,0,1.784217359,3.24340634,ITGB1;PHB;SLC25A5;PHB2;HSPD1
negative regulation of peptidase activity (GO:0010466),4/63,0.165584113,0.451760291,0,0,1.934664156,3.479060081,CSTB;UBXN1;PARK7;GAPDH
regulation of neuron death (GO:1901214),5/86,0.167945326,0.456818052,0,0,1.762098399,3.143789343,GSK3B;UBB;NENF;PARK7;EIF4G1
negative regulation of phosphorylation (GO:0042326),5/86,0.167945326,0.456818052,0,0,1.762098399,3.143789343,FKBP8;HNRNPU;PARK7;DYNLL1;PPIA
positive regulation of endothelial cell migration (GO:0010595),5/86,0.167945326,0.456818052,0,0,1.762098399,3.143789343,PDCD6;HMGB1;RAC1;CALR;AAMP
ATP-dependent chromatin remodeling (GO:0043044),3/42,0.170162576,0.458486719,0,0,2.194128357,3.885803445,SMARCA5;HNRNPC;ACTB
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),3/42,0.170162576,0.458486719,0,0,2.194128357,3.885803445,GSK3B;DDX3X;TMBIM1
mitochondrial gene expression (GO:0140053),3/42,0.170162576,0.458486719,0,0,2.194128357,3.885803445,NDUFA7;MRPS21;MRPL23
nucleic acid-templated transcription (GO:0097659),3/42,0.170162576,0.458486719,0,0,2.194128357,3.885803445,POLR2F;PTMA;POLR2L
cell projection assembly (GO:0030031),22-Feb,0.170595762,0.458486719,0,0,2.850960118,5.041804619,CDC42;RAC1
regulation of DNA recombination at telomere (GO:0072695),22-Feb,0.170595762,0.458486719,0,0,2.850960118,5.041804619,POLR2F;POLR2L
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),22-Feb,0.170595762,0.458486719,0,0,2.850960118,5.041804619,TMBIM6;PARK7
regulation of viral release from host cell (GO:1902186),22-Feb,0.170595762,0.458486719,0,0,2.850960118,5.041804619,DDB1;CHMP2A
lipid droplet organization (GO:0034389),22-Feb,0.170595762,0.458486719,0,0,2.850960118,5.041804619,RAB18;PPIA
metallo-sulfur cluster assembly (GO:0031163),22-Feb,0.170595762,0.458486719,0,0,2.850960118,5.041804619,HSPA9;GLRX5
natural killer cell mediated cytotoxicity (GO:0042267),22-Feb,0.170595762,0.458486719,0,0,2.850960118,5.041804619,KIF5B;TUBB4B
negative regulation of DNA recombination at telomere (GO:0048239),22-Feb,0.170595762,0.458486719,0,0,2.850960118,5.041804619,POLR2F;POLR2L
protein secretion (GO:0009306),4/64,0.172227623,0.462412336,0,0,1.902320988,3.34606522,RAB10;GOLPH3;CANX;PARK7
protein targeting to membrane (GO:0006612),5/87,0.173587114,0.465599598,0,0,1.740518926,3.047780411,SEC61A1;NACA;SSR2;SSR1;SEC62
regulation of carbohydrate catabolic process (GO:0043470),3/43,0.178628265,0.469492911,0,0,2.139164201,3.684599878,SEC13;EIF6;PGAM1
regulation of purine nucleotide metabolic process (GO:1900542),3/43,0.178628265,0.469492911,0,0,2.139164201,3.684599878,SEC13;EIF6;PGAM1
cytoskeleton-dependent intracellular transport (GO:0030705),23-Feb,0.182876574,0.469492911,0,0,2.715059436,4.612733436,TUBA1C;KIF5B
regulation of steroid metabolic process (GO:0019218),23-Feb,0.182876574,0.469492911,0,0,2.715059436,4.612733436,ACADL;STUB1
regulation of supramolecular fiber organization (GO:1902903),23-Feb,0.182876574,0.469492911,0,0,2.715059436,4.612733436,HSPA8;PARK7
response to nutrient levels (GO:0031667),23-Feb,0.182876574,0.469492911,0,0,2.715059436,4.612733436,ATF4;EIF4G1
negative regulation of intracellular protein transport (GO:0090317),23-Feb,0.182876574,0.469492911,0,0,2.715059436,4.612733436,UFM1;PARK7
negative regulation of phosphoprotein phosphatase activity (GO:0032515),23-Feb,0.182876574,0.469492911,0,0,2.715059436,4.612733436,FKBP1A;GSK3B
positive regulation of cell cycle G2/M phase transition (GO:1902751),23-Feb,0.182876574,0.469492911,0,0,2.715059436,4.612733436,NPM1;CDK4
positive regulation of transcription by RNA polymerase I (GO:0045943),23-Feb,0.182876574,0.469492911,0,0,2.715059436,4.612733436,NCL;ATF4
regulation of cation channel activity (GO:2001257),5/89,0.18508362,0.469492911,0,0,1.698901371,2.865957517,ITGB1;FKBP1A;APP;CALM1;CALM2
regulation of type I interferon production (GO:0032479),5/89,0.18508362,0.469492911,0,0,1.698901371,2.865957517,TAX1BP1;POLR2F;CTNNB1;GAPDH;POLR2L
cellular response to nutrient levels (GO:0031669),4/66,0.185782898,0.469492911,0,0,1.840764636,3.098331776,HSPA8;MAP1LC3B;LAMP2;EIF4G1
ERBB signaling pathway (GO:0038127),4/66,0.185782898,0.469492911,0,0,1.840764636,3.098331776,HSP90AA1;CDC37;STUB1;AAMP
protein localization to perinuclear region of cytoplasm (GO:1905719),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,SQSTM1
acetyl-CoA biosynthetic process from pyruvate (GO:0006086),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,PDHA1
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,CYCS
protein-DNA complex subunit organization (GO:0071824),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RPL23
protein-DNA covalent cross-linking repair (GO:0106300),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,VCP
adiponectin-activated signaling pathway (GO:0033211),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,CSNK2B
purine nucleobase transport (GO:0006863),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,VDAC3
aspartate metabolic process (GO:0006531),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,GOT2
regulation of blood vessel remodeling (GO:0060312),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,TMBIM1
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,LMNA
regulation of cellular response to hypoxia (GO:1900037),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,CHCHD2
regulation of centriole elongation (GO:1903722),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,CHMP2A
regulation of extracellular exosome assembly (GO:1903551),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,PDCD6IP
cellular response to X-ray (GO:0071481),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,NUCKS1
regulation of hydrogen peroxide metabolic process (GO:0010310),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RAC1
regulation of protein autoubiquitination (GO:1902498),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RBX1
regulation of protein lipidation (GO:1903059),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,DBI
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,UBB
regulation of translational elongation (GO:0006448),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,EIF5A
response to catecholamine (GO:0071869),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,GNB1
hydrogen peroxide biosynthetic process (GO:0050665),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,SOD1
ruffle assembly (GO:0097178),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RAC1
SCF complex assembly (GO:0010265),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RBX1
isoleucine metabolic process (GO:0006549),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,ACAT1
snRNA modification (GO:0040031),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,NOP10
tRNA 3'-end processing (GO:0042780),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,SSB
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,CALR
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,ITM2B
negative regulation of cell size (GO:0045792),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RHOA
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,BCAP31
negative regulation of ERAD pathway (GO:1904293),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,UBXN1
negative regulation of erythrocyte differentiation (GO:0045647),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,HSPA9
negative regulation of fibroblast migration (GO:0010764),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RAC1
negative regulation of glial cell proliferation (GO:0060253),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RNF10
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,PHB
negative regulation of glycogen biosynthetic process (GO:0045719),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,GSK3B
negative regulation of transporter activity (GO:0032410),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,NDFIP1
negative regulation of trophoblast cell migration (GO:1901164),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,CALR
oxygen homeostasis (GO:0032364),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,SOD2
"pentose-phosphate shunt, non-oxidative branch (GO:0009052)",06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,TKT
peptide antigen assembly with MHC protein complex (GO:0002501),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,CALR
peroxisome proliferator activated receptor signaling pathway (GO:0035357),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,ACTN4
positive regulation of activin receptor signaling pathway (GO:0032927),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,CSNK2B
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,TOMM7
positive regulation of gluconeogenesis (GO:0045722),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,DDB1
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,TPM1
positive regulation of immune response to tumor cell (GO:0002839),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,HSPD1
positive regulation of plasminogen activation (GO:0010756),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,ENO1
positive regulation of T cell mediated immune response to tumor cell (GO:0002842),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,HSPD1
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,DDX3X
pronephros development (GO:0048793),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,SEC61A1
protein K27-linked ubiquitination (GO:0044314),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,UBE2S
protein K29-linked ubiquitination (GO:0035519),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,UBE2S
protein localization to nuclear envelope (GO:0090435),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,TOR1AIP2
protein localization to nucleolus (GO:1902570),06-Jan,0.18719495,0.469492911,0,0,5.697935103,9.547486804,RAN
intracellular steroid hormone receptor signaling pathway (GO:0030518),3/44,0.18720617,0.469492911,0,0,2.086881224,3.496662892,DDX5;NEDD4;PHB
positive regulation of autophagy (GO:0010508),5/90,0.190933777,0.478397154,0,0,1.67882702,2.779849843,GSK3B;TMEM59;HMGB1;PARK7;PHB2
histone modification (GO:0016570),6/114,0.19145124,0.479249119,0,0,1.58601618,2.621878435,MORF4L1;ENY2;MORF4L2;UBE2N;PARK7;PHB
regulation of gene silencing by miRNA (GO:0060964),4/67,0.192686775,0.48189535,0,0,1.811452087,2.982898838,SEC13;POLR2F;POLR2L;EIF4G1
positive regulation of protein modification process (GO:0031401),10/214,0.193059933,0.482381943,0,0,1.400759108,2.303904989,APP;HSP90AA1;DDX3X;UBE2N;CDK2AP1;CALM3;RAC1;CALM1;CALM2;PPIA
regulation of cellular component organization (GO:0051128),7/139,0.19429704,0.48257332,0,0,1.51428346,2.480952289,HSPA8;HSP90AA1;NEDD4;AP2S1;HNRNPU;LAMTOR2;PARK7
purine ribonucleotide catabolic process (GO:0009154),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,HINT1;ACAT1
axon extension (GO:0048675),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,HSP90AA1;HSP90AB1
regulation of cell size (GO:0008361),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,RAC1;RHOA
cellular response to catecholamine stimulus (GO:0071870),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,GNB1;ATF4
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,PDCD6;NEDD4
long-chain fatty-acyl-CoA metabolic process (GO:0035336),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,TECR;HSD17B12
negative regulation of neuron differentiation (GO:0045665),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,GSK3B;CALR
positive regulation of lamellipodium assembly (GO:0010592),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,CDC42;RAC1
positive regulation of neuron apoptotic process (GO:0043525),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,CTNNB1;ATF4
positive regulation of phospholipase activity (GO:0010518),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,ARF4;ARL1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),24-Feb,0.195280503,0.48257332,0,0,2.591513361,4.232766135,HSPA5;ATF4
chromosome condensation (GO:0030261),3/45,0.195888137,0.483190739,0,0,2.037087912,3.320884161,SET;CSNK2B;BANF1
protein deacetylation (GO:0006476),3/45,0.195888137,0.483190739,0,0,2.037087912,3.320884161,MORF4L1;MORF4L2;PHB
neuron projection morphogenesis (GO:0048812),7/140,0.199024452,0.490479055,0,0,1.502819549,2.426043059,CDC42;RAB10;APP;UBB;CTTN;CTNNB1;ACTB
regulation of DNA metabolic process (GO:0051052),3/46,0.204666126,0.490790455,0,0,1.989610568,3.156269026,ALYREF;UBE2N;NUCKS1
erythrocyte differentiation (GO:0030218),3/46,0.204666126,0.490790455,0,0,1.989610568,3.156269026,HSPA9;RPS14;SLC25A5
establishment of protein localization to extracellular region (GO:0035592),3/46,0.204666126,0.490790455,0,0,1.989610568,3.156269026,RAB10;GOLPH3;CANX
RNA 3'-end processing (GO:0031123),4/69,0.206727165,0.490790455,0,0,1.755532764,2.767343549,ALYREF;SRSF3;SRSF5;THOC7
positive regulation of protein polymerization (GO:0032273),4/69,0.206727165,0.490790455,0,0,1.755532764,2.767343549,HSP90AA1;CTTN;RPS3;RAC1
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,VCP;STUB1
regulation of interferon-alpha production (GO:0032647),25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,DDX3X;HSPD1
endosome transport via multivesicular body sorting pathway (GO:0032509),25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,VCP;CHMP2A
energy derivation by oxidation of organic compounds (GO:0015980),25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,NDUFS4;CYCS
regulation of rhodopsin mediated signaling pathway (GO:0022400),25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,CALM1;METAP2
"RNA splicing, via transesterification reactions (GO:0000375)",25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,TRA2B;TXNL4A
ventricular cardiac muscle tissue development (GO:0003229),25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,FKBP1A;TPM1
organophosphate ester transport (GO:0015748),25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,PRELID1;SCP2
positive regulation of T cell migration (GO:2000406),25-Feb,0.20778508,0.490790455,0,0,2.478710423,3.89467624,APP;RHOA
histone deacetylation (GO:0016575),3/47,0.213532217,0.490790455,0,0,1.944291286,3.001922671,MORF4L1;MORF4L2;PHB
positive regulation of neuron death (GO:1901216),3/47,0.213532217,0.490790455,0,0,1.944291286,3.001922671,GSK3B;CTNNB1;ATF4
"DNA-templated transcription, termination (GO:0006353)",4/70,0.213855725,0.490790455,0,0,1.728843996,2.66666177,POLR2F;SNRPF;SNRPB;POLR2L
establishment of protein localization to membrane (GO:0090150),4/70,0.213855725,0.490790455,0,0,1.728843996,2.66666177,RAB10;GORASP2;NACA;RAB11B
pyrimidine ribonucleotide biosynthetic process (GO:0009220),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,CMPK1
regulation by virus of viral protein levels in host cell (GO:0046719),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,DDB1
regulation of cardiac muscle cell membrane potential (GO:0086036),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,ATP2A2
Cdc42 protein signal transduction (GO:0032488),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,CDC42
cellular protein complex disassembly (GO:0043624),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,ETF1
regulation of glucocorticoid receptor signaling pathway (GO:2000322),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PHB
regulation of glycogen (starch) synthase activity (GO:2000465),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,GSK3B
cellular response to monoamine stimulus (GO:0071868),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,GNB1
cellular response to prostaglandin E stimulus (GO:0071380),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,GNB1
cleavage furrow formation (GO:0036089),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,RHOA
regulation of microtubule binding (GO:1904526),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PPP2CA
regulation of miRNA mediated inhibition of translation (GO:1905616),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,EIF4G1
dense core granule cytoskeletal transport (GO:0099519),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,KIF5B
detection of muscle stretch (GO:0035995),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,CTNNB1
regulation of NAD(P)H oxidase activity (GO:0033860),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PARK7
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PARK7
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,VCP
G-quadruplex DNA unwinding (GO:0044806),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,HNRNPA2B1
regulation of toll-like receptor 7 signaling pathway (GO:0034155),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,DDX3X
gas homeostasis (GO:0033483),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,SOD2
regulation of transforming growth factor beta activation (GO:1901388),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,HSP90AB1
regulation of transforming growth factor beta1 production (GO:0032908),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,ATP6AP2
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,SOD2
regulation of vesicle size (GO:0097494),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,AP2M1
heart trabecula formation (GO:0060347),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,FKBP1A
response to lead ion (GO:0010288),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PPP2CA
ribose phosphate biosynthetic process (GO:0046390),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,TKT
insulin secretion involved in cellular response to glucose stimulus (GO:0035773),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,RAB11B
SMAD protein complex assembly (GO:0007183),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,FKBP1A
smooth muscle cell migration (GO:0014909),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,AAMP
sphingosine-1-phosphate receptor signaling pathway (GO:0003376),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,RAC1
long-term synaptic depression (GO:0060292),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,ARF1
miRNA catabolic process (GO:0010587),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,SND1
tRNA transcription by RNA polymerase III (GO:0042797),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,POLR2L
white fat cell differentiation (GO:0050872),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,CTBP1
xenobiotic catabolic process (GO:0042178),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,GSTO1
mRNA transcription by RNA polymerase II (GO:0042789),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,ATF4
negative regulation by host of viral genome replication (GO:0044828),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,VAPA
negative regulation of acute inflammatory response (GO:0002674),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,GSTP1
negative regulation of DNA repair (GO:0045738),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,RPS3
negative regulation of glycogen metabolic process (GO:0070874),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,GSK3B
negative regulation of low-density lipoprotein receptor activity (GO:1905598),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,APP
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,SLC25A5
negative regulation of protein import (GO:1904590),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,UFM1
negative regulation of protein import into nucleus (GO:0042308),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,UFM1
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,NPM1
negative regulation of retinoic acid receptor signaling pathway (GO:0048387),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,CALR
positive regulation by symbiont of host autophagy (GO:0075044),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PHB2
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,HMGB1
positive regulation of cytoplasmic translation (GO:2000767),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,CNBP
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,BCAP31
positive regulation of humoral immune response (GO:0002922),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PHB
positive regulation of integrin-mediated signaling pathway (GO:2001046),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,CD63
positive regulation of lymphocyte apoptotic process (GO:0070230),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PRELID1
positive regulation of miRNA mediated inhibition of translation (GO:1905618),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,EIF4G1
positive regulation of mitochondrial membrane potential (GO:0010918),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,VCP
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,TOMM7
positive regulation of multicellular organism growth (GO:0040018),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,PPIB
positive regulation of oxidative stress-induced cell death (GO:1903209),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,SOD1
positive regulation of pinocytosis (GO:0048549),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,CDC42
positive regulation of protein deubiquitination (GO:1903003),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,VCP
positive regulation of protein localization to centrosome (GO:1904781),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,GSK3B
positive regulation of striated muscle contraction (GO:0045989),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,GSTO1
positive regulation of type I interferon-mediated signaling pathway (GO:0060340),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,UBE2K
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,SOD2
protein catabolic process in the vacuole (GO:0007039),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,LAMP2
protein localization to basolateral plasma membrane (GO:1903361),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,RAB10
protein localization to endoplasmic reticulum exit site (GO:0070973),07-Jan,0.214797924,0.490790455,0,0,4.748033432,7.302748821,BCAP31
positive regulation of epithelial cell migration (GO:0010634),5/94,0.214959314,0.490790455,0,0,1.603040709,2.46436491,PDCD6;RAC1;CALR;AAMP;RTN4
regulation of synapse organization (GO:0050807),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,NEDD4;YWHAZ
hippo signaling (GO:0035329),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,YWHAE;YWHAB
RNA polyadenylation (GO:0043631),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,APP;PABPC1
mRNA polyadenylation (GO:0006378),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,APP;PABPC1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,MIF;TPT1
negative regulation of protein transport (GO:0051224),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,SNX3;NDFIP1
negative regulation of receptor-mediated endocytosis (GO:0048261),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,APP;RAC1
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,HNRNPU;HNRNPC
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,DDX3X;EIF4G1
positive regulation of microtubule polymerization or depolymerization (GO:0031112),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,RPS3;RAC1
positive regulation of viral transcription (GO:0050434),26-Feb,0.220369213,0.498506904,0,0,2.37530773,3.592536315,POLR2F;POLR2L
regulation of glycolytic process (GO:0006110),4/71,0.221051231,0.498796469,0,0,1.702951907,2.570368838,APP;SEC13;EIF6;PGAM1
negative regulation of neuron apoptotic process (GO:0043524),4/71,0.221051231,0.498796469,0,0,1.702951907,2.570368838,SET;PARK7;SOD2;SOD1
positive regulation of cellular protein localization (GO:1903829),4/71,0.221051231,0.498796469,0,0,1.702951907,2.570368838,GSK3B;HSP90AB1;PARK7;RTN4
Golgi to plasma membrane transport (GO:0006893),3/48,0.222478627,0.501179958,0,0,1.900986193,2.857038235,RAB10;GOLPH3;COMMD1
positive regulation of DNA repair (GO:0045739),3/48,0.222478627,0.501179958,0,0,1.900986193,2.857038235,RPS3;UBE2N;HMGB1
positive regulation of cellular process (GO:0048522),25/625,0.226138061,0.508742901,0,0,1.192724261,1.773115307,RNF10;HSP90AB1;DDX3X;PHB;CDC42;RPS4X;LMNA;SSR1;ROMO1;RAC1;RPS9;NPM1;RPL23;CNBP;RPS6;TPM1;PA2G4;ACTN4;CDK4;DNAJA2;P4HB;CALR;SLC25A5;EIF4G2;EIF4G1
neuron projection development (GO:0031175),8/171,0.226212597,0.508742901,0,0,1.401296481,2.082718972,CDC42;APP;GSK3B;UBB;CTTN;VAPA;NEDD4;HMGB1
positive regulation of secretion by cell (GO:1903532),4/72,0.228309719,0.513032073,0,0,1.677821351,2.478229639,GOLPH3;TMED10;IER3IP1;PPIA
adherens junction organization (GO:0034332),3/49,0.231497716,0.514350557,0,0,1.859563931,2.720886558,CTNNA1;CTNNB1;ACTB
receptor internalization (GO:0031623),3/49,0.231497716,0.514350557,0,0,1.859563931,2.720886558,ITGB1;NEDD4;AP2M1
regulation of cellular localization (GO:0060341),3/49,0.231497716,0.514350557,0,0,1.859563931,2.720886558,HSP90AA1;HSP90AB1;REEP5
regulation of cellular protein metabolic process (GO:0032268),3/49,0.231497716,0.514350557,0,0,1.859563931,2.720886558,APP;RPL10;EIF4G1
response to hydrogen peroxide (GO:0042542),3/49,0.231497716,0.514350557,0,0,1.859563931,2.720886558,RPS3;PARK7;SOD1
secondary alcohol metabolic process (GO:1902652),3/49,0.231497716,0.514350557,0,0,1.859563931,2.720886558,FDX1;IDH3B;IDH3A
positive regulation of reactive oxygen species metabolic process (GO:2000379),3/49,0.231497716,0.514350557,0,0,1.859563931,2.720886558,GSTP1;ROMO1;SOD1
dendritic spine organization (GO:0097061),27-Feb,0.233013123,0.514350557,0,0,2.280177253,3.321444153,CDC42;ARF1
regulation of vasculature development (GO:1901342),27-Feb,0.233013123,0.514350557,0,0,2.280177253,3.321444153,RNH1;CTNNB1
response to glucocorticoid (GO:0051384),27-Feb,0.233013123,0.514350557,0,0,2.280177253,3.321444153,HNRNPU;UBE2L3
mitotic chromosome condensation (GO:0007076),27-Feb,0.233013123,0.514350557,0,0,2.280177253,3.321444153,SET;CSNK2B
positive regulation of gene silencing by miRNA (GO:2000637),27-Feb,0.233013123,0.514350557,0,0,2.280177253,3.321444153,DDX5;EIF4G1
positive regulation of nitric oxide biosynthetic process (GO:0045429),27-Feb,0.233013123,0.514350557,0,0,2.280177253,3.321444153,HSP90AA1;HSP90AB1
protein export from nucleus (GO:0006611),27-Feb,0.233013123,0.514350557,0,0,2.280177253,3.321444153,CALR;RAN
protein maturation (GO:0051604),5/97,0.23356792,0.514350557,0,0,1.550525739,2.254902239,GLRX3;NDUFAB1;STUB1;HSPD1;METAP2
double-strand break repair via homologous recombination (GO:0000724),5/97,0.23356792,0.514350557,0,0,1.550525739,2.254902239,MORF4L1;SFR1;SWI5;UBE2N;NUCKS1
regulation of generation of precursor metabolites and energy (GO:0043467),3/50,0.240581998,0.514350557,0,0,1.819904318,2.592807306,SEC13;EIF6;PGAM1
protein localization to presynapse (GO:1905383),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,KIF5B
anterograde axonal protein transport (GO:0099641),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,KIF5B
regulation of anion transport (GO:0044070),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,RAB11B
regulation of apoptotic cell clearance (GO:2000425),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,HMGB1
axo-dendritic protein transport (GO:0099640),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,KIF5B
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ATP2A2
regulation of chaperone-mediated autophagy (GO:1904714),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,EEF1A1
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,DDX3X
regulation of dendritic cell chemotaxis (GO:2000508),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,CALR
regulation of extracellular matrix constituent secretion (GO:0003330),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,IER3IP1
regulation of nitric oxide metabolic process (GO:0080164),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,RAC1
regulation of oxidative stress-induced neuron death (GO:1903203),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ATF4
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,RPS21
regulation of protein K63-linked ubiquitination (GO:1900044),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,DDX3X
regulation of protein localization to chromatin (GO:1905634),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,VCP
entry of bacterium into host cell (GO:0035635),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,CTNNB1
regulation of proton transport (GO:0010155),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,PHB2
ER overload response (GO:0006983),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,GSK3B
regulation of RNA biosynthetic process (GO:2001141),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ACTN4
fructose metabolic process (GO:0006000),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ALDOA
fusion of virus membrane with host plasma membrane (GO:0019064),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,PPIA
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ATF4
glyoxylate metabolic process (GO:0046487),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,GOT2
respiratory chain complex III assembly (GO:0017062),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,UQCRFS1
hair cell differentiation (GO:0035315),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,CTNNB1
RNA secondary structure unwinding (GO:0010501),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,DDX3X
lens fiber cell development (GO:0070307),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ATF4
membrane fusion involved in viral entry into host cell (GO:0039663),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,PPIA
tRNA transcription (GO:0009304),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,POLR2L
mitochondrial respiratory chain complex III assembly (GO:0034551),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,UQCRFS1
vitamin K metabolic process (GO:0042373),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,VKORC1
negative regulation of alpha-beta T cell differentiation (GO:0046639),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,HMGB1
negative regulation of appetite (GO:0032099),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,NENF
negative regulation of calcium ion import (GO:0090281),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,VDAC1
negative regulation of fatty acid oxidation (GO:0046322),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ACADL
negative regulation of long-term synaptic potentiation (GO:1900272),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,APP
negative regulation of macrophage migration (GO:1905522),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,MIF
negative regulation of mitochondrial membrane potential (GO:0010917),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,PRELID1
negative regulation of muscle hypertrophy (GO:0014741),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,GLRX3
negative regulation of nitrogen compound metabolic process (GO:0051172),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,HSP90AB1
negative regulation of response to reactive oxygen species (GO:1901032),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,PARK7
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,P4HB
positive regulation of dendritic cell chemotaxis (GO:2000510),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,CALR
positive regulation of fibroblast migration (GO:0010763),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ITGB1
positive regulation of isomerase activity (GO:0010912),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,HNRNPU
positive regulation of leukocyte differentiation (GO:1902107),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,HMGB1
postsynapse organization (GO:0099173),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,ARF1
protein deglycosylation (GO:0006517),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,PARK7
protein localization to microtubule (GO:0035372),08-Jan,0.24146483,0.514350557,0,0,4.069532238,5.782933282,HNRNPU
regulation of cytokine-mediated signaling pathway (GO:0001959),4/74,0.242999887,0.516444397,0,0,1.629714286,2.305547511,HSP90AB1;SUMO1;CDC37;TAX1BP1
mitotic nuclear division (GO:0140014),4/74,0.242999887,0.516444397,0,0,1.629714286,2.305547511,UBE2S;CHMP2A;RHOA;RAN
regulation of cellular macromolecule biosynthetic process (GO:2000112),19/468,0.243343394,0.516444397,0,0,1.209988527,1.710054629,APP;RPL10;MAGED1;CNBP;HP1BP3;EDF1;NUCKS1;PHB;YBX1;RPL6;UBE2L3;MLF2;DRAP1;PPP2CA;HINT1;PPP2R1A;CALR;PFDN5;ATF4
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,DDX5;MIF
regulation of immunoglobulin production (GO:0002637),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,PHB;PHB2
regulation of muscle contraction (GO:0006937),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,TPM1;ENO1
glycogen metabolic process (GO:0005977),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,GSK3B;CALM1
response to interferon-beta (GO:0035456),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,NDUFA13;UBE2K
internal peptidyl-lysine acetylation (GO:0018393),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,MORF4L1;MORF4L2
negative regulation of axonogenesis (GO:0050771),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,RTN4;RHOA
negative regulation of phosphatase activity (GO:0010923),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,FKBP1A;GSK3B
phagosome acidification (GO:0090383),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,ATP6V0C;ATP6V1F
positive regulation of microtubule polymerization (GO:0031116),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,RPS3;RAC1
positive regulation of monooxygenase activity (GO:0032770),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,POR;PARK7
positive regulation of nitric oxide metabolic process (GO:1904407),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,HSP90AA1;HSP90AB1
positive regulation of response to wounding (GO:1903036),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,ITGB1;ACTG1
protein localization to lysosome (GO:0061462),28-Feb,0.245698278,0.516444397,0,0,2.192364504,3.077314642,NEDD4;RTN4
regulation of axonogenesis (GO:0050770),3/51,0.249724149,0.523683949,0,0,1.781897189,2.472201266,GSK3B;RHOA;RTN4
blood circulation (GO:0008015),3/51,0.249724149,0.523683949,0,0,1.781897189,2.472201266,CYB5R3;GCLM;SOD1
regulation of protein modification process (GO:0031399),3/51,0.249724149,0.523683949,0,0,1.781897189,2.472201266,PPP2CA;NDUFS4;PPIB
positive regulation of cytokine production (GO:0001819),14/335,0.250183055,0.524239279,0,0,1.246105919,1.726557521,APP;TMED10;MIF;PARK7;PHB;HMGB1;HSPD1;SOD1;RPS3;CTNNB1;POLR2F;GAPDH;ATF4;POLR2L
cellular response to hormone stimulus (GO:0032870),4/76,0.257894952,0.535049014,0,0,1.584279835,2.147020688,SFR1;ATP1A1;UBE2L3;CTSB
positive regulation of growth (GO:0045927),4/76,0.257894952,0.535049014,0,0,1.584279835,2.147020688,CDC42;DDX3X;EIF4G2;EIF4G1
protein import into nucleus (GO:0006606),4/76,0.257894952,0.535049014,0,0,1.584279835,2.147020688,SEC13;RPL23;PHB2;RAN
regulation of fatty acid biosynthetic process (GO:0042304),2/29,0.258407335,0.535049014,0,0,2.111056404,2.85671978,ACADL;EIF6
myeloid cell differentiation (GO:0030099),3/52,0.258917009,0.535049014,0,0,1.745441372,2.358523634,HSPA9;RPS14;SLC25A5
positive regulation of protein localization to cell periphery (GO:1904377),3/52,0.258917009,0.535049014,0,0,1.745441372,2.358523634,ITGB1;KIF5B;SQSTM1
positive regulation of protein localization to plasma membrane (GO:1903078),3/52,0.258917009,0.535049014,0,0,1.745441372,2.358523634,ITGB1;KIF5B;SQSTM1
apoptotic process (GO:0006915),10/231,0.26071481,0.535049014,0,0,1.291858585,1.736681864,PPP2CA;APP;DAP;PPP2R1A;FAM162A;VDAC1;PPIA;GAPDH;RTN4;HSPD1
purine ribonucleotide metabolic process (GO:0009150),4/77,0.265409679,0.535049014,0,0,1.562496195,2.072621027,HINT1;DBI;RAN;ACAT1
regulation of cell death (GO:0010941),5/102,0.26551178,0.535049014,0,0,1.47021934,1.949652087,UBB;CHMP2A;PARK7;PHB;EIF4G1
regulation of epidermis development (GO:0045682),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,NME2
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,BCAP31
regulation of fibroblast apoptotic process (GO:2000269),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,IER3IP1
regulation of histone H4 acetylation (GO:0090239),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,CTBP1
regulation of interleukin-23 production (GO:0032667),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,RAC1
regulation of mammary gland epithelial cell proliferation (GO:0033599),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,RTN4
cytolysis by host of symbiont cells (GO:0051838),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,ROMO1
cytolysis in other organism involved in symbiotic interaction (GO:0051801),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,ROMO1
regulation of mitotic centrosome separation (GO:0046602),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,RANBP1
regulation of nephron tubule epithelial cell differentiation (GO:0072182),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,CTNNB1
regulation of PERK-mediated unfolded protein response (GO:1903897),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,HSPA5
regulation of pinocytosis (GO:0048548),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,CDC42
endosome to melanosome transport (GO:0035646),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,CD63
endosome to pigment granule transport (GO:0043485),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,CD63
regulation of respiratory burst (GO:0060263),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,RAC1
regulation of skeletal muscle cell differentiation (GO:2001014),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,DDX5
regulation of sterol biosynthetic process (GO:0106118),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,RAN
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,ALDOA
regulation of transmembrane transporter activity (GO:0022898),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,ACTB
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,PARK7
hepoxilin biosynthetic process (GO:0051122),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,GSTP1
hepoxilin metabolic process (GO:0051121),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,GSTP1
response to misfolded protein (GO:0051788),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,STUB1
interleukin-23-mediated signaling pathway (GO:0038155),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,P4HB
ketone biosynthetic process (GO:0042181),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,TPI1
ketone body biosynthetic process (GO:0046951),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,ACAT1
lysosomal lumen acidification (GO:0007042),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,ATP6AP2
sympathetic ganglion development (GO:0061549),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,CTNNB1
maintenance of apical/basal cell polarity (GO:0035090),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,PDCD6IP
maintenance of epithelial cell apical/basal polarity (GO:0045199),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,PDCD6IP
T-helper 1 type immune response (GO:0042088),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,HMGB1
mesodermal cell differentiation (GO:0048333),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,ITGB1
mitochondrial respirasome assembly (GO:0097250),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,COX7A2
negative regulation of glycoprotein biosynthetic process (GO:0010561),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,ITM2B
negative regulation of leukocyte proliferation (GO:0070664),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,GSTP1
negative regulation of membrane potential (GO:0045837),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,PRELID1
negative regulation of systemic arterial blood pressure (GO:0003085),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,SOD2
neuronal ion channel clustering (GO:0045161),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,MTCH1
organic acid catabolic process (GO:0016054),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,TXN2
plasminogen activation (GO:0031639),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,PGK1
positive regulation of ligase activity (GO:0051351),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,GCLM
positive regulation of membrane potential (GO:0045838),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,VCP
positive regulation of mitochondrial calcium ion concentration (GO:0051561),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,BCAP31
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,VDAC2
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,DDX3X
positive regulation of protein kinase A signaling (GO:0010739),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,MIF
positive regulation of smooth muscle cell apoptotic process (GO:0034393),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,SOD2
positive regulation of smooth muscle contraction (GO:0045987),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,CTTN
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,UBE2K
protein K6-linked ubiquitination (GO:0085020),09-Jan,0.267227368,0.535049014,0,0,3.560656342,4.698839437,UBE2S
negative regulation of cysteine-type endopeptidase activity (GO:2000117),3/53,0.268153594,0.536108703,0,0,1.710443787,2.251278159,YWHAE;DDX3X;DNAJB6
positive regulation of chemokine production (GO:0032722),3/53,0.268153594,0.536108703,0,0,1.710443787,2.251278159,APP;DDX3X;HMGB1
alpha-amino acid catabolic process (GO:1901606),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,GOT2;ACAT1
cardiac muscle cell action potential (GO:0086001),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,YWHAE;ATP1A1
regulation of macrophage activation (GO:0043030),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,MIF;HSPD1
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,DDX3X;GABARAP
response to alcohol (GO:0097305),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,GOT2;SOD1
Golgi to plasma membrane protein transport (GO:0043001),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,RAB10;GOLPH3
long-chain fatty acid biosynthetic process (GO:0042759),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,GPX4;GSTP1
termination of RNA polymerase I transcription (GO:0006363),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,POLR2F;POLR2L
morphogenesis of an epithelium (GO:0002009),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,ACTB;ACTG1
mRNA splice site selection (GO:0006376),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,PUF60;SRSF5
multivesicular body assembly (GO:0036258),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,PDCD6IP;CHMP2A
negative regulation of cytoskeleton organization (GO:0051494),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,TWF1;FKBP4
plasma membrane invagination (GO:0099024),2/30,0.271124074,0.536881322,0,0,2.035556024,2.656764418,CDC42;RHOA
cellular component assembly (GO:0022607),11/261,0.274416029,0.543001974,0,0,1.256173653,1.624370675,CDC42;RTN3;PPP2R1A;ST13;GORASP2;RAC1;YWHAZ;ACTB;RHOA;RTN4;ACTG1
regulation of cyclin-dependent protein kinase activity (GO:1904029),3/54,0.277427097,0.546024743,0,0,1.676818656,2.150012009,HSP90AB1;CDC37;ACTB
regulation of focal adhesion assembly (GO:0051893),3/54,0.277427097,0.546024743,0,0,1.676818656,2.150012009,RAC1;RHOA;ACTG1
regulation of proteolysis (GO:0030162),3/54,0.277427097,0.546024743,0,0,1.676818656,2.150012009,CSTB;NEDD8;STUB1
unsaturated fatty acid metabolic process (GO:0033559),3/54,0.277427097,0.546024743,0,0,1.676818656,2.150012009,SCP2;GPX4;GSTP1
regulation of cell differentiation (GO:0045595),7/156,0.279930705,0.546024743,0,0,1.340324385,1.706518684,PPP2CA;DDX5;HSP90AB1;PPP2R1A;PA2G4;ANP32B;ATF4
protein glycosylation (GO:0006486),6/130,0.280274018,0.546024743,0,0,1.380218569,1.755620791,KRTCAP2;RPN2;DAD1;RPN1;STT3A;DDOST
positive regulation of protein phosphorylation (GO:0001934),15/371,0.280534681,0.546024743,0,0,1.203444396,1.529647531,APP;HSP90AA1;DDX3X;HSP90AB1;MIF;PARK7;CSNK2B;CDK2AP1;CALM3;RAC1;CALM1;CALM2;PPIA;UBE2K;EIF4G1
axon development (GO:0061564),4/79,0.280554566,0.546024743,0,0,1.520671605,1.932753906,RAB10;APP;ACTB;RTN4
negative regulation of NF-kappaB transcription factor activity (GO:0032088),4/79,0.280554566,0.546024743,0,0,1.520671605,1.932753906,DAP;ANXA4;TAX1BP1;COMMD1
activation of protein kinase B activity (GO:0032148),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,PARK7;PPIA
purine nucleoside bisphosphate metabolic process (GO:0034032),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,DBI;ACAT1
regulation of potassium ion transport (GO:0043266),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,CD63;KIF5B
ribonucleoside bisphosphate metabolic process (GO:0033875),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,DBI;ACAT1
multivesicular body organization (GO:0036257),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,PDCD6IP;CHMP2A
negative regulation of DNA binding (GO:0043392),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,SUMO1;SUMO3
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,PPP2CA;PPP2R1A
positive regulation of leukocyte cell-cell adhesion (GO:1903039),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,RHOA;HSPD1
positive regulation of mononuclear cell migration (GO:0071677),2/31,0.283833347,0.546024743,0,0,1.965262568,2.474988828,HMGB1;CALR
mitotic spindle organization (GO:0007052),7/157,0.28525515,0.546024743,0,0,1.331319444,1.669968817,VCP;NUDC;SEC13;DCTN2;DYNLL1;RHOA;RAN
protein sumoylation (GO:0016925),3/55,0.286730892,0.546024743,0,0,1.6444868,2.054311268,SUMO1;SUMO3;SUMO2
glycoprotein metabolic process (GO:0009100),3/55,0.286730892,0.546024743,0,0,1.6444868,2.054311268,ERP44;GOLPH3;PARK7
positive regulation of response to DNA damage stimulus (GO:2001022),3/55,0.286730892,0.546024743,0,0,1.6444868,2.054311268,DDX5;RPS3;UBE2N
organonitrogen compound biosynthetic process (GO:1901566),7/158,0.290603681,0.546024743,0,0,1.322433775,1.634256864,GOLPH3;VAPA;GSTO1;GSTP1;CSNK2B;ESD;AKR1A1
peptidyl-lysine modification (GO:0018205),5/106,0.291729258,0.546024743,0,0,1.411699033,1.739113129,SUMO1;SUMO3;SUMO2;NDUFAB1;PARK7
receptor recycling (GO:0001881),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,RAB11B
apical protein localization (GO:0045176),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,ACTB
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,CDC42
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,HSPA5
cellular response to acidic pH (GO:0071468),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,RAB11B
cellular response to dopamine (GO:1903351),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,ATF4
cellular response to oxygen levels (GO:0071453),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,NDUFS2
cellular response to prostaglandin stimulus (GO:0071379),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,GNB1
regulation of hydrogen peroxide-induced cell death (GO:1903205),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,PARK7
chylomicron assembly (GO:0034378),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,P4HB
defense response to tumor cell (GO:0002357),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,PRDX2
dicarboxylic acid biosynthetic process (GO:0043650),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,GLUD1
regulation of neutrophil migration (GO:1902622),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,RAC1
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,RPS27L
regulation of organ growth (GO:0046620),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,SOD1
regulation of peptidyl-lysine acetylation (GO:2000756),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,PARK7
dosage compensation (GO:0007549),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,HNRNPU
regulation of phospholipid metabolic process (GO:1903725),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,PHB2
regulation of protein localization to centrosome (GO:1904779),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,GSK3B
endothelium development (GO:0003158),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,EDF1
regulation of receptor binding (GO:1900120),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,ATP2A2
ESCRT complex disassembly (GO:1904896),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,CHMP2A
ESCRT III complex disassembly (GO:1904903),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,CHMP2A
response to dopamine (GO:1903350),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,ATF4
retinoic acid receptor signaling pathway (GO:0048384),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,ACTN4
inner ear receptor cell stereocilium organization (GO:0060122),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,SOD1
rRNA 3'-end processing (GO:0031125),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,RPS21
rRNA pseudouridine synthesis (GO:0031118),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,NOP10
sarcoplasmic reticulum calcium ion transport (GO:0070296),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,ATP2A2
sequestering of actin monomers (GO:0042989),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,TWF1
ionotropic glutamate receptor signaling pathway (GO:0035235),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,APP
sulfur amino acid catabolic process (GO:0000098),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,TXN2
membrane lipid catabolic process (GO:0046466),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,PDXDC1
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,CTNNB1
muscle cell migration (GO:0014812),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,AAMP
myelin maintenance (GO:0043217),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,SOD1
negative regulation of delayed rectifier potassium channel activity (GO:1902260),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,SUMO1
negative regulation of inclusion body assembly (GO:0090084),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,DNAJB6
negative regulation of receptor binding (GO:1900121),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,ATP2A2
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,NEDD4
negative regulation of transcription by competitive promoter binding (GO:0010944),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,PHB
negative regulation of transforming growth factor beta production (GO:0071635),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,HSP90AB1
neuron projection fasciculation (GO:0106030),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,RTN4
neuron projection maintenance (GO:1990535),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,APP
neuron remodeling (GO:0016322),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,APP
nuclear pore complex assembly (GO:0051292),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,RTN4
nucleoside metabolic process (GO:0009116),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,ERH
peptidyl-amino acid modification (GO:0018193),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,METAP2
positive regulation by symbiont of entry into host (GO:0075294),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,P4HB
positive regulation of dendritic spine morphogenesis (GO:0061003),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,CAPRIN1
positive regulation of lipase activity (GO:0060193),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,RHOA
positive regulation of T cell apoptotic process (GO:0070234),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,PRELID1
positive regulation of tissue remodeling (GO:0034105),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,TMBIM1
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,NCL
positive regulation of viral entry into host cell (GO:0046598),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,P4HB
primary miRNA processing (GO:0031053),10-Jan,0.292116162,0.546024743,0,0,3.164863979,3.894693453,HNRNPA2B1
regulation of nucleic acid-templated transcription (GO:1903506),17/430,0.294144769,0.547439019,0,0,1.175672809,1.438651088,MAGED1;CNBP;HP1BP3;EDF1;PHB;ACTN4;YBX1;RPL6;UBE2L3;MLF2;DRAP1;PPP2CA;HINT1;PPP2R1A;CALR;PFDN5;ATF4
autophagosome organization (GO:1905037),3/56,0.296058538,0.547439019,0,0,1.613375014,1.963796969,MAP1LC3B;ATP2A2;GABARAP
Rho protein signal transduction (GO:0007266),3/56,0.296058538,0.547439019,0,0,1.613375014,1.963796969,CDC42;CFL1;RHOA
negative regulation of metabolic process (GO:0009892),3/56,0.296058538,0.547439019,0,0,1.613375014,1.963796969,RHEB;GSTP1;ATF4
7-methylguanosine mRNA capping (GO:0006370),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,POLR2F;POLR2L
7-methylguanosine RNA capping (GO:0009452),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,POLR2F;POLR2L
activation of phospholipase C activity (GO:0007202),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,PHB;PHB2
regulation of cellular biosynthetic process (GO:0031326),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,EIF6;RAC1
cardiac muscle tissue morphogenesis (GO:0055008),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,FKBP1A;TPM1
regulation of dendritic spine morphogenesis (GO:0061001),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,CAPRIN1;CFL1
cellular response to glucose stimulus (GO:0071333),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,TRA2B;RAB11B
gene silencing by miRNA (GO:0035195),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,EIF6;RAN
response to amino acid (GO:0043200),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,LAMTOR2;TMBIM6
transcription initiation from RNA polymerase I promoter (GO:0006361),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,POLR2F;POLR2L
negative regulation of DNA biosynthetic process (GO:2000279),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,HNRNPU;HNRNPC
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,PHB;CALR
positive regulation of interleukin-10 production (GO:0032733),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,HMGB1;HSPD1
positive regulation of lamellipodium organization (GO:1902745),2/32,0.296521024,0.547439019,0,0,1.899655342,2.30929162,CDC42;RAC1
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),16/404,0.299339514,0.552265046,0,0,1.177590148,1.420381977,GSK3B;HSP90AA1;ARPC1A;ACTB;RHOA;ACTG1;CDC42;RAB14;AP2S1;POLR2F;RAC1;AAMP;ATP6V0C;AP2M1;POLR2L;ATP6V1F
regulation of G protein-coupled receptor signaling pathway (GO:0008277),4/82,0.303504973,0.558137472,0,0,1.461956315,1.743174258,YWHAB;PHB;CALM1;METAP2
cellular response to oxygen-containing compound (GO:1901701),13/323,0.304627056,0.558137472,0,0,1.197050276,1.42289418,NDUFA13;VCP;GSTP1;TPM1;HMGB1;ACTB;RHOA;HSP90B1;PRDX5;GNB1;RPS3;LAMTOR2;ROMO1
DNA replication (GO:0006260),5/108,0.305006195,0.558137472,0,0,1.384143355,1.643563919,TBRG1;SET;CDK2AP1;TOP1;PTMS
cellular response to peptide (GO:1901653),3/57,0.305403784,0.558137472,0,0,1.583415516,1.878121597,APP;GSK3B;RPL23
protein K48-linked ubiquitination (GO:0070936),3/57,0.305403784,0.558137472,0,0,1.583415516,1.878121597,UBE2D3;UBE2K;RBX1
positive regulation of protein kinase B signaling (GO:0051897),7/161,0.306781276,0.558137472,0,0,1.296469156,1.531934195,ITGB1;HSP90AA1;HSP90AB1;PARK7;PHB;RAC1;RTN4
negative regulation of cell population proliferation (GO:0008285),15/379,0.308213377,0.558137472,0,0,1.176498577,1.384695238,APP;NPM1;CTBP1;MAGED1;GSTP1;PHB;SOD2;TOB1;NME1;TBRG1;FTH1;CSNK2B;LMNA;CTNNB1;S100A11
apoptotic cell clearance (GO:0043277),2/33,0.309173938,0.558137472,0,0,1.838280841,2.157868273,HMGB1;RAC1
apoptotic mitochondrial changes (GO:0008637),2/33,0.309173938,0.558137472,0,0,1.838280841,2.157868273,SOD2;HSPD1
signal transduction by p53 class mediator (GO:0072331),2/33,0.309173938,0.558137472,0,0,1.838280841,2.157868273,DDX5;HINT1
negative regulation of smooth muscle cell proliferation (GO:0048662),2/33,0.309173938,0.558137472,0,0,1.838280841,2.157868273,TPM1;SOD2
positive regulation of histone modification (GO:0031058),2/33,0.309173938,0.558137472,0,0,1.838280841,2.157868273,CTBP1;UBE2N
long-chain fatty acid metabolic process (GO:0001676),4/83,0.311202821,0.558137472,0,0,1.443375527,1.684867297,ACADL;SCP2;GPX4;GSTP1
autophagosome assembly (GO:0000045),3/58,0.314760566,0.558137472,0,0,1.554545455,1.796965994,MAP1LC3B;ATP2A2;GABARAP
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),3/58,0.314760566,0.558137472,0,0,1.554545455,1.796965994,GSTP1;TAX1BP1;UBE2K
negative regulation of neuron projection development (GO:0010977),3/58,0.314760566,0.558137472,0,0,1.554545455,1.796965994,FKBP4;RHOA;RTN4
nucleosome assembly (GO:0006334),3/58,0.314760566,0.558137472,0,0,1.554545455,1.796965994,NPM1;SMARCA5;ANP32B
positive regulation of mitochondrion organization (GO:0010822),3/58,0.314760566,0.558137472,0,0,1.554545455,1.796965994,GSK3B;FAM162A;PARK7
purine nucleoside bisphosphate biosynthetic process (GO:0034033),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,ACAT1
regulation of amyloid precursor protein biosynthetic process (GO:0042984),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,ITM2B
regulation of biosynthetic process (GO:0009889),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,GSTP1
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,PARK7
cellular glucan metabolic process (GO:0006073),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,GSK3B
regulation of endocytic recycling (GO:2001135),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,RAB11B
regulation of ERAD pathway (GO:1904292),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,UBXN1
regulation of inclusion body assembly (GO:0090083),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,DNAJB6
coenzyme A biosynthetic process (GO:0015937),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,ACAT1
regulation of long-term neuronal synaptic plasticity (GO:0048169),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,APP
copper ion transport (GO:0006825),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,ATOX1
cyclooxygenase pathway (GO:0019371),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,PTGES3
regulation of microtubule-based movement (GO:0060632),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,LAMP1
regulation of monocyte chemotactic protein-1 production (GO:0071637),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,GSTP1
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,RPS27L
ER-associated misfolded protein catabolic process (GO:0071712),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,VCP
regulation of stress-activated protein kinase signaling cascade (GO:0070302),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,GSTP1
regulation of synapse maturation (GO:0090128),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,YWHAZ
regulation of T cell apoptotic process (GO:0070232),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,PRELID1
regulation of T cell mediated immunity (GO:0002709),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,HMGB1
glutamine family amino acid biosynthetic process (GO:0009084),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,GLUD1
glutathione biosynthetic process (GO:0006750),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,GCLM
glycerol metabolic process (GO:0006071),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,TPI1
Golgi inheritance (GO:0048313),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,YWHAZ
Golgi to lysosome transport (GO:0090160),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,LAMP1
hepatocyte growth factor receptor signaling pathway (GO:0048012),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,RAC1
response to prostaglandin E (GO:0034695),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,GNB1
rhodopsin mediated signaling pathway (GO:0016056),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,GNB1
ribonucleoside bisphosphate biosynthetic process (GO:0034030),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,ACAT1
interleukin-35-mediated signaling pathway (GO:0070757),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,CANX
signal peptide processing (GO:0006465),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,SPCS1
isotype switching (GO:0045190),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,HSPD1
ketone body metabolic process (GO:1902224),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,ACAT1
synaptic vesicle transport (GO:0048489),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,KIF5B
midbrain dopaminergic neuron differentiation (GO:1904948),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,CTNNB1
miRNA mediated inhibition of translation (GO:0035278),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,EIF6
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,UAP1
V(D)J recombination (GO:0033151),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,HMGB1
negative regulation of centrosome duplication (GO:0010826),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,NPM1
negative regulation of protein localization to cell surface (GO:2000009),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,COMMD1
negative regulation of protein maturation (GO:1903318),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,TMEM59
"negative regulation of translation, ncRNA-mediated (GO:0040033)",11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,EIF6
negative regulation of voltage-gated potassium channel activity (GO:1903817),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,SUMO1
peptidyl-proline hydroxylation (GO:0019511),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,P4HB
positive regulation of myelination (GO:0031643),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,RNF10
positive regulation of neuroblast proliferation (GO:0002052),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,CTNNB1
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,DDX5
positive regulation of transforming growth factor beta production (GO:0071636),11-Jan,0.316160804,0.558137472,0,0,2.848230088,3.279749255,ATP6AP2
regulation of activated T cell proliferation (GO:0046006),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,RPS3;HMGB1
epithelial tube morphogenesis (GO:0060562),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,CSNK2B;CTNNB1
regulation of transmembrane transport (GO:0034762),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,NEDD4;ACTB
response to steroid hormone (GO:0048545),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,ATP1A1;UBE2L3
striated muscle tissue development (GO:0014706),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,MYL6;NDUFV2
termination of RNA polymerase II transcription (GO:0006369),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,SNRPF;SNRPB
transcription by RNA polymerase I (GO:0006360),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,POLR2F;POLR2L
ventricular cardiac muscle tissue morphogenesis (GO:0055010),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,FKBP1A;TPM1
positive regulation of interleukin-12 production (GO:0032735),2/34,0.32177984,0.564735118,0,0,1.780742245,2.019161719,HMGB1;HSPD1
negative regulation of autophagy (GO:0010507),3/59,0.324123012,0.568478088,0,0,1.526706467,1.720036617,DAP;EIF4G2;EIF4G1
regulation of macroautophagy (GO:0016241),5/112,0.331803215,0.574008815,0,0,1.332122355,1.469614983,RHEB;NEDD4;LAMTOR2;ATP6V0C;GAPDH
apical junction assembly (GO:0043297),3/60,0.333485442,0.574008815,0,0,1.499844285,1.647063103,PDCD6IP;CTNNA1;RHOA
cellular response to amyloid-beta (GO:1904646),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,APP;GSK3B
cellular response to hydrogen peroxide (GO:0070301),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,RPS3;PARK7
regulation of ion transmembrane transport (GO:0034765),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,YWHAE;NEDD4
regulation of JUN kinase activity (GO:0043506),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,GSTP1;RPS3
regulation of protein polymerization (GO:0032271),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,HSP90AA1;CTTN
intracellular pH reduction (GO:0051452),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,ATP6V0C;ATP6V1F
negative regulation of neurogenesis (GO:0050768),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,RTN4;RHOA
oxoacid metabolic process (GO:0043436),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,PPA1;MIF
positive regulation of immunoglobulin production (GO:0002639),2/35,0.33432735,0.574008815,0,0,1.726690837,1.891822356,PHB;PHB2
"transcription, DNA-templated (GO:0006351)",9/221,0.336818878,0.574008815,0,0,1.210792734,1.317596697,BTF3;DRAP1;DDX5;SMARCA5;TCEA1;POLR2F;PTMA;ATF4;POLR2L
sulfur compound biosynthetic process (GO:0044272),5/113,0.338539876,0.574008815,0,0,1.3197192,1.42940554,GSTO1;GSTP1;ESD;AKR1A1;GCLM
amino sugar biosynthetic process (GO:0046349),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,UAP1
pyrimidine-containing compound metabolic process (GO:0072527),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ERH
angiotensin maturation (GO:0002003),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ATP6AP2
regulation of actin nucleation (GO:0051125),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ARF1
regulation of alcohol biosynthetic process (GO:1902930),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,RAN
regulation of angiotensin levels in blood (GO:0002002),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ATP6AP2
ATP transport (GO:0015867),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,SLC25A5
axonal fasciculation (GO:0007413),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,RTN4
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,HMGB1
carnitine metabolic process (GO:0009437),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ACADL
regulation of dendritic cell differentiation (GO:2001198),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,HMGB1
cellular response to thyroid hormone stimulus (GO:0097067),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,CTSB
regulation of muscle system process (GO:0090257),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,TPM1
regulation of nucleobase-containing compound metabolic process (GO:0019219),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,PCBP1
dosage compensation by inactivation of X chromosome (GO:0009048),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,HNRNPU
regulation of plasminogen activation (GO:0010755),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ENO1
endoplasmic reticulum membrane organization (GO:0090158),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,RTN4
regulation of pseudopodium assembly (GO:0031272),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,CDC42
regulation of sister chromatid cohesion (GO:0007063),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,CTNNB1
ganglion development (GO:0061548),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,CTNNB1
regulation of vascular associated smooth muscle cell migration (GO:1904752),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,TPM1
glutamine metabolic process (GO:0006541),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,GLUD1
replicative senescence (GO:0090399),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ROMO1
lysine catabolic process (GO:0006554),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,OGDH
lysine metabolic process (GO:0006553),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,OGDH
mitotic G1/S transition checkpoint signaling (GO:0044819),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,RPS27L
very-low-density lipoprotein particle assembly (GO:0034379),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,P4HB
negative regulation of amyloid fibril formation (GO:1905907),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,PFDN5
negative regulation of calcineurin-mediated signaling (GO:0106057),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,GSK3B
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,GSK3B
negative regulation of fatty acid biosynthetic process (GO:0045717),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ACADL
negative regulation of JUN kinase activity (GO:0043508),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,GSTP1
negative regulation of leukocyte chemotaxis (GO:0002689),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,MIF
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,HNRNPU
nonribosomal peptide biosynthetic process (GO:0019184),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,GCLM
nuclear body organization (GO:0030575),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,SERBP1
peptidyl-methionine modification (GO:0018206),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,METAP2
phagolysosome assembly (GO:0001845),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,RAB14
phosphate ion transmembrane transport (GO:0035435),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,SLC25A3
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ANAPC5
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ANAPC5
positive regulation of mitotic sister chromatid separation (GO:1901970),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,ANAPC5
positive regulation of pseudopodium assembly (GO:0031274),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,CDC42
positive regulation of ubiquitin protein ligase activity (GO:1904668),12-Jan,0.339389884,0.574008815,0,0,2.589165996,2.797867616,UBE2S
calcium ion transmembrane transport (GO:0070588),4/87,0.342140313,0.57829849,0,0,1.373529674,1.473157761,FKBP1A;ATP2A2;PHB;PHB2
positive regulation of cell population proliferation (GO:0008284),18/474,0.346716301,0.581037812,0,0,1.12658253,1.193330753,RPS9;NPM1;RPL23;CNBP;RPS6;NME2;HNRNPU;PHB;MIF;NME1;RPS4X;CDK4;DNAJA2;NDUFS4;SSR1;ROMO1;CALR;SLC25A5
regulation of embryonic development (GO:0045995),2/36,0.346805913,0.581037812,0,0,1.675818924,1.774675457,RAB14;CFL1
regulation of mRNA processing (GO:0050684),2/36,0.346805913,0.581037812,0,0,1.675818924,1.774675457,HNRNPK;SRSF3
regulation of protein import into nucleus (GO:0042306),2/36,0.346805913,0.581037812,0,0,1.675818924,1.774675457,UFM1;RAN
regulation of receptor internalization (GO:0002090),2/36,0.346805913,0.581037812,0,0,1.675818924,1.774675457,CD63;ARF1
regulation of sodium ion transport (GO:0002028),2/36,0.346805913,0.581037812,0,0,1.675818924,1.774675457,NEDD4;ATP1A1
membrane fusion (GO:0061025),2/36,0.346805913,0.581037812,0,0,1.675818924,1.774675457,NAPA;VAPA
transition metal ion transport (GO:0000041),2/36,0.346805913,0.581037812,0,0,1.675818924,1.774675457,FTH1;ATOX1
positive regulation of interferon-beta production (GO:0032728),2/36,0.346805913,0.581037812,0,0,1.675818924,1.774675457,HSP90AA1;DDX3X
sensory perception of mechanical stimulus (GO:0050954),4/88,0.349894582,0.581037812,0,0,1.357107584,1.42513038,TIMM8B;NDUFB9;TIMM13;SOD1
chromatin organization (GO:0006325),6/142,0.351946513,0.581037812,0,0,1.257647933,1.313331637,NPM1;HP1BP3;GATAD1;SMARCA5;NUCKS1;TOP1
double-strand break repair via nonhomologous end joining (GO:0006303),3/62,0.35218849,0.581037812,0,0,1.44885167,1.512005323,SUMO1;UBE2N;HMGB1
positive regulation of interleukin-1 production (GO:0032732),3/62,0.35218849,0.581037812,0,0,1.44885167,1.512005323,APP;TMED10;HMGB1
regulation of endothelial cell migration (GO:0010594),4/89,0.357650391,0.581037812,0,0,1.341071895,1.378889227,PDCD6;RAC1;CALR;AAMP
monocarboxylic acid metabolic process (GO:0032787),6/143,0.358011198,0.581037812,0,0,1.248402946,1.282348288,PDHA1;SCP2;GLO1;BSG;GOT2;VDAC1
negative regulation of DNA-binding transcription factor activity (GO:0043433),6/143,0.358011198,0.581037812,0,0,1.248402946,1.282348288,DAP;SUMO1;ANXA4;TAX1BP1;COMMD1;PHB2
cytosolic transport (GO:0016482),5/116,0.358804346,0.581037812,0,0,1.283850616,1.315918683,VPS29;LAMP1;RAB14;ARL1;RAB6A
sphingolipid metabolic process (GO:0006665),5/116,0.358804346,0.581037812,0,0,1.283850616,1.315918683,PPP2CA;PDXDC1;VAPA;PPP2R1A;TECR
regulation of signal transduction (GO:0009966),8/198,0.358986515,0.581037812,0,0,1.200470625,1.229846688,SNX3;PPP2CA;APP;CD63;MTCH1;PPP2R1A;NUCKS1;PPIA
acyl-CoA metabolic process (GO:0006637),2/37,0.359205755,0.581037812,0,0,1.627853978,1.666694446,OGDH;DBI
anterograde axonal transport (GO:0008089),2/37,0.359205755,0.581037812,0,0,1.627853978,1.666694446,KIF5B;SOD1
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),2/37,0.359205755,0.581037812,0,0,1.627853978,1.666694446,TPM1;SOD2
negative regulation of stress-activated MAPK cascade (GO:0032873),2/37,0.359205755,0.581037812,0,0,1.627853978,1.666694446,GSTP1;PPIA
"phagocytosis, engulfment (GO:0006911)",2/37,0.359205755,0.581037812,0,0,1.627853978,1.666694446,CDC42;RAC1
positive regulation of cytokinesis (GO:0032467),2/37,0.359205755,0.581037812,0,0,1.627853978,1.666694446,CDC42;RHOA
positive regulation of exocytosis (GO:0045921),2/37,0.359205755,0.581037812,0,0,1.627853978,1.666694446,PDCD6IP;CHMP2A
positive regulation of signaling receptor activity (GO:2000273),2/37,0.359205755,0.581037812,0,0,1.627853978,1.666694446,ITGB1;PARK7
monocarboxylic acid biosynthetic process (GO:0072330),3/63,0.361518707,0.581037812,0,0,1.424630178,1.449477852,SCP2;NDUFAB1;PARK7
positive regulation of DNA metabolic process (GO:0051054),3/63,0.361518707,0.581037812,0,0,1.424630178,1.449477852,RPS3;UBE2N;HMGB1
pseudouridine synthesis (GO:0001522),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,NOP10
purine nucleotide catabolic process (GO:0006195),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,HINT1
alpha-linolenic acid metabolic process (GO:0036109),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,SCP2
purine ribonucleoside triphosphate metabolic process (GO:0009205),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,RAN
purine-containing compound salvage (GO:0043101),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,ADK
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,HMGB1
cellular potassium ion homeostasis (GO:0030007),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,ATP1A1
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,RHOA
regulation of lysosomal lumen pH (GO:0035751),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,ATP6AP2
regulation of membrane repolarization (GO:0060306),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,YWHAE
cytoplasmic sequestering of protein (GO:0051220),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,YWHAB
regulation of nucleocytoplasmic transport (GO:0046822),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,NEDD4
embryonic hemopoiesis (GO:0035162),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,ATF4
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,RPS21
regulation of protein exit from endoplasmic reticulum (GO:0070861),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,SAR1A
regulation of response to stress (GO:0080134),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,EIF4G1
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,BCAP31
fatty acid elongation (GO:0030497),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,TECR
regulation of T cell differentiation in thymus (GO:0033081),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,SOD1
regulation of tube diameter (GO:0035296),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,GCLM
relaxation of cardiac muscle (GO:0055119),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,ATP1A1
Golgi ribbon formation (GO:0090161),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,GOLPH3
response to interleukin-6 (GO:0070741),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,PHB
response to thyroid hormone (GO:0097066),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,CTSB
homeostasis of number of cells (GO:0048872),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,OCIAD2
sodium ion export across plasma membrane (GO:0036376),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,ATP1A1
synaptic vesicle localization (GO:0097479),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,KIF5B
tRNA 5'-leader removal (GO:0001682),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,SSB
mitochondrial outer membrane permeabilization (GO:0097345),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,VDAC2
UDP-N-acetylglucosamine metabolic process (GO:0006047),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,UAP1
UV-damage excision repair (GO:0070914),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,DDB1
mitochondrion transport along microtubule (GO:0047497),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,UBB
vascular process in circulatory system (GO:0003018),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,GCLM
very long-chain fatty acid biosynthetic process (GO:0042761),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,TECR
myelination in peripheral nervous system (GO:0022011),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,SOD1
negative regulation by host of viral transcription (GO:0043922),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,PSMC3
negative regulation of alcohol biosynthetic process (GO:1902931),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,SOD1
"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,HMGB1
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,ACTN4
negative regulation of cellular senescence (GO:2000773),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,YBX1
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,HSPA5
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,PARK7
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,MIF
negative regulation of macromolecule biosynthetic process (GO:0010558),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,GSTP1
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,PARK7
negative regulation of stem cell differentiation (GO:2000737),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,HNRNPU
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,ACTN4
pentose-phosphate shunt (GO:0006098),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,TKT
positive regulation of cell aging (GO:0090343),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,LMNA
positive regulation of ERAD pathway (GO:1904294),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,BCAP31
positive regulation of histone deacetylation (GO:0031065),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,CTBP1
positive regulation of protein acetylation (GO:1901985),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,DDX3X
positive regulation of protein localization to cell surface (GO:2000010),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,HSP90AB1
positive regulation of vascular endothelial cell proliferation (GO:1905564),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,HMGB1
protein localization to mitochondrion (GO:0070585),13-Jan,0.361831026,0.581037812,0,0,2.373279253,2.412623373,MTCH2
cellular amino acid catabolic process (GO:0009063),4/90,0.36540465,0.586079549,0,0,1.32540913,1.334355521,GLUD1;GOT2;OGDH;ACAT1
negative regulation of protein kinase activity (GO:0006469),4/90,0.36540465,0.586079549,0,0,1.32540913,1.334355521,NPM1;GSTP1;PARK7;PPIA
regulation of macromolecule metabolic process (GO:0060255),8/200,0.369282187,0.591947292,0,0,1.18784153,1.183320834,APP;ARF1;HNRNPK;CDK4;PCBP1;YBX1;TOB1;HNRNPAB
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/64,0.370828102,0.592604416,0,0,1.401202832,1.390016553,ROMO1;RPL39;GAPDH
tRNA processing (GO:0008033),3/64,0.370828102,0.592604416,0,0,1.401202832,1.390016553,TSEN34;SSB;DDX1
actin-myosin filament sliding (GO:0033275),2/38,0.371517843,0.592604416,0,0,1.58255375,1.566978866,MYL6;TPM1
muscle filament sliding (GO:0030049),2/38,0.371517843,0.592604416,0,0,1.58255375,1.566978866,MYL6;TPM1
negative regulation of endothelial cell migration (GO:0010596),2/38,0.371517843,0.592604416,0,0,1.58255375,1.566978866,CSNK2B;HMGB1
positive regulation of potassium ion transport (GO:0043268),2/38,0.371517843,0.592604416,0,0,1.58255375,1.566978866,KIF5B;GNB1
positive regulation of production of molecular mediator of immune response (GO:0002702),2/38,0.371517843,0.592604416,0,0,1.58255375,1.566978866,PHB;PHB2
cellular response to cytokine stimulus (GO:0071345),18/482,0.373112297,0.592604416,0,0,1.106689186,1.091058129,ITGB1;HSPA8;GSK3B;HSP90AA1;NDUFA13;HNRNPU;RPL13A;PHB;YWHAZ;RHOA;HSP90B1;UBB;UBC;RPS3;RPS27A;UBA52;GAPDH;UBE2K
sensory perception of sound (GO:0007605),4/91,0.373154344,0.592604416,0,0,1.310106428,1.291454646,TIMM8B;NDUFB9;TIMM13;SOD1
positive regulation of supramolecular fiber organization (GO:1902905),4/91,0.373154344,0.592604416,0,0,1.310106428,1.291454646,APP;CTTN;RPS3;RAC1
regulation of cell-matrix adhesion (GO:0001952),3/65,0.38011195,0.592604416,0,0,1.378531208,1.333438712,GSK3B;RHOA;ACTG1
regulation of RNA metabolic process (GO:0051252),3/65,0.38011195,0.592604416,0,0,1.378531208,1.333438712,MBNL2;PCBP1;TRA2B
protein autoubiquitination (GO:0051865),3/65,0.38011195,0.592604416,0,0,1.378531208,1.333438712,RNF10;UBE2D3;STUB1
protein localization to vacuole (GO:0072665),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,RTN4
protein modification by small protein conjugation or removal (GO:0070647),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,UBA1
branching involved in blood vessel morphogenesis (GO:0001569),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,CTNNB1
regulation of chromatin organization (GO:1902275),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,HNRNPU
cellular response to low-density lipoprotein particle stimulus (GO:0071404),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,ITGB1
regulation of histone deacetylation (GO:0031063),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,CTBP1
regulation of integrin-mediated signaling pathway (GO:2001044),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,CD63
regulation of IRE1-mediated unfolded protein response (GO:1903894),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,HSPA5
regulation of lipase activity (GO:0060191),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,RHOA
coenzyme A metabolic process (GO:0015936),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,ACAT1
covalent chromatin modification (GO:0016569),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,PARK7
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,GSTP1
endothelial cell differentiation (GO:0045446),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,EDF1
regulation of retinoic acid receptor signaling pathway (GO:0048385),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,CALR
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,NCL
regulation of trophoblast cell migration (GO:1901163),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,CALR
relaxation of muscle (GO:0090075),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,ATP1A1
response to chemokine (GO:1990868),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,RHOA
heart process (GO:0003015),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,SOD1
heterochromatin organization (GO:0070828),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,HP1BP3
response to X-ray (GO:0010165),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,NUCKS1
ribonucleoside monophosphate biosynthetic process (GO:0009156),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,ADK
T-helper cell differentiation (GO:0042093),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,HMGB1
thymus development (GO:0048538),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,SOD1
myeloid dendritic cell activation (GO:0001773),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,HMGB1
N-terminal protein amino acid modification (GO:0031365),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,METAP2
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,RHOA
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,MIF
"negative regulation of DNA-templated transcription, elongation (GO:0032785)",14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,HNRNPU
negative regulation of smooth muscle cell migration (GO:0014912),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,TPM1
negative regulation of translational initiation (GO:0045947),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,EIF3E
nuclear pore organization (GO:0006999),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,RTN4
ovarian follicle development (GO:0001541),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,SOD1
peptidyl-serine dephosphorylation (GO:0070262),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,PPP2CA
positive regulation of brown fat cell differentiation (GO:0090336),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,HNRNPU
positive regulation of glucose metabolic process (GO:0010907),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,DDB1
positive regulation of leukocyte degranulation (GO:0043302),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,LAMP1
positive regulation of protein deacetylation (GO:0090312),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,CTBP1
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,ACTN4
positive regulation of T cell receptor signaling pathway (GO:0050862),14-Jan,0.383510917,0.592604416,0,0,2.190605854,2.099448592,RPS3
protein monoubiquitination (GO:0006513),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,UBE2D3;RBX1
regulation of cellular component biogenesis (GO:0044087),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,HSPA8;HSP90AA1
regulation of dendrite development (GO:0050773),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,GSK3B;NEDD4
cellular response to ketone (GO:1901655),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,GOLPH3;GNB1
regulation of nitric-oxide synthase activity (GO:0050999),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,HSP90AA1;CALM1
regulation of T cell differentiation (GO:0045580),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,PRELID1;SOD1
regulation of viral entry into host cell (GO:0046596),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,SNX3;P4HB
replication fork processing (GO:0031297),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,ALYREF;NUCKS1
vesicle cytoskeletal trafficking (GO:0099518),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,KIF5B;ACTN4
organophosphate biosynthetic process (GO:0090407),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,TPI1;TKT
positive regulation of intracellular transport (GO:0032388),2/39,0.383733848,0.592604416,0,0,1.539702184,1.474736099,NEDD4;OAZ1
positive regulation of cell cycle (GO:0045787),3/66,0.389365712,0.600614957,0,0,1.356579318,1.279574778,APP;CDK4;CALR
positive regulation of cell death (GO:0010942),3/66,0.389365712,0.600614957,0,0,1.356579318,1.279574778,GSK3B;PHB;EIF4G1
protein homooligomerization (GO:0051260),5/121,0.392633676,0.60531025,0,0,1.228192469,1.148210394,PDCD6IP;CHMP2A;MIF;ALDOA;SOD2
regulation of microtubule polymerization (GO:0031113),2/40,0.395846104,0.606570732,0,0,1.499105963,1.389266124,RPS3;RAC1
fatty acid derivative biosynthetic process (GO:1901570),2/40,0.395846104,0.606570732,0,0,1.499105963,1.389266124,SLC25A1;ACAT1
intraciliary transport involved in cilium assembly (GO:0035735),2/40,0.395846104,0.606570732,0,0,1.499105963,1.389266124,DYNLRB1;DYNLL1
sulfur compound catabolic process (GO:0044273),2/40,0.395846104,0.606570732,0,0,1.499105963,1.389266124,ACAT1;TXN2
negative regulation of cell-substrate adhesion (GO:0010812),2/40,0.395846104,0.606570732,0,0,1.499105963,1.389266124,ACTN4;RHOA
positive regulation of catalytic activity (GO:0043085),2/40,0.395846104,0.606570732,0,0,1.499105963,1.389266124,YWHAB;SOD1
positive regulation of wound healing (GO:0090303),2/40,0.395846104,0.606570732,0,0,1.499105963,1.389266124,ITGB1;ACTG1
negative regulation of MAPK cascade (GO:0043409),4/94,0.396346947,0.606570732,0,0,1.266238683,1.171859991,GSTP1;PEBP1;PHB;PPIA
nucleosome organization (GO:0034728),4/94,0.396346947,0.606570732,0,0,1.266238683,1.171859991,NPM1;SET;SMARCA5;ANP32B
transcription elongation from RNA polymerase II promoter (GO:0006368),3/67,0.398585035,0.606570732,0,0,1.335313425,1.228267243,POLR2F;TCEA1;POLR2L
acetyl-CoA metabolic process (GO:0006084),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,ACAT1
protein trimerization (GO:0070206),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,MIF
pyrimidine nucleoside metabolic process (GO:0006213),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,ERH
androgen receptor signaling pathway (GO:0030521),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,DDX5
Arp2/3 complex-mediated actin nucleation (GO:0034314),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,ARPC1A
C21-steroid hormone biosynthetic process (GO:0006700),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,FDX1
regulation of cytoplasmic translation (GO:2000765),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CNBP
cellular response to ATP (GO:0071318),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,HSP90B1
cellular response to estrogen stimulus (GO:0071391),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,SFR1
cellular sodium ion homeostasis (GO:0006883),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,ATP1A1
engulfment of apoptotic cell (GO:0043652),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,RAC1
establishment of spindle localization (GO:0051293),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CFL1
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,SCP2
glucan catabolic process (GO:0009251),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CALM1
glycogen catabolic process (GO:0005980),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CALM1
response to acidic pH (GO:0010447),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,RAB11B
GTP metabolic process (GO:0046039),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,RAN
response to muscle stretch (GO:0035994),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CTNNB1
histone mRNA catabolic process (GO:0071044),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,SSB
interleukin-27-mediated signaling pathway (GO:0070106),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CANX
lipoxygenase pathway (GO:0019372),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,GPX4
macrophage differentiation (GO:0030225),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CDC42
tRNA 5'-end processing (GO:0099116),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,SSB
ubiquinone biosynthetic process (GO:0006744),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,NDUFA9
myoblast differentiation (GO:0045445),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,DDX5
negative regulation of androgen receptor signaling pathway (GO:0060766),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,PHB
negative regulation of protein processing (GO:0010955),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,TMEM59
nitric oxide biosynthetic process (GO:0006809),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CYB5R3
nucleosome positioning (GO:0016584),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,SMARCA5
"phototransduction, visible light (GO:0007603)",15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,GNB1
placenta development (GO:0001890),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,SOD1
positive regulation of acute inflammatory response (GO:0002675),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,PARK7
positive regulation of cell killing (GO:0031343),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,RAC1
positive regulation of chromatin organization (GO:1905269),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,UBE2N
positive regulation of histone H3-K4 methylation (GO:0051571),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,CTNNB1
positive regulation of keratinocyte differentiation (GO:0045618),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,NME2
positive regulation of lyase activity (GO:0051349),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,PARK7
positive regulation of natural killer cell activation (GO:0032816),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,LAMP1
protein homotrimerization (GO:0070207),15-Jan,0.404455345,0.606570732,0,0,2.034028656,1.8412311,MIF
regulation of protein kinase B signaling (GO:0051896),8/207,0.40545536,0.607733034,0,0,1.145638775,1.0342191,ITGB1;HSP90AA1;HSP90AB1;PDCD6;RAC1;PARK7;PHB;RTN4
regulation of anatomical structure morphogenesis (GO:0022603),5/123,0.406137731,0.608418198,0,0,1.207249912,1.087808154,GSK3B;RNH1;NEDD4;CFL1;CTNNB1
canonical Wnt signaling pathway (GO:0060070),3/68,0.407765748,0.60861674,0,0,1.314701866,1.179369632,GSK3B;CSNK1A1;CTNNB1
regulation of cell development (GO:0060284),2/41,0.407847575,0.60861674,0,0,1.460591599,1.309948761,RHEB;CTNNB1
cortical cytoskeleton organization (GO:0030865),2/41,0.407847575,0.60861674,0,0,1.460591599,1.309948761,RAC1;RHOA
endosome organization (GO:0007032),2/41,0.407847575,0.60861674,0,0,1.460591599,1.309948761,SNX3;SQSTM1
regulation of viral transcription (GO:0046782),2/41,0.407847575,0.60861674,0,0,1.460591599,1.309948761,POLR2F;POLR2L
heart contraction (GO:0060047),2/41,0.407847575,0.60861674,0,0,1.460591599,1.309948761,TPM1;SOD1
hexose metabolic process (GO:0019318),2/41,0.407847575,0.60861674,0,0,1.460591599,1.309948761,AKR1A1;ALDOA
actin filament organization (GO:0007015),6/152,0.41271672,0.615542717,0,0,1.170897026,1.036236644,CDC42;TPM1;DSTN;RAC1;ALDOA;RHOA
"DNA-templated transcription, elongation (GO:0006354)",3/69,0.416903863,0.621101673,0,0,1.2947149,1.132745585,POLR2F;TCEA1;POLR2L
negative regulation of cellular catabolic process (GO:0031330),3/69,0.416903863,0.621101673,0,0,1.2947149,1.132745585,DAP;EIF4G2;EIF4G1
regulation of protein secretion (GO:0050708),5/125,0.419603093,0.623755081,0,0,1.18700544,1.030850164,GOLPH3;TMED10;HADH;IER3IP1;PPIA
negative regulation of protein catabolic process (GO:0042177),2/42,0.419731821,0.623755081,0,0,1.424002954,1.236232918,SNX3;PHB
apoptotic DNA fragmentation (GO:0006309),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,HMGB1
cellular polysaccharide catabolic process (GO:0044247),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,CALM1
regulation of fatty acid oxidation (GO:0046320),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,ACADL
regulation of leukocyte activation (GO:0002694),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,MIF
dendrite self-avoidance (GO:0070593),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,BSG
dendritic cell chemotaxis (GO:0002407),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,HMGB1
dendritic spine morphogenesis (GO:0060997),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,CDC42
regulation of phosphate metabolic process (GO:0019220),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,PGAM1
epiboly involved in wound healing (GO:0090505),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,RHOA
regulation of Rac protein signal transduction (GO:0035020),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,GABARAP
glutamine family amino acid catabolic process (GO:0009065),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,GLUD1
Golgi to endosome transport (GO:0006895),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,RAB14
response to organophosphorus (GO:0046683),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,NDUFS4
sphingolipid catabolic process (GO:0030149),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,PDXDC1
sympathetic nervous system development (GO:0048485),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,CTNNB1
membrane repolarization (GO:0086009),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,ATP1A1
motor neuron axon guidance (GO:0008045),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,RAC1
negative regulation of anoikis (GO:2000811),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,ITGB1
negative regulation of DNA replication (GO:0008156),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,S100A11
nitric oxide metabolic process (GO:0046209),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,CYB5R3
nucleotide catabolic process (GO:0009166),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,VCP
positive regulation by host of viral transcription (GO:0043923),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,NUCKS1
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,RHOA
protein localization to microtubule organizing center (GO:1905508),16-Jan,0.424689224,0.623755081,0,0,1.898328417,1.625723928,DCTN2
regulation of plasma membrane bounded cell projection assembly (GO:0120032),3/70,0.425995568,0.62499404,0,0,1.275324561,1.088268036,CDC42;TWF1;RAC1
neutrophil chemotaxis (GO:0030593),3/70,0.425995568,0.62499404,0,0,1.275324561,1.088268036,BSG;PPIB;PPIA
anion transport (GO:0006820),2/43,0.431492966,0.630661527,0,0,1.389199121,1.167627515,VDAC2;VDAC1
regulation of cell-substrate adhesion (GO:0010810),2/43,0.431492966,0.630661527,0,0,1.389199121,1.167627515,RAC1;RHOA
cellular glucose homeostasis (GO:0001678),2/43,0.431492966,0.630661527,0,0,1.389199121,1.167627515,TRA2B;NUCKS1
cellular response to glucose starvation (GO:0042149),2/43,0.431492966,0.630661527,0,0,1.389199121,1.167627515,HSPA5;ATF4
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),2/43,0.431492966,0.630661527,0,0,1.389199121,1.167627515,ALYREF;NUCKS1
negative regulation of proteolysis (GO:0045861),2/43,0.431492966,0.630661527,0,0,1.389199121,1.167627515,CSTB;TMEM59
positive regulation of phospholipase C activity (GO:0010863),2/43,0.431492966,0.630661527,0,0,1.389199121,1.167627515,PHB;PHB2
response to UV (GO:0009411),4/99,0.434649706,0.634126038,0,0,1.199282651,0.99926011,NPM1;NEDD4;RPL26;ATF4
regulation of endopeptidase activity (GO:0052548),3/71,0.435037226,0.634126038,0,0,1.256504525,1.045818462,PSMA3;PRELID1;GAPDH
regulation of G1/S transition of mitotic cell cycle (GO:2000045),3/71,0.435037226,0.634126038,0,0,1.256504525,1.045818462,DDX3X;CDK4;EIF4G1
fatty acid biosynthetic process (GO:0006633),3/71,0.435037226,0.634126038,0,0,1.256504525,1.045818462,GPX4;TECR;NDUFAB1
myeloid leukocyte differentiation (GO:0002573),3/71,0.435037226,0.634126038,0,0,1.256504525,1.045818462,CDC42;CDK4;GLO1
microtubule cytoskeleton organization involved in mitosis (GO:1902850),5/128,0.439697227,0.634187698,0,0,1.157873151,0.951388369,NUDC;SEC13;DCTN2;DYNLL1;RAN
cell-matrix adhesion (GO:0007160),4/100,0.442234717,0.634187698,0,0,1.186728395,0.968268909,ITGB1;CD63;CTTN;RAC1
cardiac ventricle morphogenesis (GO:0003208),2/44,0.443125666,0.634187698,0,0,1.356052613,1.103693768,FKBP1A;TPM1
response to amyloid-beta (GO:1904645),2/44,0.443125666,0.634187698,0,0,1.356052613,1.103693768,APP;GSK3B
mRNA catabolic process (GO:0006402),2/44,0.443125666,0.634187698,0,0,1.356052613,1.103693768,DDX5;RNH1
positive regulation of cell division (GO:0051781),2/44,0.443125666,0.634187698,0,0,1.356052613,1.103693768,CDC42;RHOA
positive regulation of cell-matrix adhesion (GO:0001954),2/44,0.443125666,0.634187698,0,0,1.356052613,1.103693768,GSK3B;RAC1
positive regulation of mRNA catabolic process (GO:0061014),2/44,0.443125666,0.634187698,0,0,1.356052613,1.103693768,PABPC1;TOB1
positive regulation of receptor-mediated endocytosis (GO:0048260),2/44,0.443125666,0.634187698,0,0,1.356052613,1.103693768,CD63;HNRNPK
cell morphogenesis involved in differentiation (GO:0000904),3/72,0.444025376,0.634187698,0,0,1.238229997,1.005286203,RAC1;RHOA;ATF4
cytoskeleton-dependent cytokinesis (GO:0061640),3/72,0.444025376,0.634187698,0,0,1.238229997,1.005286203,PDCD6IP;DCTN3;RHOA
extrinsic apoptotic signaling pathway (GO:0097191),3/72,0.444025376,0.634187698,0,0,1.238229997,1.005286203,GSK3B;DDX3X;GABARAP
negative regulation of supramolecular fiber organization (GO:1902904),3/72,0.444025376,0.634187698,0,0,1.238229997,1.005286203,HSPA8;TWF1;PFDN5
positive regulation of neurogenesis (GO:0050769),3/72,0.444025376,0.634187698,0,0,1.238229997,1.005286203,CAPRIN1;CTNNB1;RHOA
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,ARF1
regulation of cell killing (GO:0031341),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,RAC1
cell communication by electrical coupling involved in cardiac conduction (GO:0086064),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,ATP1A1
cellular modified amino acid catabolic process (GO:0042219),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,GOT2
cellular response to gamma radiation (GO:0071480),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,RPL26
regulation of leukocyte migration (GO:0002685),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,RAC1
regulation of neuroblast proliferation (GO:1902692),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,CTNNB1
DNA biosynthetic process (GO:0071897),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,PPIA
regulation of NLRP3 inflammasome complex assembly (GO:1900225),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,DDX3X
regulation of osteoblast proliferation (GO:0033688),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,RHOA
regulation of stem cell proliferation (GO:0072091),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,HNRNPU
gliogenesis (GO:0042063),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,NDUFS2
histone H2A monoubiquitination (GO:0035518),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,DDB1
histone H2A ubiquitination (GO:0033522),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,DDB1
response to purine-containing compound (GO:0014074),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,NDUFS4
stem cell development (GO:0048864),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,PDCD6
maturation of 5.8S rRNA (GO:0000460),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,EIF6
negative regulation of chemokine production (GO:0032682),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,GSTP1
negative regulation of fatty acid metabolic process (GO:0045922),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,ACADL
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,MIF
negative regulation of viral entry into host cell (GO:0046597),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,SNX3
phosphate ion transport (GO:0006817),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,SLC25A3
positive regulation of macrophage activation (GO:0043032),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,HSPD1
positive regulation of smooth muscle cell migration (GO:0014911),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,S100A11
positive regulation of stem cell proliferation (GO:2000648),17-Jan,0.444236625,0.634187698,0,0,1.779590708,1.443956197,HNRNPU
chromatin assembly (GO:0031497),3/73,0.452956721,0.645612719,0,0,1.220477599,0.96656785,NPM1;SMARCA5;ANP32B
granulocyte chemotaxis (GO:0071621),3/73,0.452956721,0.645612719,0,0,1.220477599,0.96656785,BSG;PPIB;PPIA
insulin receptor signaling pathway (GO:0008286),3/73,0.452956721,0.645612719,0,0,1.220477599,0.96656785,GSK3B;ATP6V0C;ATP6V1F
regulation of DNA repair (GO:0006282),2/45,0.454625082,0.646120503,0,0,1.324447803,1.044038622,RPS3;UBE2N
cellular response to radiation (GO:0071478),2/45,0.454625082,0.646120503,0,0,1.324447803,1.044038622,EEF1D;SWI5
cell junction assembly (GO:0034329),4/102,0.457310599,0.646120503,0,0,1.162388511,0.90944402,CDC42;ACTB;RHOA;ACTG1
intrinsic apoptotic signaling pathway (GO:0097193),4/102,0.457310599,0.646120503,0,0,1.162388511,0.90944402,DDX5;HINT1;DDX3X;ATF4
positive regulation of cell growth (GO:0030307),4/102,0.457310599,0.646120503,0,0,1.162388511,0.90944402,CDC42;DDX3X;EIF4G2;EIF4G1
3'-UTR-mediated mRNA stabilization (GO:0070935),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,HNRNPC
adenine nucleotide transport (GO:0051503),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,SLC25A5
regulation of brown fat cell differentiation (GO:0090335),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,HNRNPU
regulation of catabolic process (GO:0009894),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,ITGB1
regulation of cellular protein catabolic process (GO:1903362),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,HSP90AA1
regulation of delayed rectifier potassium channel activity (GO:1902259),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,SUMO1
regulation of early endosome to late endosome transport (GO:2000641),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,SNX3
cellular response to dsRNA (GO:0071359),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,NPM1
regulation of fatty acid metabolic process (GO:0019217),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,EIF6
cellular response to pH (GO:0071467),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,RAB11B
chromatin disassembly (GO:0031498),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,SET
dendritic cell migration (GO:0036336),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,HMGB1
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,DDX5
epithelial structure maintenance (GO:0010669),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,STRAP
establishment of vesicle localization (GO:0051650),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,KIF5B
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,GNB1
regulation of telomere maintenance via telomere lengthening (GO:1904356),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,HNRNPA2B1
regulation of vascular endothelial cell proliferation (GO:1905562),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,HMGB1
release of cytochrome c from mitochondria (GO:0001836),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,SOD2
response to axon injury (GO:0048678),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,SOD1
intermediate filament organization (GO:0045109),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,DNAJB6
intracellular estrogen receptor signaling pathway (GO:0030520),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,DDX5
"synaptic transmission, glutamatergic (GO:0035249)",18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,NAPA
maintenance of gastrointestinal epithelium (GO:0030277),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,STRAP
melanosome transport (GO:0032402),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,RAB11B
tRNA metabolic process (GO:0006399),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,SSB
negative regulation of cation transmembrane transport (GO:1904063),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,COMMD1
negative regulation of interleukin-8 production (GO:0032717),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,ANXA4
negative regulation of signal transduction by p53 class mediator (GO:1901797),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,MIF
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,GSTP1
nucleosome disassembly (GO:0006337),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,SET
pigment granule transport (GO:0051904),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,RAB11B
positive regulation of extracellular matrix organization (GO:1903055),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,IER3IP1
positive regulation of nervous system process (GO:0031646),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,RNF10
prostanoid metabolic process (GO:0006692),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,GSTP1
protein localization to centrosome (GO:0071539),18-Jan,0.463120805,0.646120503,0,0,1.674822141,1.289223386,DCTN2
alpha-amino acid metabolic process (GO:1901605),2/46,0.465986848,0.64911319,0,0,1.294279576,0.988309125,GLUD1;GOT2
vesicle organization (GO:0016050),2/46,0.465986848,0.64911319,0,0,1.294279576,0.988309125,SAR1A;SQSTM1
posttranscriptional regulation of gene expression (GO:0010608),2/46,0.465986848,0.64911319,0,0,1.294279576,0.988309125,APP;RPL10
fibroblast growth factor receptor signaling pathway (GO:0008543),3/75,0.470636645,0.654914775,0,0,1.18645217,0.894192145,RAB14;POLR2F;POLR2L
integrin-mediated signaling pathway (GO:0007229),3/75,0.470636645,0.654914775,0,0,1.18645217,0.894192145,ITGB1;CDC42;NME2
cellular metal ion homeostasis (GO:0006875),4/104,0.472246717,0.655324998,0,0,1.139022222,0.854555665,ATP2A2;CALR;ATP1A1;TPT1
regulation of cell adhesion (GO:0030155),5/133,0.472798852,0.655324998,0,0,1.11235395,0.833247927,PPP1CB;PPP2CA;PPP2R1A;TPM1;P4HB
regulation of synapse assembly (GO:0051963),2/47,0.477207049,0.655324998,0,0,1.265452158,0.936187603,APP;EIF4G1
regulation of T cell activation (GO:0050863),2/47,0.477207049,0.655324998,0,0,1.265452158,0.936187603,PRELID1;HSPD1
regulation of wound healing (GO:0061041),2/47,0.477207049,0.655324998,0,0,1.265452158,0.936187603,ITGB1;ACTG1
negative regulation of cold-induced thermogenesis (GO:0120163),2/47,0.477207049,0.655324998,0,0,1.265452158,0.936187603,RHEB;ATF4
actomyosin structure organization (GO:0031032),3/76,0.479379451,0.655324998,0,0,1.170138607,0.860359415,ITGB1;TPM1;RHOA
regulation of cell division (GO:0051302),3/76,0.479379451,0.655324998,0,0,1.170138607,0.860359415,CALM3;CALM1;CALM2
cell morphogenesis involved in neuron differentiation (GO:0048667),3/76,0.479379451,0.655324998,0,0,1.170138607,0.860359415,RAB10;APP;ACTB
positive regulation of interleukin-6 production (GO:0032755),3/76,0.479379451,0.655324998,0,0,1.170138607,0.860359415,APP;HMGB1;HSPD1
actin filament capping (GO:0051693),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,TWF1
Rac protein signal transduction (GO:0016601),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,RAC1
aspartate family amino acid metabolic process (GO:0009066),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,GOT2
barbed-end actin filament capping (GO:0051016),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,TWF1
regulation of centriole replication (GO:0046599),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,NPM1
cardiac muscle cell contraction (GO:0086003),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,ATP1A1
regulation of histone H3-K4 methylation (GO:0051569),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,CTNNB1
regulation of mitochondrial membrane permeability (GO:0046902),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,SLC25A5
detection of mechanical stimulus (GO:0050982),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,CTNNB1
regulation of nervous system process (GO:0031644),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,APP
DNA double-strand break processing (GO:0000729),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,UBE2N
establishment of melanosome localization (GO:0032401),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,RAB11B
excitatory postsynaptic potential (GO:0060079),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,GSK3B
regulation of synaptic vesicle exocytosis (GO:2000300),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,GSK3B
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,CD63
glycerolipid catabolic process (GO:0046503),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,PRDX6
response to ATP (GO:0033198),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,HSP90B1
heart trabecula morphogenesis (GO:0061384),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,FKBP1A
histone deubiquitination (GO:0016578),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,ENY2
mesenchymal cell development (GO:0014031),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,PDCD6
vesicle transport along actin filament (GO:0030050),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,ACTN4
negative regulation of calcium ion transport (GO:0051926),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,TMBIM6
neural crest cell differentiation (GO:0014033),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,PDCD6
nuclear membrane organization (GO:0071763),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,CHMP2A
nucleotide-sugar biosynthetic process (GO:0009226),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,UAP1
pore complex assembly (GO:0046931),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,RTN4
positive regulation of actin cytoskeleton reorganization (GO:2000251),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,CDC42
positive regulation of cellular protein catabolic process (GO:1903364),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,HSP90AA1
positive regulation of focal adhesion assembly (GO:0051894),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,RAC1
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,PHB
positive regulation of leukocyte activation (GO:0002696),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,HSPD1
positive regulation of monocyte chemotaxis (GO:0090026),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,HMGB1
positive regulation of neutrophil chemotaxis (GO:0090023),19-Jan,0.481364234,0.655324998,0,0,1.581694526,1.156425983,RAC1
neutrophil migration (GO:1990266),3/77,0.488053897,0.662405928,0,0,1.154265952,0.827988943,BSG;PPIB;PPIA
positive regulation of tumor necrosis factor production (GO:0032760),3/77,0.488053897,0.662405928,0,0,1.154265952,0.827988943,APP;HMGB1;MIF
regulation of interleukin-10 production (GO:0032653),2/48,0.488282193,0.662405928,0,0,1.237878107,0.887387499,HMGB1;HSPD1
histone H4 acetylation (GO:0043967),2/48,0.488282193,0.662405928,0,0,1.237878107,0.887387499,MORF4L1;MORF4L2
substrate adhesion-dependent cell spreading (GO:0034446),2/48,0.488282193,0.662405928,0,0,1.237878107,0.887387499,RAC1;RHOA
nucleus organization (GO:0006997),2/48,0.488282193,0.662405928,0,0,1.237878107,0.887387499,PDCD6IP;CHMP2A
positive regulation of endocytosis (GO:0045807),2/48,0.488282193,0.662405928,0,0,1.237878107,0.887387499,CDC42;HNRNPK
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,PHB
regulation of acute inflammatory response (GO:0002673),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,GSTP1
branched-chain amino acid catabolic process (GO:0009083),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,ACAT1
branched-chain amino acid metabolic process (GO:0009081),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,ACAT1
cellular modified amino acid biosynthetic process (GO:0042398),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,GCLM
cellular monovalent inorganic cation homeostasis (GO:0030004),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,ATP1A1
regulation of lymphocyte differentiation (GO:0045619),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,PRELID1
dopaminergic neuron differentiation (GO:0071542),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,CTNNB1
regulation of protein kinase A signaling (GO:0010738),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,MIF
regulation of protein localization to cell periphery (GO:1904375),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,ACTB
energy reserve metabolic process (GO:0006112),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,GSK3B
regulation of smooth muscle cell migration (GO:0014910),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,S100A11
regulation of smooth muscle contraction (GO:0006940),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,CTTN
fatty acid transport (GO:0015908),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,GOT2
granulocyte differentiation (GO:0030851),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,CDK4
mesoderm formation (GO:0001707),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,ITGB1
myeloid cell development (GO:0061515),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,APP
negative regulation of dephosphorylation (GO:0035305),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,YWHAB
nucleobase-containing compound biosynthetic process (GO:0034654),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,ADK
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,HSP90AB1
positive regulation of dendrite morphogenesis (GO:0050775),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,CAPRIN1
positive regulation of embryonic development (GO:0040019),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,CFL1
positive regulation of epidermal cell differentiation (GO:0045606),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,NME2
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,CDK4
positive regulation of heart contraction (GO:0045823),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,ATP2A2
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,LAMP1
positive regulation of nitrogen compound metabolic process (GO:0051173),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,APP
positive regulation of protein processing (GO:0010954),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,ENO1
post-transcriptional gene silencing by RNA (GO:0035194),20-Jan,0.498988622,0.665858772,0,0,1.498369818,1.04162472,EIF6
regulation of interferon-beta production (GO:0032648),2/49,0.499209186,0.665858772,0,0,1.211477419,0.84164978,HSP90AA1;DDX3X
regulation of smooth muscle cell proliferation (GO:0048660),2/49,0.499209186,0.665858772,0,0,1.211477419,0.84164978,CTNNB1;PHB
regulation of stress-activated MAPK cascade (GO:0032872),2/49,0.499209186,0.665858772,0,0,1.211477419,0.84164978,GSTP1;PPIA
RNA catabolic process (GO:0006401),2/49,0.499209186,0.665858772,0,0,1.211477419,0.84164978,RNH1;SND1
negative regulation of catabolic process (GO:0009895),2/49,0.499209186,0.665858772,0,0,1.211477419,0.84164978,SNX3;PHB
regulation of ion transport (GO:0043269),3/79,0.505187858,0.673500693,0,0,1.123773746,0.767340722,NEDD4;ATP1A1;RAB11B
positive regulation of multicellular organismal process (GO:0051240),12/345,0.507327871,0.676020019,0,0,1.025865446,0.696150031,ACADL;CFL1;NME2;GNAS;CTNNB1;ENO1;MIF;HADH;PPIB;GAPDH;RTN4;SOD1
regulation of cellular component movement (GO:0051270),2/50,0.509985314,0.677958828,0,0,1.18617676,0.798739819,ACTN4;RHOA
regulation of complement activation (GO:0030449),2/50,0.509985314,0.677958828,0,0,1.18617676,0.798739819,PHB;PHB2
negative regulation of ERK1 and ERK2 cascade (GO:0070373),2/50,0.509985314,0.677958828,0,0,1.18617676,0.798739819,GSTP1;PHB
organic hydroxy compound biosynthetic process (GO:1901617),2/50,0.509985314,0.677958828,0,0,1.18617676,0.798739819,SCP2;PARK7
negative regulation of cellular response to growth factor stimulus (GO:0090288),3/80,0.513642811,0.677958828,0,0,1.109121648,0.738926981,PDCD6;NEDD4;UBE2D3
positive regulation of cell adhesion (GO:0045785),3/80,0.513642811,0.677958828,0,0,1.109121648,0.738926981,TPM1;RAC1;P4HB
acetylcholine receptor signaling pathway (GO:0095500),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,GNB1
actin filament-based transport (GO:0099515),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,ACTN4
actin nucleation (GO:0045010),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,ARPC1A
regulation of anoikis (GO:2000209),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,ITGB1
calcium-mediated signaling using intracellular calcium source (GO:0035584),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,BCAP31
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,GSK3B
focal adhesion assembly (GO:0048041),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,CTTN
regulation of transcription by RNA polymerase III (GO:0006359),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,PRDX5
histone ubiquitination (GO:0016574),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,UBE2N
innate immune response in mucosa (GO:0002227),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,RPL39
rRNA modification (GO:0000154),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,NOP10
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,RPS27L
linoleic acid metabolic process (GO:0043651),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,GSTP1
melanosome localization (GO:0032400),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,RAB11B
vacuolar acidification (GO:0007035),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,ATP6AP2
negative regulation of reproductive process (GO:2000242),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,CALR
poly(A)+ mRNA export from nucleus (GO:0016973),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,ENY2
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,RPS3
positive regulation of glycolytic process (GO:0045821),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,APP
positive regulation of purine nucleotide metabolic process (GO:1900544),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,APP
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,ATF4
positive regulation of transcription regulatory region DNA binding (GO:2000679),21-Jan,0.516014945,0.677958828,0,0,1.423377581,0.941734435,PARK7
regulation of protein kinase activity (GO:0045859),4/110,0.516061959,0.677958828,0,0,1.074213836,0.710623009,GSTP1;PARK7;PPIA;SOD1
regulation of interleukin-12 production (GO:0032655),2/51,0.520608213,0.683266658,0,0,1.161908781,0.758444684,HMGB1;HSPD1
negative regulation of transport (GO:0051051),2/51,0.520608213,0.683266658,0,0,1.161908781,0.758444684,SNX3;NDFIP1
regulation of interleukin-8 production (GO:0032677),3/81,0.522020276,0.684454741,0,0,1.094845244,0.711702889,ANXA4;HMGB1;PARK7
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),3/81,0.522020276,0.684454741,0,0,1.094845244,0.711702889,APP;HMGB1;MIF
regulation of cell population proliferation (GO:0042127),26/764,0.523898777,0.686584471,0,0,1.002581373,0.648125534,APP;CTBP1;HP1BP3;PHB;TOB1;RPS4X;TBRG1;FTH1;LMNA;SSR1;ROMO1;S100A11;RPS9;NPM1;RPL23;CNBP;RPS6;SOD2;RHOA;NME1;CDK4;DNAJA2;CSNK2B;CTNNB1;CALR;SLC25A5
positive regulation of cellular catabolic process (GO:0031331),5/141,0.524338203,0.686827102,0,0,1.046484989,0.675629941,APP;GSK3B;TMEM59;HSP90AA1;HMGB1
Ras protein signal transduction (GO:0007265),5/142,0.530629867,0.689445747,0,0,1.038792263,0.65827284,CFL1;GNB1;PARK7;RAC1;RHOA
plasma membrane bounded cell projection morphogenesis (GO:0120039),2/52,0.531075855,0.689445747,0,0,1.138611521,0.720570773,CTTN;UBB
protein homotetramerization (GO:0051289),2/52,0.531075855,0.689445747,0,0,1.138611521,0.720570773,ALDOA;SOD2
cellular response to osmotic stress (GO:0071470),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,DDX3X
regulation of macrophage chemotaxis (GO:0010758),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,MIF
fatty-acyl-CoA metabolic process (GO:0035337),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,SLC25A1
female gonad development (GO:0008585),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,SOD1
regulation of vacuole organization (GO:0044088),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,ENO1
heme biosynthetic process (GO:0006783),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,PGRMC1
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,RPS21
membrane lipid metabolic process (GO:0006643),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,TECR
microglial cell activation (GO:0001774),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,APP
mitochondrial calcium ion homeostasis (GO:0051560),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,BCAP31
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,NEDD4
negative regulation of lipid biosynthetic process (GO:0051055),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,ACADL
negative regulation of myeloid cell differentiation (GO:0045638),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,HSPA9
negative regulation of phosphate metabolic process (GO:0045936),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,DYNLL1
osteoclast differentiation (GO:0030316),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,GLO1
peptidyl-threonine dephosphorylation (GO:0035970),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,PPP2CA
positive regulation of dendritic spine development (GO:0060999),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,CAPRIN1
positive regulation of granulocyte chemotaxis (GO:0071624),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,RAC1
positive regulation of neural precursor cell proliferation (GO:2000179),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,CTNNB1
positive regulation of neutrophil migration (GO:1902624),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,RAC1
positive regulation of translational initiation (GO:0045948),22-Jan,0.532463469,0.689445747,0,0,1.355527462,0.854308965,DDX3X
neuron development (GO:0048666),5/143,0.536884163,0.694836668,0,0,1.031211027,0.641385332,APP;GSK3B;VAPA;NEDD4;HMGB1
glycoprotein biosynthetic process (GO:0009101),3/83,0.538535148,0.696306096,0,0,1.067363166,0.660593747,GOLPH3;DAD1;DDOST
peptide metabolic process (GO:0006518),3/83,0.538535148,0.696306096,0,0,1.067363166,0.660593747,SPCS1;GSTP1;SOD1
"negative regulation of transcription, DNA-templated (GO:0045892)",32/948,0.53988634,0.697719141,0,0,0.993770375,0.612556722,NDUFA13;DDX5;SET;RPL10;CTBP1;TCF25;UBE2D3;HNRNPU;ENO1;PHB;HMGB1;PHB2;RPS14;PRDX5;SUMO1;UBB;YWHAQ;UBC;RPS27A;HSPA8;HSBP1;RPL23;CNBP;PA2G4;DRAP1;DAP;CTNNB1;HDGF;CALR;UBA52;PFDN5;ATF4
positive regulation of macroautophagy (GO:0016239),2/53,0.541386526,0.699323294,0,0,1.11622788,0.684941748,VDAC1;SLC25A5
positive regulation of macromolecule metabolic process (GO:0010604),13/384,0.543987087,0.702346616,0,0,0.99702128,0.607016237,APP;RPL5;CD63;GSK3B;DDX3X;RPS7;RPL23;RPL11;PARK7;PHB;ACTG1;RPS3;ATF4
activation of protein kinase activity (GO:0032147),4/114,0.544310294,0.702428143,0,0,1.034936027,0.629485144,PARK7;PHB;PHB2;PPIA
"DNA catabolic process, endonucleolytic (GO:0000737)",23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,HMGB1
glucose 6-phosphate metabolic process (GO:0051156),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,TKT
vesicle transport along microtubule (GO:0047496),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,KIF5B
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,YWHAB
negative regulation of GTPase activity (GO:0034260),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,TMED2
negative regulation of reactive oxygen species metabolic process (GO:2000378),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,PARK7
negative regulation of smoothened signaling pathway (GO:0045879),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,VCP
positive regulation of interleukin-17 production (GO:0032740),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,PHB
positive regulation of JUN kinase activity (GO:0043507),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,RPS3
positive regulation of natural killer cell mediated immunity (GO:0002717),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,LAMP1
positive regulation of receptor internalization (GO:0002092),23-Jan,0.548353773,0.70394655,0,0,1.293845535,0.777387202,CD63
negative regulation of transcription by RNA polymerase II (GO:0000122),23/684,0.549488081,0.705067604,0,0,0.98976975,0.592642648,DDX5;RPL10;CTBP1;TCF25;HSBP1;RPL23;CNBP;UBE2D3;HNRNPU;ENO1;PHB;HMGB1;DRAP1;RPS14;SUMO1;UBB;NEDD4;UBC;HDGF;CALR;RPS27A;UBA52;ATF4
cellular amide metabolic process (GO:0043603),4/115,0.551238856,0.706356716,0,0,1.025558892,0.610809615,PPP2CA;PPP2R1A;DBI;ATF4
regulation of cell cycle (GO:0051726),10/296,0.551429347,0.706356716,0,0,0.994857161,0.592180328,TBRG1;HSP90AB1;CTBP1;CDK4;RPL23;HNRNPU;MIF;CALR;SND1;EIF4G2
striated muscle contraction (GO:0006941),2/54,0.551538806,0.706356716,0,0,1.094705147,0.651396721,TPM1;ALDOA
positive regulation of leukocyte chemotaxis (GO:0002690),2/54,0.551538806,0.706356716,0,0,1.094705147,0.651396721,HMGB1;CALR
regulation of blood vessel endothelial cell migration (GO:0043535),2/55,0.561531551,0.712812077,0,0,1.073994593,0.619788657,CSNK2B;HMGB1
regulation of cardiac conduction (GO:1903779),2/55,0.561531551,0.712812077,0,0,1.073994593,0.619788657,ATP2A2;ATP1A1
ceramide metabolic process (GO:0006672),2/55,0.561531551,0.712812077,0,0,1.073994593,0.619788657,PPP2CA;PPP2R1A
regulation of Ras protein signal transduction (GO:0046578),3/86,0.562682247,0.712812077,0,0,1.028623369,0.591499791,LRRC59;SQSTM1;GABARAP
glucose homeostasis (GO:0042593),3/86,0.562682247,0.712812077,0,0,1.028623369,0.591499791,RPS6;NUCKS1;PARK7
apoptotic nuclear changes (GO:0030262),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,HMGB1
regulation of cardiac muscle hypertrophy (GO:0010611),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,GLRX3
C21-steroid hormone metabolic process (GO:0008207),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,FDX1
defense response to fungus (GO:0050832),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,GAPDH
DNA packaging (GO:0006323),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,BANF1
establishment of mitotic spindle orientation (GO:0000132),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,ITGB1
response to gamma radiation (GO:0010332),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,RPL26
histone monoubiquitination (GO:0010390),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,DDB1
sulfur amino acid metabolic process (GO:0000096),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,TXN2
"wound healing, spreading of cells (GO:0044319)",24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,RHOA
ncRNA 3'-end processing (GO:0043628),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,SSB
negative regulation of NIK/NF-kappaB signaling (GO:1901223),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,DDX3X
negative regulation of synaptic transmission (GO:0050805),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,ARF1
neuromuscular junction development (GO:0007528),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,NEDD4
peptidyl-glutamic acid modification (GO:0018200),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,VKORC1
phospholipid catabolic process (GO:0009395),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,PRDX6
porphyrin-containing compound biosynthetic process (GO:0006779),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,PGRMC1
positive regulation of carbohydrate metabolic process (GO:0045913),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,APP
positive regulation of cell-substrate junction organization (GO:0150117),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,RAC1
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,HSP90AB1
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,HSP90AB1
potassium ion homeostasis (GO:0055075),24-Jan,0.563704775,0.712812077,0,0,1.237527254,0.709381082,ATP1A1
positive regulation of cell projection organization (GO:0031346),4/117,0.56492713,0.714023481,0,0,1.007302524,0.575228697,SNX3;CAPRIN1;TWF1;RHOA
regulation of gene expression (GO:0010468),36/1079,0.56843207,0.718117409,0,0,0.981151094,0.554226216,RPL5;APP;GSK3B;DDX3X;MAGED1;RPL11;HP1BP3;PARK7;PHB;YBX1;TOB1;RPL6;UBE2L3;ACTG1;PPP2CA;HINT1;PPP2R1A;PCBP1;TRA2B;RPS3;MBNL2;NDFIP1;RPS7;RPL23;CNBP;CNPY2;EDF1;MIF;HNRNPAB;MLF2;DRAP1;HNRNPK;CDK4;CALR;PFDN5;ATF4
tight junction assembly (GO:0120192),2/56,0.571363879,0.721483794,0,0,1.054051097,0.589982973,PDCD6IP;ACTG1
positive regulation of neuron projection development (GO:0010976),3/88,0.578346881,0.725114787,0,0,1.004316046,0.549944836,SNX3;CAPRIN1;TWF1
regulation of calcium ion import (GO:0090279),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,CTNNB1
cellular response to hexose stimulus (GO:0071331),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,TRA2B
"chemical synaptic transmission, postsynaptic (GO:0099565)",25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,GSK3B
regulation of neutrophil chemotaxis (GO:0090022),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,RAC1
regulation of protein processing (GO:0070613),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,TMEM59
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,UBB
fat-soluble vitamin metabolic process (GO:0006775),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,VKORC1
sodium ion homeostasis (GO:0055078),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,ATP1A1
negative regulation of actin filament polymerization (GO:0030837),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,TWF1
negative regulation of endocytosis (GO:0045806),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,RAC1
negative regulation of ion transport (GO:0043271),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,NEDD4
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,ALYREF
positive regulation of ERBB signaling pathway (GO:1901186),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,RTN4
positive regulation of release of cytochrome c from mitochondria (GO:0090200),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,FAM162A
positive regulation of vascular endothelial growth factor production (GO:0010575),25-Jan,0.578534752,0.725114787,0,0,1.185902163,0.648992858,ATF4
brain development (GO:0007420),5/150,0.579534781,0.726031282,0,0,0.981070296,0.535202884,UFM1;NDUFS4;UFC1;RAB18;IER3IP1
arachidonic acid metabolic process (GO:0019369),2/57,0.581035148,0.726899461,0,0,1.034832819,0.561856298,GPX4;PTGES3
negative regulation of DNA recombination (GO:0045910),2/57,0.581035148,0.726899461,0,0,1.034832819,0.561856298,POLR2F;POLR2L
positive regulation of proteolysis (GO:0045862),2/57,0.581035148,0.726899461,0,0,1.034832819,0.561856298,NDUFA13;STUB1
cytoskeleton organization (GO:0007010),4/120,0.585021335,0.731547511,0,0,0.98109834,0.525973651,CFL1;TPM1;RAC1;RHOA
regulation of phagocytosis (GO:0050764),2/58,0.590544948,0.735562032,0,0,1.016300907,0.53529537,SNX3;CALR
RNA modification (GO:0009451),2/58,0.590544948,0.735562032,0,0,1.016300907,0.53529537,SSB;NOP10
negative regulation of hydrolase activity (GO:0051346),2/58,0.590544948,0.735562032,0,0,1.016300907,0.53529537,CSTB;TMED2
purine-containing compound biosynthetic process (GO:0072522),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,ADK
regulation of glycogen biosynthetic process (GO:0005979),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,GSK3B
regulation of mitotic metaphase/anaphase transition (GO:0030071),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,ANAPC5
regulation of monocyte chemotaxis (GO:0090025),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,HMGB1
regulation of myelination (GO:0031641),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,RNF10
glial cell development (GO:0021782),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,APP
regulation of viral life cycle (GO:1903900),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,PPIA
TOR signaling (GO:0031929),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,RPS6
negative regulation of cell development (GO:0010721),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,GSK3B
negative regulation of interleukin-1 beta production (GO:0032691),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,GSTP1
positive regulation of filopodium assembly (GO:0051491),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,CDC42
positive regulation of histone methylation (GO:0031062),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,CTNNB1
positive regulation of interleukin-2 production (GO:0032743),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,RPS3
positive regulation of ion transmembrane transporter activity (GO:0032414),26-Jan,0.592861364,0.735562032,0,0,1.13840708,0.595153182,NDUFA4
epithelium development (GO:0060429),4/122,0.598114244,0.741738555,0,0,0.964369115,0.49566017,ANXA4;PGK1;VDAC1;CTSB
phospholipid transport (GO:0015914),2/59,0.59989308,0.743262022,0,0,0.998419239,0.510196065,PRELID1;SCP2
positive regulation of apoptotic signaling pathway (GO:2001235),2/59,0.59989308,0.743262022,0,0,0.998419239,0.510196065,BCAP31;RPS3
regulation of actin cytoskeleton organization (GO:0032956),3/91,0.601170919,0.744162536,0,0,0.969926708,0.493572417,TWF1;RAC1;RHOA
positive regulation of transport (GO:0051050),3/91,0.601170919,0.744162536,0,0,0.969926708,0.493572417,GSK3B;CALR;ACTB
positive regulation of epithelial cell proliferation (GO:0050679),4/123,0.604567231,0.744864187,0,0,0.956215375,0.481208117,PDCD6;NME2;RTN4;NME1
regulation of cardiac muscle cell contraction (GO:0086004),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,ATP2A2
bile acid biosynthetic process (GO:0006699),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,SCP2
cellular lipid catabolic process (GO:0044242),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,ACADL
regulation of epidermal growth factor-activated receptor activity (GO:0007176),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,APP
cellular response to cadmium ion (GO:0071276),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,SUMO1
cellular senescence (GO:0090398),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,CALR
entrainment of circadian clock by photoperiod (GO:0043153),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,PPP1CB
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,HNRNPU
regulation of transcription regulatory region DNA binding (GO:2000677),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,PARK7
regulation of vascular endothelial growth factor production (GO:0010574),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,ATF4
modulation of excitatory postsynaptic potential (GO:0098815),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,APP
negative regulation of catalytic activity (GO:0043086),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,TMBIM1
negative regulation of protein polymerization (GO:0032272),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,TWF1
peptide hormone secretion (GO:0030072),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,PARK7
positive regulation of cellular component movement (GO:0051272),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,ACTN4
positive regulation of mitotic cell cycle (GO:0045931),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,APP
presynaptic endocytosis (GO:0140238),27-Jan,0.60670167,0.744864187,0,0,1.094565464,0.546974164,CANX
cellular response to fibroblast growth factor stimulus (GO:0044344),3/92,0.608595893,0.746426427,0,0,0.958978791,0.476229625,RAB14;POLR2F;POLR2L
T cell activation (GO:0042110),3/92,0.608595893,0.746426427,0,0,0.958978791,0.476229625,FKBP1A;DDOST;HSPD1
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),2/60,0.609079543,0.746426427,0,0,0.981154179,0.486462529,ITGB1;BSG
peptidyl-threonine phosphorylation (GO:0018107),2/60,0.609079543,0.746426427,0,0,0.981154179,0.486462529,GSK3B;CSNK2B
regulation of tumor necrosis factor production (GO:0032680),4/124,0.610956929,0.748387603,0,0,0.948197531,0.467204246,APP;GSTP1;MIF;HMGB1
regulation of epithelial cell proliferation (GO:0050678),3/93,0.61592814,0.749693327,0,0,0.948274162,0.459557345,MAGED1;NME2;NME1
B cell differentiation (GO:0030183),2/61,0.618104525,0.749693327,0,0,0.964474376,0.464006405,ITGB1;SLC25A5
"regulation of DNA-templated transcription, initiation (GO:2000142)",2/61,0.618104525,0.749693327,0,0,0.964474376,0.464006405,CDK4;CTNNB1
positive regulation of interleukin-8 production (GO:0032757),2/61,0.618104525,0.749693327,0,0,0.964474376,0.464006405,HMGB1;PARK7
regulation of calcineurin-NFAT signaling cascade (GO:0070884),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,GSK3B
calcium ion import (GO:0070509),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,ATP2A2
"regulation of DNA-templated transcription, elongation (GO:0032784)",28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,ALYREF
cellular response to acid chemical (GO:0071229),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,LAMTOR2
cellular response to epidermal growth factor stimulus (GO:0071364),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,EEF1A1
cellular response to interleukin-6 (GO:0071354),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,PHB
cytosolic calcium ion transport (GO:0060401),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,ATP2A2
regulation of microtubule polymerization or depolymerization (GO:0031110),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,FKBP4
regulation of multicellular organismal development (GO:2000026),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,RAB14
regulation of phosphatase activity (GO:0010921),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,HSP90B1
regulation of plasma membrane bounded cell projection organization (GO:0120035),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,GSK3B
regulation of postsynapse organization (GO:0099175),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,CFL1
regulation of reactive oxygen species biosynthetic process (GO:1903426),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,PARK7
regulation of small molecule metabolic process (GO:0062012),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,ACADL
regulation of sodium ion transmembrane transport (GO:1902305),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,COMMD1
glycerophospholipid catabolic process (GO:0046475),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,PRDX6
sarcomere organization (GO:0045214),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,TPM1
leukocyte cell-cell adhesion (GO:0007159),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,ITGB1
macromolecule catabolic process (GO:0009057),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,NEDD4
transcription by RNA polymerase III (GO:0006383),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,POLR2L
mucosal immune response (GO:0002385),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,RPL39
photoperiodism (GO:0009648),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,PPP1CB
positive regulation of defense response to virus by host (GO:0002230),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,HSP90AA1
positive regulation of protein import into nucleus (GO:0042307),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,RAN
protein localization to cell surface (GO:0034394),28-Jan,0.620072156,0.749693327,0,0,1.053971376,0.503713396,CTNNB1
regulation of kinase activity (GO:0043549),3/94,0.623167075,0.753098107,0,0,0.937804799,0.443525981,EEF1A1;HNRNPU;SOD1
skeletal system development (GO:0001501),5/158,0.625593309,0.755692097,0,0,0.929384612,0.435932299,VKORC1;PRDX1;GNAS;RPL13;PPIB
actin filament polymerization (GO:0030041),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,RAC1
regulation of actin polymerization or depolymerization (GO:0008064),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,CTTN
beta-catenin-TCF complex assembly (GO:1904837),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,CTNNB1
regulation of gluconeogenesis (GO:0006111),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,DDB1
regulation of neuronal synaptic plasticity (GO:0048168),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,APP
establishment of mitotic spindle localization (GO:0040001),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,ITGB1
response to cadmium ion (GO:0046686),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,SUMO1
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,ATF4
lipid catabolic process (GO:0016042),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,ACADL
transition metal ion homeostasis (GO:0055076),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,COMMD1
negative regulation of epithelial to mesenchymal transition (GO:0010719),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,PPP2CA
negative regulation of interferon-gamma production (GO:0032689),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,HMGB1
production of miRNAs involved in gene silencing by miRNA (GO:0035196),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,HNRNPA2B1
protein ADP-ribosylation (GO:0006471),29-Jan,0.632988746,0.759867823,0,0,1.016276865,0.464746089,ARF4
actin cytoskeleton reorganization (GO:0031532),2/63,0.635671647,0.761734303,0,0,0.932755406,0.422606409,CTTN;RHOA
cell cycle G1/S phase transition (GO:0044843),2/63,0.635671647,0.761734303,0,0,0.932755406,0.422606409,CDK4;GSPT1
organonitrogen compound catabolic process (GO:1901565),2/63,0.635671647,0.761734303,0,0,0.932755406,0.422606409,PDXDC1;TXN2
positive regulation of Ras protein signal transduction (GO:0046579),2/63,0.635671647,0.761734303,0,0,0.932755406,0.422606409,LRRC59;RAC1
regulation of vesicle-mediated transport (GO:0060627),3/96,0.637363112,0.763422512,0,0,0.917541516,0.413275151,RAB10;AP2S1;RAB11B
cellular response to insulin stimulus (GO:0032869),4/129,0.641934595,0.765995562,0,0,0.910032593,0.403389108,RAB10;GSK3B;ATP6V0C;ATP6V1F
muscle contraction (GO:0006936),4/129,0.641934595,0.765995562,0,0,0.910032593,0.403389108,MYL6;TPM1;CALM1;ALDOA
regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/64,0.64421498,0.765995562,0,0,0.917663315,0.403517472,GSTP1;PARK7
regulation of innate immune response (GO:0045088),2/64,0.64421498,0.765995562,0,0,0.917663315,0.403517472,HSP90AB1;CDC37
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),2/64,0.64421498,0.765995562,0,0,0.917663315,0.403517472,CDK4;CTNNB1
negative regulation of cell cycle process (GO:0010948),2/64,0.64421498,0.765995562,0,0,0.917663315,0.403517472,CHMP2A;RBBP7
calcium ion homeostasis (GO:0055074),3/97,0.644319475,0.765995562,0,0,0.907733224,0.399003757,ATP2A2;CALR;TPT1
positive regulation of cold-induced thermogenesis (GO:0120162),3/97,0.644319475,0.765995562,0,0,0.907733224,0.399003757,ACADL;GNAS;HADH
regulation of cation transmembrane transport (GO:1904062),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,CD63
regulation of natural killer cell mediated cytotoxicity (GO:0042269),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,LAMP1
regulation of protein localization to membrane (GO:1905475),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,ACTB
establishment of spindle orientation (GO:0051294),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,ITGB1
heterotypic cell-cell adhesion (GO:0034113),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,ITGB1
ncRNA catabolic process (GO:0034661),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,SND1
"negative regulation of gene expression, epigenetic (GO:0045814)",30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,RBBP7
negative regulation of interleukin-1 production (GO:0032692),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,GSTP1
phosphatidylcholine acyl-chain remodeling (GO:0036151),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,DBI
positive regulation of B cell proliferation (GO:0030890),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,MIF
positive regulation of endopeptidase activity (GO:0010950),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,PRELID1
positive regulation of protein import (GO:1904591),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,RAN
positive regulation of small GTPase mediated signal transduction (GO:0051057),30-Jan,0.645466827,0.765995562,0,0,0.981181975,0.429543279,LRRC59
regulation of response to external stimulus (GO:0032101),4/130,0.647932381,0.768583821,0,0,0.902763081,0.391771136,PSMA6;PARK7;CALM1;METAP2
negative regulation of macromolecule metabolic process (GO:0010605),6/194,0.648380815,0.76877813,0,0,0.907321931,0.393121795,APP;NDFIP1;HSP90AB1;CNPY2;MIF;PARK7
mitotic G1 DNA damage checkpoint signaling (GO:0031571),2/65,0.652599196,0.773440293,0,0,0.903050339,0.385414775,RPS27L;RPL26
protein localization to membrane (GO:0072657),6/195,0.653267725,0.773893037,0,0,0.902474115,0.384244817,TM9SF2;RAB10;BSG;TMED2;TM9SF3;RAB11B
regulation of cellular senescence (GO:2000772),31-Jan,0.657521265,0.776547852,0,0,0.948426745,0.397654633,YBX1
cardiac muscle cell action potential involved in contraction (GO:0086002),31-Jan,0.657521265,0.776547852,0,0,0.948426745,0.397654633,ATP1A1
cellular nitrogen compound biosynthetic process (GO:0044271),31-Jan,0.657521265,0.776547852,0,0,0.948426745,0.397654633,CYB5R3
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),31-Jan,0.657521265,0.776547852,0,0,0.948426745,0.397654633,FKBP1A
steroid hormone biosynthetic process (GO:0120178),31-Jan,0.657521265,0.776547852,0,0,0.948426745,0.397654633,FDX1
negative regulation of axon extension (GO:0030517),31-Jan,0.657521265,0.776547852,0,0,0.948426745,0.397654633,RTN4
positive regulation of Rho protein signal transduction (GO:0035025),31-Jan,0.657521265,0.776547852,0,0,0.948426745,0.397654633,RAC1
embryonic organ development (GO:0048568),2/66,0.660825235,0.779768003,0,0,0.888894018,0.368238453,RPL10;ATF4
positive regulation of T cell proliferation (GO:0042102),2/66,0.660825235,0.779768003,0,0,0.888894018,0.368238453,RPS3;HMGB1
regulation of neuron projection development (GO:0010975),5/165,0.663306176,0.782353704,0,0,0.888399481,0.364704503,SNX3;GSK3B;CFL1;TWF1;FKBP4
regulation of MAPK cascade (GO:0043408),5/166,0.668487376,0.783110273,0,0,0.882835395,0.355551155,GSTP1;ATP6AP2;PEBP1;HMGB1;YWHAZ
anion transmembrane transport (GO:0098656),2/67,0.668894156,0.783110273,0,0,0.875173276,0.351932942,SLC25A1;SLC25A5
peptidyl-threonine modification (GO:0018210),2/67,0.668894156,0.783110273,0,0,0.875173276,0.351932942,GSK3B;CSNK2B
B cell proliferation (GO:0042100),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,HSPD1
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,RHOA
regulation of cell morphogenesis (GO:0022604),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,CFL1
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,UFM1
regulation of intracellular protein transport (GO:0033157),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,OAZ1
regulation of NMDA receptor activity (GO:2000310),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,APP
RNA biosynthetic process (GO:0032774),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,SMARCA5
skeletal muscle organ development (GO:0060538),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,MYL6
metal ion export (GO:0070839),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,ATP1A1
modulation by host of symbiont process (GO:0051851),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,NUCKS1
negative regulation of developmental growth (GO:0048640),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,RTN4
negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,FKBP4
positive regulation of immune effector process (GO:0002699),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,PHB
positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,OCIAD2
positive regulation of telomere maintenance (GO:0032206),1/32,0.669166423,0.783110273,0,0,0.917784756,0.368694773,HNRNPA2B1
positive regulation of cell cycle process (GO:0090068),3/101,0.671195595,0.785144782,0,0,0.870501751,0.347064423,CDC42;RANBP1;RHOA
regulation of myeloid cell differentiation (GO:0045637),2/68,0.676807131,0.791023825,0,0,0.861868314,0.336446616,HSPA9;EIF6
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),2/68,0.676807131,0.791023825,0,0,0.861868314,0.336446616,PPP2CA;PPP2R1A
actin filament bundle assembly (GO:0051017),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,HSP90B1
bile acid metabolic process (GO:0008206),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,SCP2
regulation of interleukin-17 production (GO:0032660),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,PHB
regulation of neurotransmitter secretion (GO:0046928),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,GSK3B
very long-chain fatty acid metabolic process (GO:0000038),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,TECR
negative chemotaxis (GO:0050919),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,RHOA
negative regulation of JNK cascade (GO:0046329),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,GSTP1
phosphatidylcholine biosynthetic process (GO:0006656),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,CSNK2B
positive regulation of cholesterol transport (GO:0032376),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,SCP2
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),1/33,0.680416177,0.791815637,0,0,0.889057891,0.342332312,OCIAD2
protein localization to plasma membrane (GO:0072659),4/136,0.682504807,0.793562412,0,0,0.861459035,0.32906504,RAB10;GORASP2;BSG;TMED2
cellular calcium ion homeostasis (GO:0006874),4/136,0.682504807,0.793562412,0,0,0.861459035,0.32906504,YWHAE;ATP2A2;CALR;TPT1
organelle assembly (GO:0070925),13/425,0.688669963,0.799979588,0,0,0.895860666,0.334149876,ARF4;NPM1;PDCD6IP;DDX3X;ATP2A2;DYNLL1;GABARAP;MAP1LC3B;GORASP2;CSDE1;RPS3;CHMP2A;RPS23
cardiac muscle contraction (GO:0060048),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,TPM1
cell-substrate junction assembly (GO:0007044),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,CTTN
cellular response to amino acid stimulus (GO:0071230),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,LAMTOR2
central nervous system neuron differentiation (GO:0021953),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,CTNNB1
regulation of keratinocyte differentiation (GO:0045616),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,NME2
sister chromatid segregation (GO:0000819),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,RAN
synaptic vesicle recycling (GO:0036465),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,CANX
organic cyclic compound biosynthetic process (GO:1901362),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,SCP2
protein destabilization (GO:0031648),1/34,0.691283933,0.799979588,0,0,0.862072048,0.318280998,SERF2
carbohydrate homeostasis (GO:0033500),2/70,0.692170417,0.799979588,0,0,0.836432357,0.307742774,RPS6;PARK7
defense response to Gram-positive bacterium (GO:0050830),2/70,0.692170417,0.799979588,0,0,0.836432357,0.307742774,ROMO1;RPL39
snRNA transcription by RNA polymerase II (GO:0042795),2/70,0.692170417,0.799979588,0,0,0.836432357,0.307742774,POLR2F;POLR2L
negative regulation of viral process (GO:0048525),2/70,0.692170417,0.799979588,0,0,0.836432357,0.307742774,BANF1;PPIA
central nervous system development (GO:0007417),8/268,0.693295885,0.800937632,0,0,0.87405709,0.320165721,COX7B;UFM1;GSTP1;ATP6AP2;NDUFS4;UFC1;RAB18;IER3IP1
positive regulation of ERK1 and ERK2 cascade (GO:0070374),5/172,0.698465359,0.805573703,0,0,0.850850228,0.305344362,APP;MIF;PHB;HMGB1;PHB2
protein tetramerization (GO:0051262),2/71,0.699623546,0.805573703,0,0,0.824267335,0.294438909,ALDOA;SOD2
histone acetylation (GO:0016573),2/71,0.699623546,0.805573703,0,0,0.824267335,0.294438909,MORF4L1;MORF4L2
snRNA transcription (GO:0009301),2/71,0.699623546,0.805573703,0,0,0.824267335,0.294438909,POLR2F;POLR2L
regulation of blood circulation (GO:1903522),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,TPM1
blood vessel diameter maintenance (GO:0097746),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,GCLM
regulation of lipid biosynthetic process (GO:0046890),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,EIF6
regulation of postsynaptic membrane potential (GO:0060078),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,GSK3B
regulation of regulated secretory pathway (GO:1903305),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,GSK3B
regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,RPS3
regulation of trans-synaptic signaling (GO:0099177),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,PSMC5
response to estrogen (GO:0043627),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,SFR1
semaphorin-plexin signaling pathway (GO:0071526),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,RAC1
negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,CDK4
positive regulation of lymphocyte activation (GO:0051251),1/35,0.701782645,0.805573703,0,0,0.836673607,0.296292518,HSPD1
regulation of ERK1 and ERK2 cascade (GO:0070372),7/238,0.702097861,0.80559317,0,0,0.860840548,0.304464221,APP;GSTP1;MIF;PHB;HMGB1;PHB2;YWHAZ
response to ionizing radiation (GO:0010212),2/72,0.706926343,0.810788981,0,0,0.812449884,0.28178102,EEF1D;SWI5
regulation of small GTPase mediated signal transduction (GO:0051056),4/141,0.709443728,0.81101179,0,0,0.829802649,0.284849755,CDC42;RAC1;SQSTM1;RHOA
axonogenesis (GO:0007409),7/240,0.710249022,0.81101179,0,0,0.853361946,0.291968944,RAB10;APP;HSP90AA1;HSP90AB1;KIF5B;BSG;ACTB
negative regulation of nucleic acid-templated transcription (GO:1903507),14/464,0.711712734,0.81101179,0,0,0.882853801,0.300241726,HSPA8;NDUFA13;SET;CTBP1;ENO1;PA2G4;PHB;PHB2;DAP;SUMO1;YWHAQ;CTNNB1;CALR;PFDN5
axonal transport (GO:0098930),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,SOD1
regulation of cell cycle G1/S phase transition (GO:1902806),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,PHB2
regulation of defense response to virus by host (GO:0050691),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,HSP90AA1
regulation of microtubule-based process (GO:0032886),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,GSK3B
dendrite morphogenesis (GO:0048813),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,CDC42
embryonic limb morphogenesis (GO:0030326),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,CTNNB1
macrophage activation (GO:0042116),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,APP
membrane assembly (GO:0071709),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,CHMP2A
negative regulation of DNA metabolic process (GO:0051053),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,RPS3
positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,UBE2K
positive regulation of innate immune response (GO:0045089),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,UBE2K
positive regulation of mitotic nuclear division (GO:0045840),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,ANAPC5
positive regulation of T cell mediated immunity (GO:0002711),1/36,0.711924826,0.81101179,0,0,0.812726507,0.276150614,HSPD1
regulation of actin filament polymerization (GO:0030833),2/73,0.714080408,0.81209734,0,0,0.800965319,0.269732846,CTTN;TWF1
regulation of actin filament-based process (GO:0032970),2/73,0.714080408,0.81209734,0,0,0.800965319,0.269732846,RAC1;RHOA
positive regulation of JNK cascade (GO:0046330),2/73,0.714080408,0.81209734,0,0,0.800965319,0.269732846,APP;HMGB1
positive regulation of synaptic transmission (GO:0050806),2/73,0.714080408,0.81209734,0,0,0.800965319,0.269732846,APP;SQSTM1
lipid transport (GO:0006869),3/109,0.720400095,0.816952735,0,0,0.804468572,0.263824289,PRELID1;SCP2;GOT2
modulation of chemical synaptic transmission (GO:0050804),3/109,0.720400095,0.816952735,0,0,0.804468572,0.263824289,ITGB1;APP;PSMC5
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/74,0.721087408,0.816952735,0,0,0.78979977,0.258260511,RPS27L;RPL26
regulation of actin cytoskeleton reorganization (GO:2000249),1/37,0.721722566,0.816952735,0,0,0.7901098,0.25766624,CDC42
regulation of erythrocyte differentiation (GO:0045646),1/37,0.721722566,0.816952735,0,0,0.7901098,0.25766624,HSPA9
regulation of microtubule cytoskeleton organization (GO:0070507),1/37,0.721722566,0.816952735,0,0,0.7901098,0.25766624,GSK3B
glutamate receptor signaling pathway (GO:0007215),1/37,0.721722566,0.816952735,0,0,0.7901098,0.25766624,APP
skeletal muscle tissue development (GO:0007519),1/37,0.721722566,0.816952735,0,0,0.7901098,0.25766624,MYL6
lysosome localization (GO:0032418),1/37,0.721722566,0.816952735,0,0,0.7901098,0.25766624,KIF5B
ncRNA metabolic process (GO:0034660),1/37,0.721722566,0.816952735,0,0,0.7901098,0.25766624,RAN
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.721722566,0.816952735,0,0,0.7901098,0.25766624,CDK4
positive regulation of developmental process (GO:0051094),5/177,0.721979333,0.816952735,0,0,0.825900559,0.269044346,HSP90AB1;CFL1;LMNA;PA2G4;RTN4
negative regulation of cell migration (GO:0030336),4/144,0.724788519,0.81978802,0,0,0.81189418,0.261328735,TPM1;MIF;CALR;RAC1
regulation of interleukin-6 production (GO:0032675),3/110,0.726129195,0.820960634,0,0,0.796908699,0.25503256,APP;HMGB1;HSPD1
phosphate-containing compound metabolic process (GO:0006796),6/212,0.729763935,0.823233666,0,0,0.827262367,0.260615916,GPX4;PPA1;PGK1;TOP1;CALM1;ALDOA
regulation of cell communication (GO:0010646),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,MTCH1
response to cAMP (GO:0051591),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,NDUFS4
response to estradiol (GO:0032355),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,CTNNB1
lymphocyte proliferation (GO:0046651),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,HSPD1
synaptic vesicle endocytosis (GO:0048488),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,CANX
tRNA aminoacylation (GO:0043039),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,PPA1
negative regulation of G0 to G1 transition (GO:0070317),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,RBBP7
negative regulation of TOR signaling (GO:0032007),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,PDCD6
positive regulation of insulin secretion (GO:0032024),1/38,0.731187547,0.823233666,0,0,0.768715618,0.240673552,GLUD1
cellular divalent inorganic cation homeostasis (GO:0072503),3/111,0.731766069,0.82354173,0,0,0.789488823,0.246552933,ATP2A2;CALR;TPT1
regulation of epithelial to mesenchymal transition (GO:0010717),2/76,0.734667154,0.826118228,0,0,0.768373987,0.236918694,PPP2CA;CTNNB1
water-soluble vitamin metabolic process (GO:0006767),2/76,0.734667154,0.826118228,0,0,0.768373987,0.236918694,CYB5R3;GSTO1
regulation of cytoskeleton organization (GO:0051493),3/112,0.737311267,0.828746455,0,0,0.782205092,0.238373195,GSK3B;RAC1;RHOA
regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.740331053,0.83040178,0,0,0.748447446,0.22502658,YWHAE
DNA recombination (GO:0006310),1/39,0.740331053,0.83040178,0,0,0.748447446,0.22502658,HMGB1
endothelial cell migration (GO:0043542),1/39,0.740331053,0.83040178,0,0,0.748447446,0.22502658,RHOA
regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.740331053,0.83040178,0,0,0.748447446,0.22502658,APP
regulation of organelle assembly (GO:1902115),2/77,0.741243499,0.83040178,0,0,0.758089611,0.226991814,NPM1;PDCD6IP
negative regulation of developmental process (GO:0051093),2/77,0.741243499,0.83040178,0,0,0.758089611,0.226991814,MIF;ANP32B
phosphatidylcholine metabolic process (GO:0046470),2/77,0.741243499,0.83040178,0,0,0.758089611,0.226991814,CSNK2B;DBI
positive regulation of endothelial cell proliferation (GO:0001938),2/77,0.741243499,0.83040178,0,0,0.758089611,0.226991814,PDCD6;HMGB1
positive regulation of metabolic process (GO:0009893),3/113,0.742765376,0.831620593,0,0,0.775053792,0.230481671,ACADL;GNAS;HADH
cilium assembly (GO:0060271),9/314,0.742947238,0.831620593,0,0,0.837504282,0.248847855,YWHAE;ARF4;HSP90AA1;DCTN2;PPP2R1A;DCTN3;DYNLRB1;DYNLL1;TUBB4B
negative regulation of blood vessel morphogenesis (GO:2000181),2/78,0.747679965,0.836153692,0,0,0.748075877,0.217525688,PGK1;CTNNB1
regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.749163989,0.836153692,0,0,0.729218667,0.210596438,NEDD4
response to organonitrogen compound (GO:0010243),1/40,0.749163989,0.836153692,0,0,0.729218667,0.210596438,VCP
stem cell differentiation (GO:0048863),1/40,0.749163989,0.836153692,0,0,0.729218667,0.210596438,PSMD11
negative regulation of ERBB signaling pathway (GO:1901185),1/40,0.749163989,0.836153692,0,0,0.729218667,0.210596438,CDC42
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.749163989,0.836153692,0,0,0.729218667,0.210596438,GSTP1
negative regulation of protein kinase B signaling (GO:0051898),1/40,0.749163989,0.836153692,0,0,0.729218667,0.210596438,PDCD6
calcium ion transport (GO:0006816),3/115,0.753402857,0.840190387,0,0,0.761134298,0.215519128,FKBP1A;ATP2A2;TPT1
cellular response to molecule of bacterial origin (GO:0071219),3/115,0.753402857,0.840190387,0,0,0.761134298,0.215519128,GSTP1;HMGB1;RHOA
regulation of neuron differentiation (GO:0045664),2/79,0.753978453,0.840485267,0,0,0.738322239,0.208495916,CALR;RHOA
cellular response to lipid (GO:0071396),6/219,0.757566145,0.841504643,0,0,0.799782349,0.222055111,NDUFA13;GSTP1;HMGB1;ATP1A1;RHOA;UBE2L3
regulation of filopodium assembly (GO:0051489),1/41,0.757696887,0.841504643,0,0,0.710951327,0.197268986,CDC42
regulation of G0 to G1 transition (GO:0070316),1/41,0.757696887,0.841504643,0,0,0.710951327,0.197268986,RBBP7
epithelial cell migration (GO:0010631),1/41,0.757696887,0.841504643,0,0,0.710951327,0.197268986,RHOA
regulation of response to DNA damage stimulus (GO:2001020),1/41,0.757696887,0.841504643,0,0,0.710951327,0.197268986,UBE2N
response to growth factor (GO:0070848),1/41,0.757696887,0.841504643,0,0,0.710951327,0.197268986,CTNNB1
visual system development (GO:0150063),1/41,0.757696887,0.841504643,0,0,0.710951327,0.197268986,RAB18
nucleobase-containing compound catabolic process (GO:0034655),1/41,0.757696887,0.841504643,0,0,0.710951327,0.197268986,SND1
positive regulation of cation transmembrane transport (GO:1904064),1/41,0.757696887,0.841504643,0,0,0.710951327,0.197268986,GNB1
positive regulation of phosphorylation (GO:0042327),7/253,0.759558897,0.843178876,0,0,0.807715108,0.222135719,APP;HSP90AA1;PTGES3;CDK2AP1;MIF;RAC1;PPIA
response to interferon-gamma (GO:0034341),2/80,0.760140897,0.843178876,0,0,0.728818695,0.1998796,RPL13A;GAPDH
lipid biosynthetic process (GO:0008610),2/80,0.760140897,0.843178876,0,0,0.728818695,0.1998796,SCP2;NDUFAB1
transcription by RNA polymerase II (GO:0006366),9/320,0.76238649,0.845322623,0,0,0.821087489,0.222762388,BTF3;DRAP1;DDX5;TCEA1;POLR2F;SNRPF;ATF4;SNRPB;POLR2L
regulation of chemokine production (GO:0032642),1/42,0.765939926,0.847523039,0,0,0.693575077,0.184942861,APP
regulation of DNA recombination (GO:0000018),1/42,0.765939926,0.847523039,0,0,0.693575077,0.184942861,ALYREF
regulation of nervous system development (GO:0051960),1/42,0.765939926,0.847523039,0,0,0.693575077,0.184942861,CTNNB1
positive regulation of epithelial to mesenchymal transition (GO:0010718),1/42,0.765939926,0.847523039,0,0,0.693575077,0.184942861,CTNNB1
potassium ion import across plasma membrane (GO:1990573),1/42,0.765939926,0.847523039,0,0,0.693575077,0.184942861,ATP1A1
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),2/82,0.772065524,0.851450848,0,0,0.710524372,0.183802606,CDC37;ACTB
positive regulation of cytoskeleton organization (GO:0051495),2/82,0.772065524,0.851450848,0,0,0.710524372,0.183802606,CDC42;CTTN
cellular response to retinoic acid (GO:0071300),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,NDUFA13
development of primary male sexual characteristics (GO:0046546),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,CSDE1
signal release from synapse (GO:0099643),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,HSPA8
male gonad development (GO:0008584),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,CSDE1
tRNA aminoacylation for protein translation (GO:0006418),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,PPA1
myofibril assembly (GO:0030239),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,TPM1
natural killer cell activation (GO:0030101),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,PRDX1
negative regulation of type I interferon production (GO:0032480),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,TAX1BP1
positive regulation of axonogenesis (GO:0050772),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,RHOA
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,LAMP1
positive regulation of neuron differentiation (GO:0045666),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,RHOA
positive regulation of peptide hormone secretion (GO:0090277),1/43,0.773902936,0.851450848,0,0,0.677026268,0.173527803,GLUD1
regulation of defense response (GO:0031347),2/83,0.777831698,0.854033909,0,0,0.701715995,0.176302709,PSMA6;PARK7
regulation of interleukin-1 beta production (GO:0032651),2/83,0.777831698,0.854033909,0,0,0.701715995,0.176302709,APP;GSTP1
regulation of osteoblast differentiation (GO:0045667),2/83,0.777831698,0.854033909,0,0,0.701715995,0.176302709,DDX5;ATF4
epidermis development (GO:0008544),2/83,0.777831698,0.854033909,0,0,0.701715995,0.176302709,ATP2A2;YBX1
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),2/83,0.777831698,0.854033909,0,0,0.701715995,0.176302709,CDC42;RAC1
cellular response to lipopolysaccharide (GO:0071222),3/120,0.778450071,0.854365559,0,0,0.728417539,0.182432482,GSTP1;HMGB1;RHOA
antibacterial humoral response (GO:0019731),1/44,0.781595419,0.855384613,0,0,0.66124717,0.162943231,RPL39
branching morphogenesis of an epithelial tube (GO:0048754),1/44,0.781595419,0.855384613,0,0,0.66124717,0.162943231,CTNNB1
mitotic spindle assembly (GO:0090307),1/44,0.781595419,0.855384613,0,0,0.66124717,0.162943231,RHOA
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/44,0.781595419,0.855384613,0,0,0.66124717,0.162943231,CDC42
neurogenesis (GO:0022008),1/44,0.781595419,0.855384613,0,0,0.66124717,0.162943231,NDUFS2
neurotransmitter secretion (GO:0007269),1/44,0.781595419,0.855384613,0,0,0.66124717,0.162943231,HSPA8
positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.781595419,0.855384613,0,0,0.66124717,0.162943231,GNB1
response to insulin (GO:0032868),2/84,0.783469801,0.856394955,0,0,0.693122456,0.169137655,RAB10;EIF6
spindle assembly (GO:0051225),2/84,0.783469801,0.856394955,0,0,0.693122456,0.169137655,RPS3;RHOA
lymphocyte differentiation (GO:0030098),2/84,0.783469801,0.856394955,0,0,0.693122456,0.169137655,ITGB1;SLC25A5
G1/S transition of mitotic cell cycle (GO:0000082),2/85,0.78898187,0.860032572,0,0,0.68473599,0.162290603,CDK4;GSPT1
regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.789026551,0.860032572,0,0,0.646185304,0.153117038,NUCKS1
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.789026551,0.860032572,0,0,0.646185304,0.153117038,DDX5
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.789026551,0.860032572,0,0,0.646185304,0.153117038,OCIAD2
zymogen activation (GO:0031638),1/45,0.789026551,0.860032572,0,0,0.646185304,0.153117038,PGK1
neural crest cell development (GO:0014032),1/45,0.789026551,0.860032572,0,0,0.646185304,0.153117038,PDCD6
positive regulation of RNA metabolic process (GO:0051254),1/45,0.789026551,0.860032572,0,0,0.646185304,0.153117038,DDX5
cellular response to organic substance (GO:0071310),3/123,0.792449033,0.863414618,0,0,0.710096154,0.165187599,CTNNB1;PARK7;RHOA
regulation of interferon-gamma production (GO:0032649),2/86,0.794369948,0.86515856,0,0,0.676549202,0.155745683,HMGB1;HSPD1
regulation of B cell proliferation (GO:0030888),1/46,0.796205198,0.865760966,0,0,0.631792855,0.143984543,MIF
negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.796205198,0.865760966,0,0,0.631792855,0.143984543,GSTP1
positive regulation of organelle assembly (GO:1902117),1/46,0.796205198,0.865760966,0,0,0.631792855,0.143984543,PDCD6IP
positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.796205198,0.865760966,0,0,0.631792855,0.143984543,PHB
negative regulation of angiogenesis (GO:0016525),2/87,0.799636085,0.869141677,0,0,0.668555044,0.149487937,PGK1;CTNNB1
epidermal growth factor receptor signaling pathway (GO:0007173),1/47,0.803139928,0.871547186,0,0,0.618026164,0.135487604,AAMP
telomere organization (GO:0032200),1/47,0.803139928,0.871547186,0,0,0.618026164,0.135487604,PTGES3
polyol metabolic process (GO:0019751),1/47,0.803139928,0.871547186,0,0,0.618026164,0.135487604,CALM1
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/47,0.803139928,0.871547186,0,0,0.618026164,0.135487604,CSNK2B
metal ion transport (GO:0030001),2/88,0.804782337,0.872978752,0,0,0.660746797,0.143503254,NDFIP1;TPT1
negative regulation of signal transduction (GO:0009968),7/267,0.805570456,0.873277071,0,0,0.763661859,0.165107216,VCP;YWHAB;NEDD4;PDCD6;TMBIM1;TMBIM6;CALR
synapse organization (GO:0050808),3/126,0.805703984,0.873277071,0,0,0.692668495,0.149643319,CDC42;APP;NEDD4
negative regulation of intracellular signal transduction (GO:1902532),5/198,0.806287321,0.873558786,0,0,0.735228548,0.158305825,NDUFA13;DDX3X;GSTP1;PDCD6;PEBP1
collagen fibril organization (GO:0030199),2/89,0.809810759,0.873901392,0,0,0.65311805,0.137778315,P4HB;PPIB
second-messenger-mediated signaling (GO:0019932),2/89,0.809810759,0.873901392,0,0,0.65311805,0.137778315,PPP2CA;PPP2R1A
purine ribonucleotide biosynthetic process (GO:0009152),1/48,0.809839017,0.873901392,0,0,0.60484529,0.127573845,ACAT1
regulation of interleukin-2 production (GO:0032663),1/48,0.809839017,0.873901392,0,0,0.60484529,0.127573845,RPS3
cognition (GO:0050890),1/48,0.809839017,0.873901392,0,0,0.60484529,0.127573845,APP
inositol phosphate metabolic process (GO:0043647),1/48,0.809839017,0.873901392,0,0,0.60484529,0.127573845,CALM1
negative regulation of MAP kinase activity (GO:0043407),1/48,0.809839017,0.873901392,0,0,0.60484529,0.127573845,GSTP1
negative regulation of mitotic cell cycle (GO:0045930),1/48,0.809839017,0.873901392,0,0,0.60484529,0.127573845,CTNNB1
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.809839017,0.873901392,0,0,0.60484529,0.127573845,GSTP1
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.809839017,0.873901392,0,0,0.60484529,0.127573845,HMGB1
positive regulation of cell migration (GO:0030335),7/269,0.811556898,0.875405424,0,0,0.757752863,0.158219389,ITGB1;HSPA5;ACTN4;SOD2;S100A11;RTN4;ACTG1
protein complex oligomerization (GO:0051259),2/90,0.814723407,0.878428108,0,0,0.645662683,0.132300546,PDCD6IP;CHMP2A
cellular defense response (GO:0006968),1/49,0.816310459,0.878428108,0,0,0.592213618,0.120195991,ITGB1
response to glucose (GO:0009749),1/49,0.816310459,0.878428108,0,0,0.592213618,0.120195991,TRA2B
mitotic cytokinesis (GO:0000281),1/49,0.816310459,0.878428108,0,0,0.592213618,0.120195991,PDCD6IP
negative regulation of cell projection organization (GO:0031345),1/49,0.816310459,0.878428108,0,0,0.592213618,0.120195991,FKBP4
positive regulation of actin filament polymerization (GO:0030838),1/49,0.816310459,0.878428108,0,0,0.592213618,0.120195991,CTTN
neuron migration (GO:0001764),1/50,0.82256198,0.884450601,0,0,0.580097526,0.113311287,RAC1
positive regulation of ion transport (GO:0043270),1/50,0.82256198,0.884450601,0,0,0.580097526,0.113311287,KIF5B
regulation of angiogenesis (GO:0045765),5/203,0.823054236,0.884627732,0,0,0.716474837,0.139521424,ITGB1;RNH1;PDCD6;PGK1;CTNNB1
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),2/92,0.824209576,0.885165035,0,0,0.631248974,0.122039643,APP;MIF
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),2/92,0.824209576,0.885165035,0,0,0.631248974,0.122039643,HSP90AB1;CSNK2B
regulation of epithelial cell migration (GO:0010632),1/51,0.828601044,0.887411348,0,0,0.568466077,0.106880996,RTN4
regulation of smoothened signaling pathway (GO:0008589),1/51,0.828601044,0.887411348,0,0,0.568466077,0.106880996,VCP
gonad development (GO:0008406),1/51,0.828601044,0.887411348,0,0,0.568466077,0.106880996,CSDE1
inositol lipid-mediated signaling (GO:0048017),1/51,0.828601044,0.887411348,0,0,0.568466077,0.106880996,RHOA
sensory perception (GO:0007600),1/51,0.828601044,0.887411348,0,0,0.568466077,0.106880996,GNAS
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.828601044,0.887411348,0,0,0.568466077,0.106880996,RPS27L
positive regulation of fat cell differentiation (GO:0045600),1/51,0.828601044,0.887411348,0,0,0.568466077,0.106880996,HNRNPU
hemopoiesis (GO:0030097),2/94,0.833257174,0.89083342,0,0,0.617461948,0.112633057,GLRX5;ATF4
regulation of cell motility (GO:2000145),3/133,0.833878451,0.89083342,0,0,0.655131998,0.119016277,LMNA;RAC1;RHOA
ameboidal-type cell migration (GO:0001667),1/52,0.834434858,0.89083342,0,0,0.557290763,0.100869962,PDXDC1
regulation of exocytosis (GO:0017157),1/52,0.834434858,0.89083342,0,0,0.557290763,0.100869962,RAB10
response to peptide hormone (GO:0043434),1/52,0.834434858,0.89083342,0,0,0.557290763,0.100869962,EIF6
negative regulation of BMP signaling pathway (GO:0030514),1/52,0.834434858,0.89083342,0,0,0.557290763,0.100869962,UBE2D3
negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.834434858,0.89083342,0,0,0.557290763,0.100869962,ACADL
positive regulation of developmental growth (GO:0048639),1/52,0.834434858,0.89083342,0,0,0.557290763,0.100869962,PPIB
bicellular tight junction assembly (GO:0070830),1/53,0.840070391,0.894022902,0,0,0.546545269,0.095246221,PDCD6IP
cardiac muscle tissue development (GO:0048738),1/53,0.840070391,0.894022902,0,0,0.546545269,0.095246221,NDUFV2
cellular macromolecule catabolic process (GO:0044265),1/53,0.840070391,0.894022902,0,0,0.546545269,0.095246221,SND1
regulation of immune effector process (GO:0002697),1/53,0.840070391,0.894022902,0,0,0.546545269,0.095246221,PHB2
epidermal cell differentiation (GO:0009913),1/53,0.840070391,0.894022902,0,0,0.546545269,0.095246221,CTNNB1
heart morphogenesis (GO:0003007),1/53,0.840070391,0.894022902,0,0,0.546545269,0.095246221,FKBP1A
positive regulation of B cell activation (GO:0050871),1/53,0.840070391,0.894022902,0,0,0.546545269,0.095246221,MIF
positive regulation of phagocytosis (GO:0050766),1/53,0.840070391,0.894022902,0,0,0.546545269,0.095246221,CALR
positive regulation of transcription by RNA polymerase II (GO:0045944),26/908,0.841345996,0.89502778,0,0,0.832394009,0.143797975,ARF4;RNF10;APP;DDX3X;HNRNPU;PARK7;YBX1;HMGB1;CHCHD2;UBB;PCBP1;UBC;RPS27A;EIF5A;NPM1;CNBP;PTOV1;SMARCA5;NME2;DRAP1;PSMC3;CTNNB1;TCEA1;UBA52;SQSTM1;ATF4
regulation of humoral immune response (GO:0002920),1/54,0.84551437,0.898047312,0,0,0.536205265,0.089980667,PHB2
regulation of megakaryocyte differentiation (GO:0045652),1/54,0.84551437,0.898047312,0,0,0.536205265,0.089980667,EIF6
cytoplasmic microtubule organization (GO:0031122),1/54,0.84551437,0.898047312,0,0,0.536205265,0.089980667,RHOA
negative regulation of viral genome replication (GO:0045071),1/54,0.84551437,0.898047312,0,0,0.536205265,0.089980667,BANF1
negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.850773299,0.903277783,0,0,0.526248225,0.085046754,GSTP1
positive regulation of stress-activated MAPK cascade (GO:0032874),2/99,0.854063099,0.906178044,0,0,0.585481734,0.092359862,APP;HMGB1
protein dephosphorylation (GO:0006470),3/139,0.855160626,0.906178044,0,0,0.626033328,0.097952906,PPP1CB;PPP2CA;PPP2R1A
negative regulation of multicellular organismal process (GO:0051241),5/214,0.855819399,0.906178044,0,0,0.678375193,0.105620241,PPP2CA;GSK3B;RHEB;CALR;ATF4
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/56,0.855853458,0.906178044,0,0,0.516653258,0.080420237,RPL26
sensory organ development (GO:0007423),1/56,0.855853458,0.906178044,0,0,0.516653258,0.080420237,RAB18
telomere maintenance (GO:0000723),1/56,0.855853458,0.906178044,0,0,0.516653258,0.080420237,PTGES3
positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.855853458,0.906178044,0,0,0.516653258,0.080420237,APP
protein localization to cell periphery (GO:1990778),3/140,0.85846649,0.908588554,0,0,0.621431348,0.094835167,RAB10;BSG;TMED2
icosanoid metabolic process (GO:0006690),1/57,0.860760915,0.909947253,0,0,0.507400969,0.076078938,GPX4
positive regulation of cell junction assembly (GO:1901890),1/57,0.860760915,0.909947253,0,0,0.507400969,0.076078938,RAC1
positive regulation of interferon-gamma production (GO:0032729),1/57,0.860760915,0.909947253,0,0,0.507400969,0.076078938,HSPD1
calcium-mediated signaling (GO:0019722),2/102,0.865382167,0.912102865,0,0,0.567828656,0.082098971,BCAP31;ATP2A2
positive regulation of vasculature development (GO:1904018),2/102,0.865382167,0.912102865,0,0,0.567828656,0.082098971,ITGB1;PDCD6
regulation of calcium ion transport (GO:0051924),1/58,0.865501534,0.912102865,0,0,0.498473322,0.072002543,CTNNB1
regulation of neurotransmitter receptor activity (GO:0099601),1/58,0.865501534,0.912102865,0,0,0.498473322,0.072002543,APP
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/58,0.865501534,0.912102865,0,0,0.498473322,0.072002543,CSNK2B
eye development (GO:0001654),1/58,0.865501534,0.912102865,0,0,0.498473322,0.072002543,RAB18
fat cell differentiation (GO:0045444),1/58,0.865501534,0.912102865,0,0,0.498473322,0.072002543,CTBP1
membrane lipid biosynthetic process (GO:0046467),1/58,0.865501534,0.912102865,0,0,0.498473322,0.072002543,VAPA
negative regulation of cytokine production (GO:0001818),4/182,0.869663141,0.915856867,0,0,0.637303371,0.088998993,ANXA4;TAX1BP1;HMGB1;RAC1
regulation of secretion by cell (GO:1903530),1/59,0.870080978,0.915856867,0,0,0.489853525,0.068172422,RAB10
mitotic DNA damage checkpoint signaling (GO:0044773),1/59,0.870080978,0.915856867,0,0,0.489853525,0.068172422,RPS27L
regulation of insulin secretion (GO:0050796),2/104,0.87247493,0.917661521,0,0,0.556636835,0.075937154,GLUD1;HADH
steroid metabolic process (GO:0008202),2/104,0.87247493,0.917661521,0,0,0.556636835,0.075937154,SCP2;FDX1
positive regulation of cell motility (GO:2000147),5/221,0.8739169,0.918365192,0,0,0.656150401,0.088429381,ITGB1;HSPA5;ACTN4;SOD2;ACTG1
cellular response to chemokine (GO:1990869),1/60,0.874504718,0.918365192,0,0,0.481525924,0.064571466,RHOA
response to organic cyclic compound (GO:0014070),1/60,0.874504718,0.918365192,0,0,0.481525924,0.064571466,CTNNB1
Notch signaling pathway (GO:0007219),1/60,0.874504718,0.918365192,0,0,0.481525924,0.064571466,YBX1
positive regulation of cell differentiation (GO:0045597),6/258,0.874843998,0.918365192,0,0,0.67462676,0.090204139,CDC42;HSP90AB1;CTNNA1;CTNNB1;PA2G4;RHOA
regulation of JNK cascade (GO:0046328),2/105,0.875890902,0.919106964,0,0,0.551203912,0.07304209,APP;HMGB1
regulation of endocytosis (GO:0030100),1/61,0.878778042,0.92142061,0,0,0.47347591,0.061183942,AP2S1
negative regulation of response to stimulus (GO:0048585),1/61,0.878778042,0.92142061,0,0,0.47347591,0.061183942,YBX1
protein processing (GO:0016485),2/106,0.879222361,0.921528753,0,0,0.545875469,0.070263694,SPCS1;METAP2
regulation of cytosolic calcium ion concentration (GO:0051480),3/148,0.882611849,0.924313667,0,0,0.586900633,0.073286139,YWHAE;BCAP31;HMGB1
regulation of neurogenesis (GO:0050767),1/62,0.882906057,0.924313667,0,0,0.46568983,0.05799537,CTNNB1
response to retinoic acid (GO:0032526),1/62,0.882906057,0.924313667,0,0,0.46568983,0.05799537,NDUFA13
anterior/posterior pattern specification (GO:0009952),1/63,0.886893697,0.927769123,0,0,0.458154915,0.054992403,ATP6AP2
negative regulation of endopeptidase activity (GO:0010951),1/63,0.886893697,0.927769123,0,0,0.458154915,0.054992403,GAPDH
regulation of GTPase activity (GO:0043087),4/189,0.887627316,0.927895308,0,0,0.612964965,0.073067455,ITGB1;GSK3B;TMED2;SOD1
regulation of cytokine production (GO:0001817),3/150,0.888044935,0.927895308,0,0,0.578855211,0.068729178,MIF;GAPDH;SOD1
response to cytokine (GO:0034097),3/150,0.888044935,0.927895308,0,0,0.578855211,0.068729178,APP;DDOST;RHOA
regulation of cell migration (GO:0030334),10/408,0.889980619,0.929558257,0,0,0.710690974,0.082835007,ITGB1;HSPA5;TPM1;LMNA;ACTN4;MIF;RAC1;SOD2;RHOA;ACTG1
lipid homeostasis (GO:0055088),1/64,0.890745727,0.929863955,0,0,0.450859203,0.052162729,DDX3X
innate immune response (GO:0045087),7/302,0.890961834,0.929863955,0,0,0.671822034,0.077564331,APP;PPP1R14B;DDX3X;PHB;HMGB1;PHB2;RPL39
negative regulation of cell differentiation (GO:0045596),4/191,0.892346605,0.93094947,0,0,0.606345811,0.069063183,PPP2CA;HNRNPU;ANP32B;CALR
BMP signaling pathway (GO:0030509),1/65,0.894466754,0.931003739,0,0,0.443791482,0.049494974,DDX5
regulation of cellular catabolic process (GO:0031329),1/65,0.894466754,0.931003739,0,0,0.443791482,0.049494974,VPS29
chemical homeostasis (GO:0048878),1/65,0.894466754,0.931003739,0,0,0.443791482,0.049494974,DDX3X
inorganic anion transmembrane transport (GO:0098661),1/65,0.894466754,0.931003739,0,0,0.443791482,0.049494974,SLC25A3
steroid biosynthetic process (GO:0006694),1/65,0.894466754,0.931003739,0,0,0.443791482,0.049494974,SCP2
tRNA modification (GO:0006400),1/65,0.894466754,0.931003739,0,0,0.443791482,0.049494974,SSB
dephosphorylation (GO:0016311),3/153,0.895773545,0.932004755,0,0,0.567189349,0.062429192,PPP1CB;PPP2CA;PPP2R1A
protein-containing complex subunit organization (GO:0043933),2/112,0.897534908,0.932947452,0,0,0.515939304,0.055774723,PPP2R1A;ST13
phosphatidylinositol metabolic process (GO:0046488),2/112,0.897534908,0.932947452,0,0,0.515939304,0.055774723,ARF1;RAB14
cellular component disassembly (GO:0022411),1/66,0.898061227,0.932947452,0,0,0.43694123,0.046978624,BSG
extracellular matrix disassembly (GO:0022617),1/66,0.898061227,0.932947452,0,0,0.43694123,0.046978624,BSG
"positive regulation of transcription, DNA-templated (GO:0045893)",33/1183,0.900489909,0.935110821,0,0,0.807165164,0.084604082,ARF4;RNF10;APP;ENY2;DDX3X;HNRNPU;PARK7;PHB;YBX1;HMGB1;CHCHD2;UBB;SFR1;PCBP1;UBC;RPS27A;EIF5A;NPM1;CNBP;ALYREF;PTOV1;SMARCA5;NME2;EDF1;HNRNPAB;DRAP1;PSMC5;PSMC3;CTNNB1;TCEA1;UBA52;SQSTM1;ATF4
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/67,0.901533443,0.935834677,0,0,0.430298561,0.044603948,CDC42
peptidyl-serine phosphorylation (GO:0018105),3/156,0.903019523,0.936679924,0,0,0.555980972,0.056716234,GSK3B;CSNK1A1;TOP1
negative regulation of cell motility (GO:2000146),2/114,0.90304129,0.936679924,0,0,0.506673349,0.051674096,TPM1;MIF
positive regulation of MAP kinase activity (GO:0043406),1/69,0.908127574,0.94101978,0,0,0.417599341,0.04024422,RPS3
ion transport (GO:0006811),2/116,0.90827048,0.94101978,0,0,0.497732514,0.047888368,VDAC2;VDAC1
positive regulation of angiogenesis (GO:0045766),2/116,0.90827048,0.94101978,0,0,0.497732514,0.047888368,ITGB1;PDCD6
response to lipopolysaccharide (GO:0032496),3/159,0.90980771,0.942251007,0,0,0.545203687,0.051533748,GSTP1;HMGB1;RHOA
sterol metabolic process (GO:0016125),1/70,0.911257375,0.943029184,0,0,0.411525801,0.038243052,FDX1
wound healing (GO:0042060),1/70,0.911257375,0.943029184,0,0,0.411525801,0.038243052,TPM1
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),2/118,0.913234881,0.944348826,0,0,0.489099985,0.044391775,GNB1;GNAS
cellular response to BMP stimulus (GO:0071773),1/71,0.914280704,0.944348826,0,0,0.40562579,0.036351226,DDX5
cholesterol homeostasis (GO:0042632),1/71,0.914280704,0.944348826,0,0,0.40562579,0.036351226,CNBP
gland development (GO:0048732),1/71,0.914280704,0.944348826,0,0,0.40562579,0.036351226,SOD1
phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.914280704,0.944348826,0,0,0.40562579,0.036351226,RHOA
sterol homeostasis (GO:0055092),1/72,0.917201175,0.946641335,0,0,0.399891977,0.034562042,CNBP
negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.917201175,0.946641335,0,0,0.399891977,0.034562042,MAGED1
regulation of hydrolase activity (GO:0051336),1/73,0.920022285,0.947214255,0,0,0.394317437,0.032869271,SOD1
defense response to Gram-negative bacterium (GO:0050829),1/73,0.920022285,0.947214255,0,0,0.394317437,0.032869271,ROMO1
regulation of Rho protein signal transduction (GO:0035023),1/73,0.920022285,0.947214255,0,0,0.394317437,0.032869271,RAC1
negative regulation of cell adhesion (GO:0007162),1/73,0.920022285,0.947214255,0,0,0.394317437,0.032869271,RHOA
neurotransmitter transport (GO:0006836),1/73,0.920022285,0.947214255,0,0,0.394317437,0.032869271,HSPA8
heart development (GO:0007507),3/164,0.920169289,0.947214255,0,0,0.528134073,0.043939496,FKBP1A;TCF25;NDUFV2
cellular response to interferon-gamma (GO:0071346),2/121,0.920211109,0.947214255,0,0,0.476695257,0.039638245,RPL13A;GAPDH
regulation of peptide hormone secretion (GO:0090276),1/74,0.922747408,0.94910158,0,0,0.388895624,0.031267109,HADH
sphingolipid biosynthetic process (GO:0030148),1/74,0.922747408,0.94910158,0,0,0.388895624,0.031267109,VAPA
positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.925379806,0.951084801,0,0,0.383620346,0.029750151,MIF
positive regulation of T cell activation (GO:0050870),1/75,0.925379806,0.951084801,0,0,0.383620346,0.029750151,HSPD1
fatty acid metabolic process (GO:0006631),2/124,0.926657123,0.951887209,0,0,0.464900598,0.03541225,GPX4;NDUFAB1
proteolysis (GO:0006508),6/287,0.927471892,0.951887209,0,0,0.604083273,0.045483115,PSMA6;PSMB5;SPCS1;NEDD8;CTSB;METAP2
"DNA-templated transcription, initiation (GO:0006352)",3/168,0.927663208,0.951887209,0,0,0.515223238,0.038686328,SMARCA5;POLR2F;POLR2L
regulation of BMP signaling pathway (GO:0030510),1/76,0.92792263,0.951887209,0,0,0.378485742,0.028313354,UBE2D3
phospholipid metabolic process (GO:0006644),1/76,0.92792263,0.951887209,0,0,0.378485742,0.028313354,GPX4
peptidyl-serine modification (GO:0018209),3/169,0.929433073,0.952904262,0,0,0.51209275,0.037475192,GSK3B;CSNK1A1;TOP1
cholesterol metabolic process (GO:0008203),1/77,0.930378922,0.952904262,0,0,0.37348626,0.026952013,FDX1
inorganic cation import across plasma membrane (GO:0098659),1/77,0.930378922,0.952904262,0,0,0.37348626,0.026952013,ATP1A1
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.930378922,0.952904262,0,0,0.37348626,0.026952013,NEDD4
phosphatidylinositol biosynthetic process (GO:0006661),2/126,0.930678062,0.952904262,0,0,0.457354553,0.032857202,ARF1;RAB14
positive regulation of signal transduction (GO:0009967),5/252,0.932587125,0.954053486,0,0,0.572868487,0.039982038,CD63;ATP6AP2;RPS3;PHB;ATP6V0C
negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.932751624,0.954053486,0,0,0.368616634,0.025661736,GSTP1
positive regulation of nucleic acid-templated transcription (GO:1903508),12/511,0.932860146,0.954053486,0,0,0.678610595,0.047163427,RNF10;PSMC5;ENY2;NPM1;SFR1;CNBP;NME2;CTNNB1;EDF1;PHB;HNRNPAB;ATF4
glycerophospholipid metabolic process (GO:0006650),1/80,0.937257522,0.958187951,0,0,0.359247228,0.023278214,PRDX6
cell-cell junction organization (GO:0045216),1/82,0.941461911,0.962122067,0,0,0.350340508,0.021133025,CTNNA1
glycerophospholipid biosynthetic process (GO:0046474),3/177,0.942220914,0.962533544,0,0,0.488344215,0.029064058,ARF1;RAB14;CSNK2B
defense response to virus (GO:0051607),2/133,0.943169653,0.963138462,0,0,0.432757901,0.025320277,PHB;PHB2
organic substance transport (GO:0071702),2/136,0.947840513,0.967542413,0,0,0.423003153,0.022659867,CHMP2A;HSP90B1
response to interleukin-1 (GO:0070555),1/86,0.94904541,0.968406367,0,0,0.333784487,0.017456472,APP
sodium ion transmembrane transport (GO:0035725),1/87,0.950782716,0.969812733,0,0,0.329886122,0.016649261,ATP1A1
transcription initiation from RNA polymerase II promoter (GO:0006367),2/140,0.953501783,0.97221907,0,0,0.410656562,0.019552995,POLR2F;POLR2L
positive regulation of inflammatory response (GO:0050729),1/89,0.954081883,0.972443459,0,0,0.322355189,0.015152557,APP
cellular response to DNA damage stimulus (GO:0006974),7/350,0.955132253,0.973146819,0,0,0.576348397,0.02645754,DDB1;NPM1;VCP;SUMO1;RPS3;UBA1;PARK7
sodium ion transport (GO:0006814),1/90,0.955647697,0.973304838,0,0,0.318716648,0.014458884,NDUFA9
nitrogen compound transport (GO:0071705),2/143,0.957357332,0.97449597,0,0,0.401856333,0.017512324,CHMP2A;HSP90B1
inorganic cation transmembrane transport (GO:0098662),5/274,0.957970208,0.97449597,0,0,0.52541008,0.022560373,FKBP1A;ATP2A2;ATP1A1;ATP6V0C;ATP6V1F
positive regulation of MAPK cascade (GO:0043410),5/274,0.957970208,0.97449597,0,0,0.52541008,0.022560373,APP;MIF;PHB;HMGB1;PHB2
regulation of endothelial cell proliferation (GO:0001936),1/92,0.958621175,0.97449597,0,0,0.311679471,0.013171357,PDCD6
regulation of lipid metabolic process (GO:0019216),1/92,0.958621175,0.97449597,0,0,0.311679471,0.013171357,EDF1
plasma membrane bounded cell projection assembly (GO:0120031),5/278,0.961516108,0.977071109,0,0,0.51760307,0.020312795,ITGB1;ARF4;GOLPH3;RAC1;DYNLL1
positive regulation of cytosolic calcium ion concentration (GO:0007204),2/147,0.962024336,0.977219906,0,0,0.390689146,0.015125738,BCAP31;HMGB1
regulation of intracellular signal transduction (GO:1902531),9/437,0.963175891,0.978021835,0,0,0.592959269,0.022247378,CDC42;RPL5;RPL11;CSNK2B;ATP6AP2;RBBP7;RAC1;SQSTM1;RHOA
phosphorylation (GO:0016310),8/400,0.963993352,0.978484045,0,0,0.575717023,0.02111205,APP;GSK3B;CTBP1;CSNK1A1;CDK4;PGK1;TOP1;YWHAZ
regulation of MAP kinase activity (GO:0043405),1/97,0.96521274,0.979353723,0,0,0.295369346,0.010458067,GSTP1
positive regulation of defense response (GO:0031349),1/98,0.966399447,0.9801896,0,0,0.292309096,0.009990547,APP
sensory perception of chemical stimulus (GO:0007606),1/99,0.967545725,0.98098386,0,0,0.2893113,0.00954513,GNAS
organic acid transport (GO:0015849),1/100,0.968652951,0.981737944,0,0,0.286374065,0.009120694,GOT2
axon guidance (GO:0007411),3/203,0.970415524,0.983155413,0,0,0.424282544,0.012741597,KIF5B;BSG;RAC1
cellular response to growth factor stimulus (GO:0071363),2/158,0.972465456,0.984692699,0,0,0.362932243,0.010133331,EEF1A1;CTNNB1
regulation of inflammatory response (GO:0050727),3/206,0.972662022,0.984692699,0,0,0.417946775,0.011584905,APP;PSMA6;PARK7
cellular response to peptide hormone stimulus (GO:0071375),1/106,0.97454753,0.985862501,0,0,0.269925551,0.006959217,RAB10
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.97454753,0.985862501,0,0,0.269925551,0.006959217,NEDD4
extracellular matrix organization (GO:0030198),5/300,0.97656496,0.987533492,0,0,0.478448926,0.011345941,ITGB1;APP;BSG;P4HB;PPIB
response to tumor necrosis factor (GO:0034612),1/110,0.977848434,0.98846131,0,0,0.259965901,0.005823391,RPS3
extracellular structure organization (GO:0043062),3/216,0.979038277,0.989293822,0,0,0.39811651,0.008433915,ITGB1;APP;BSG
external encapsulating structure organization (GO:0045229),3/217,0.97959154,0.989482703,0,0,0.396235414,0.008170212,ITGB1;APP;BSG
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/170,0.980692064,0.98988395,0,0,0.336797496,0.006566463,ITGB1;BSG
response to lipid (GO:0033993),1/114,0.980721751,0.98988395,0,0,0.250711358,0.004880472,CTNNB1
cation transport (GO:0006812),2/174,0.982861631,0.991673241,0,0,0.328896293,0.005685607,NDUFA9;NDFIP1
defense response to bacterium (GO:0042742),2/176,0.983855742,0.992305586,0,0,0.32508192,0.005291032,ROMO1;RPL39
regulation of immune response (GO:0050776),2/179,0.985242658,0.99333349,0,0,0.319521985,0.004750434,ITGB1;FKBP1A
inflammatory response (GO:0006954),3/230,0.985628482,0.99335169,0,0,0.373289367,0.005403658,PRDX5;RAC1;HMGB1
circulatory system development (GO:0072359),1/126,0.987294531,0.994659652,0,0,0.226501475,0.002896246,TCF25
cellular response to metal ion (GO:0071248),1/131,0.989321416,0.996330032,0,0,0.217733152,0.002337585,SUMO1
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.99037901,0.997023372,0,0,0.212788609,0.002057149,MIF
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.991025284,0.997082443,0,0,0.209614334,0.001889722,GNB1
regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.991331972,0.997082443,0,0,0.208062207,0.001811351,GNB1
positive regulation of response to external stimulus (GO:0032103),1/139,0.9919143,0.997082443,0,0,0.205025437,0.001664513,APP
potassium ion transmembrane transport (GO:0071805),1/139,0.9919143,0.997082443,0,0,0.205025437,0.001664513,ATP1A1
generation of neurons (GO:0048699),2/202,0.992639724,0.997440437,0,0,0.282437223,0.002086504,CTNNB1;RAC1
chemical synaptic transmission (GO:0007268),4/306,0.993240759,0.99767322,0,0,0.373195977,0.002531085,NAPA;HSPA8;CALM1;GABARAP
negative regulation of inflammatory response (GO:0050728),2/212,0.994579577,0.998334655,0,0,0.268847155,0.001461229,GSTP1;GNB1
positive regulation of GTPase activity (GO:0043547),2/214,0.994902441,0.998334655,0,0,0.266282991,0.001360865,ITGB1;GSK3B
protein phosphorylation (GO:0006468),8/496,0.995008105,0.998334655,0,0,0.460115805,0.002302602,APP;GSK3B;CTBP1;CSNK1A1;CDK4;CSNK2B;TOP1;YWHAZ
protein autophosphorylation (GO:0046777),1/159,0.99596752,0.998726688,0,0,0.178886151,7.23E-04,GSK3B
cilium organization (GO:0044782),2/228,0.996690124,0.998726688,0,0,0.24960458,8.28E-04,ARF4;DYNLL1
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.996727392,0.998726688,0,0,0.172287575,5.65E-04,GNAS
neuron differentiation (GO:0030182),1/174,0.997607466,0.998726688,0,0,0.163247907,3.91E-04,CTNNB1
negative regulation of immune response (GO:0050777),1/178,0.997918415,0.998726688,0,0,0.159525357,3.32E-04,GNB1
nervous system development (GO:0007399),6/447,0.997985736,0.998726688,0,0,0.381680161,7.70E-04,COX7B;GSTP1;NDUFS2;SDHA;NDUFV2;ITM2B
anterograde trans-synaptic signaling (GO:0098916),2/244,0.997987164,0.998726688,0,0,0.232906479,4.69E-04,CALM1;GABARAP
regulation of transcription by RNA polymerase II (GO:0006357),47/2206,0.999906045,0.999986489,0,0,0.591147742,5.55E-05,ARF4;RNF10;APP;ENY2;DDX5;DDX3X;RPL10;CTBP1;TCF25;UBE2D3;HNRNPU;NUCKS1;ENO1;PARK7;PHB;YBX1;HMGB1;HSPD1;RPS14;CHCHD2;SUMO1;UBB;PCBP1;UBC;RPS27A;EIF5A;NPM1;HSBP1;RPL23;ANXA4;CNBP;PTOV1;SMARCA5;NME2;SOD2;DRAP1;PSMC5;HNRNPK;PSMC3;CDK4;CTNNB1;TCEA1;HDGF;CALR;UBA52;SQSTM1;ATF4
"regulation of transcription, DNA-templated (GO:0006355)",44/2244,0.999986489,0.999986489,0,0,0.539244094,7.29E-06,RNF10;ENY2;NDUFA13;DDX5;SET;CTBP1;MAGED1;HP1BP3;NUCKS1;ENO1;PHB;YBX1;HMGB1;PHB2;RPL6;UBE2L3;HSPD1;PPP2CA;HINT1;SUMO1;YWHAQ;SFR1;PPP2R1A;POLR2L;HSPA8;NPM1;ANXA4;CNBP;SMARCA5;NME2;EDF1;PA2G4;SOD2;HNRNPAB;MLF2;DRAP1;PSMC5;DAP;HNRNPK;CTNNB1;HDGF;CALR;PFDN5;ATF4
